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Separation of mitogenic fraction (PH-I) from PseudostelJLaria 
heterophylla and characterization of its biological activities 
were attained. PH-I is a water-soluble substance consisting of 
mainly carbohydrates, a small amount of proteins and uronic acid. 
PH-I was found to be a polyclonal mitogen of murine B lymphocytes 
and exhibited co-mitogenic activity on Con A-stimulated 
lymphocytes in vitro. PH-I can act as an adjuvant for the 
primary antibody response to SRBC in vivo. PH-I could upregulate 
the expression of interleukin-2 (IL-2) receptors on mouse 
lymphocytes but failed to trigger 工 L j - 2 release from lymphocytes 
in vi tro. The mitogenic activity of PH-I has been attributed to 
its polysaccharide components rather than due to contamination 
by bacterial lipopolysaccharides (LPS)• 
PH-I was also found to be an activator of murine peritoneal 
macrophages. Itf could enhance the cytostatic activity of 
picolinic acid-activated peritoneal macrophages on MBL-2 tumor 
and upregulate the transcription of E>-actin gene in peritoneal 
macrophages. Moreover, PH-I could act as a priming agent rather 
than an eliciting agent for the release of tumor necrosis factor-
a (TNF-a) in mice, and it exhibited potent anti—tumor activity 
against Ehrlich ascites tumor (EAT) cells in vivo but not in 
vitro. Collectively, the data suggest that the anti - t u m o r 
activity of PH—工 was mediated by stimulation of the host's immune 
system rather than resulting from the direct suppressive effect 
工 
Abstract 
of PH-工 on the tumor cells. 
) 
PH-工 could be separated by Sephadex G-lOO column 
chromatography into three fractions : PH-工 A, PH-工 B and PH-工 C. 
PH-工 A , PH-I B and PH-I C could be further separated into PH-工 
Aa and PH-I Ab; PH-工 Ba and PH-工 Bb as well as PH-工 Ca and PH-I 
Cb respectively by DEAE anion-exchange chromatography. All these 
fractions contained mainly carbohydrates and small amount of 
proteins. Therefore, these bioactive fractions were believed to 
be polysaccharides or proteoglycans. Molecular weights of PH-I 
A, PH-I B and PH-I C were estimated to be 40,000, 9,500-5, 000 and 
5,000 respectively. 
PH-I, PH-I A, PH-I B and PH-I C： showed no bio-toxicity by 
the brine shrimp assay. The acidic fraction PH-I Ab displayed 
the most potent mitogenic activity on murine B lymphocytes among 
all fractions tested. The potent mitogenic activity of PH-I Ab 
may be related to its high molecular weight (40,000) acidic 
carbohydrates. The primary antibody response to sheep 
erythrocytes was also markedly augmented by i.p. injection with 
PH-I Ab into mice. 
PH-I Ba exhibited a stimulating effect on the proliferation 
of mouse bone marrow cells and induced differentiation of these 
cells into macrophage-like cells in vitro. The stimulation of 
mouse marrow haematopoiesis by PH-I Ba may be related, at least 
in part, to the autocrine or paracrine stimulation by 
工工 
Abstract 
granulocyte-macrophage colony-stimulating factor (GM-CSF) 
released from the PH-工 Ba stimulated bone marrow cells in vitro. 
On the other hand, PH-工，PH-工 A, PH-I B and PH-工 Ab were found 
to induce the differentiation of myeloid leukaemia Ml cells to 
macrophage-like cells in vitro. 
PH-I C and PH-I Cb could markedly suppress the growth of EAT 
cells in vivo but not in vi tro. After i .p. injection into mice, 
PH-I C could activate the phagocytic activity of thioglycollate-
elicited peritoneal macrophages. Moreover, PH-I C showed a 
potent activating effect on natural killer (NK) cells and 
increased the number of tumor infiltrating lymphocytes (TILs) in 
the tumor site of WEHI-164-bearing mice. In addition, PH-工 C 
could increase the MurIL-2-induced lymphokine activated killer 
cell (LAK) activity in vitro and enhance LAK cell activity in 
EAT-bearing mice. 
The effects of the anti-tumor fractions (i.e. PH_I C and PH_ 
工 Cb) on cytokine production were examined. The data show that 
both fractions stimulated the release of TNF-a and interleukin-1 
(IL一1)一like substance release from peritoneal macrophages in 
vi tro. Moreover, intravenously (i.v. ) administration of PH-I C 
and PH-I Cb into mice induced TNF-a and interf e r o n - g a m m a ( 工 F N -
gamma) formation in the sera and ascitic fluids of EAT-bearing 
mice. The proliferation of EAT cells was found to be 
significantly suppressed after the administration of these 
fractions. 
工 工 I 
Abstract 
TNF-a eliciting activity of PH-工 C and its subfraction PH-I 
Cb is likely due to the uronic acidic structure of a polymer 
having 1,3 linkage. These results, when taken together, suggest 
that the potent anti-tumor activity of PH-I C and PH-工 Cb may be 
related to their capacity to stimulate cytokine ( 工 L - 1 , TNF-a and 
IFN-gamma) production as well as the activation of macrophages, 
cytotoxic T cells, NK cells, LAK cells and TILs in vivo rather 
than due to the direct cytotoxicity of the fractions on the tumor 
cells. Finally, P. heterophylla fractions were found to exhibit 
significant immunorestorative activity in EAT-bearing mice, aged 
mice and cyclophosphamide (CY)-treated mice. 
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People have a long history of using herbal remedies, yet 
plants are relatively unexploited sources of medicines in the 
developed world. Augmentation of utilisation of indigenous plant 
medicines in developing countries became a World Health 
Organization policy in the 1970s (Phillips, 1992). Over three-
quarters of a million plant species are now awaiting 
investigation of their therapeutic potential (Farnsworth, 1981, 
1984) . In developing countries, people are dependent on natural 
sources of medicines, and many people in these countries are 
still using these treatments. Evidence indicates that the use 
of plants as medicines dated back from the earliest years of 
man's evolution. Almost 400 plants were recorded as Chinese 
herbal drugs at 2800 BC • Consumption of medicinal plants has 
almost doubled . in Western Europe after 1945. Major 
pharmaceutical companies are showing renewed interest in higher 
plants as a source for new leading medicine. National cancer 
institute of the United States screened some 35,000 plant species 
for anti-tumor activity from 1957 to 1981 and is processing to 
acquire some 2000 tropical species from Latin America, Africa and 
southeast Asia (Hamburger and Hostettmann, 1991). 
It is generally believed that the application of tonic 
Chinese medicinal herbs may enhance the body resistance and is 
1 
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likely to be beneficial to the anti-neoplastic therapy. 
Recently, it has been found that many Chinese herbal medicines 
with tonic effects can modulate immunologic functions (Kumazawa 
et al. , 1982； Zhao et al. , 1990) • Moreover, some of the Chinese 
herbs serve as an inhibitor or killer of the tumor cells (Ebina 
and Kohya, 1988; Kumazawa et al. , 1982; Miyazaki et al, , 1979). 
It is likely that most of the anti-tumor activities of Chinese 
herb are mediated by the immune system of the host. Therefore, 
the search for novel, safe and effective immunomodulatory 
compounds, especially biological response modifiers (e.g. 
polysaccharides), with therapeutic potentials for the treatment 
of cancer, has become a major goal of my research. 
In the first part of this introductory chapter, the major 
effector cell types that mediate anti-tumor immunity will be 
reviewed. This is followed by a brief overview on the biological 
response modifiers as a new modality for the immunotherapy of 
cancer. Moreover,, the anti-tumor activities of various cytokines 
and their therapeutic use as biological response modifiers will 
be discussed. Finally, the immunomodulatory activities and 
potential use of bioactive polysaccharides from Chinese medicinal 
herbs as biological response modifiers in the treatment of cancer 
will be highlighted. Because of the vast literature in these 
areas, the discussion that follows is neither intended to be 
comprehensive nor referenced in every details. Only those topics 




1.1 EFFECTOR CELLS MEDIATING ANTI-TUMOR IMMUNITY 
The immune system is the body's defence system which 
consists of a number of organs and various cell types which have 
evolved to fight against invading microorganisms as well as 
attacking malignant cells and other foreign cells. The cells of 
the immune system arise from pluripotent stem cells through two 
main lines of differentiation： the lymphoid lineage producing 
lymphocytes and the myeloid lineage producing phagocytes 
including monocytes and polymorphonuclear granulocytes 
(neutrophils, eosinophils and basophils) (Hillman et al. , 1992). 
Cytotoxic T lymphocytes appear to be the most important killer 
cells. Other lymphatic cells, such as natural killer (NK) cells 
and lymphokine-activated killer (LAK) cells, tumor infiltrating 
lymphocytes (TILs) as well as macrophages are also highly 
effective in the lysis of certain tumor targets. Although the 
immune surveillance mechanisms involving the above effector 
cells, tumor cells often do escape destruction and kill the host. 
The failure of immunosurveillance may be due to the antigenic 
heterogeneity of the original tumor, the shedding of tumor 
antigens, and host-mediated immunosuppression. The aim of tumor 
immunology research therefore include the elucidation of the 
mechanism(s) of tumor cell destruction by cytotoxic effector 
cells, its regulation, and the development of methods for 
increasing cellular immunity to tumors suitable for clinical 
application (Hillman et al., 1992). 
3 
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1.1.1 CYTOTOXIC T LYMPHOCYTES 
Cytotoxic T lymphocytes (CTLs) are a subpopulation of T 
cells with immunological specificity for antigens expressed by 
virus-infected cells, tumor cells or even parasites (Katz, 1977). 
The majority of CTLs express the CDS molecule and specifically 
recognize foreign peptides derived from intracellular ly 
synthesized antigens associated with self class 工 MHC molecules. 
The function of differentiated CTLs involves the lysis of target 
cells. The mechanism of CTL mediated anti-tumor lysis involves 
three key features ： (1) CTL killing is antigen-specific, (2) CTL 
killing requires cell contact, (3) CTLs themselves are not 
injured during lysis of target cells. The lysis process includes 
two parallel sets of changes. Firstly, CTLs develop specific 
membrane-bound cytoplasmic granules. These granules contain 
several macromolecules, including a membrane pore-forming protein 
called perforin or cytolysin; a series of enzymes (serine 
esterases) that contain reactive serines in their active site; 
a protein toxin, which is either identical or structurally 
related to lymphotoxin (LT)； and proteoglycans. Secondly, 
activated CTLs develop the capacity to transcribe and secrete 
cytokines such as 工 F N - g a m m a , LT and other proteins to kill the 
tumor cells (Groscurth, 1989)• 
1.1.2 MACROPHAGES 
Macrophages are potentially important cellular mediators of 
4 
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anti-tumor immunity. The activated macrophages preferentially 
recognize and destroy tumor cells and not normal cells in vitro 
(Adams and Somers, 1985; Keller et al. , 1986) . They also express 
class 工工 MHC antigens and act as antigen-presenting cells for T 
cells. Macrophages can be activated by lymphokines released by 
antigen-activated T lymphocytes . Activated macrophages can cause 
the lysis of target cells by antibody-dependent cell cytotoxicity 
(ADCC) in which antibodies are directed against specific cell 
surface molecules. Macrophages express FcT receptors and they 
can be targeted to tumor cells coated with antibody. A variety 
of macrophage products, such as proteases (Adams, 1980), 
interleukin-1 (Onozaki et al., 1985), reactive oxygen 
intermediates (Nathan, 1982) and metabolites of L-arginine such 
as nitric oxide (Tayeh and Marietta, 1989) may be involved in 
macrophage-mediated cytotoxicity. There is also convincing 
evidence that a major component of macrophage—mediated killing 
of tumors is due to TNF-a secretion (reviewed by Old, 1988) • 
1.1.3 NATURAL KILLER CELLS 
NK cells are a subset of lymphocytes found in blood and 
lymphoid tissues, such as spleen. NK cells, like all lympho-
haematopoietic cells, are derived from the bone marrow and appear 
as large lymphocytes with numerous cytoplasmic granules and are 
sometimes called large granular lymphocytes (LGLs) (Nieminen and 
Saksela, 1985)• NK cells do not express the CDS antigen or any 
of the known T cell receptor chains (a, gamma or 6) on their 
5 
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surface but they do express CD16 and CD56 surface antigens in 
humans, and NK-1.1/2 .1 in mice (reviewed by Yu et al. , 1992). 
The NK-1.1 antigen is by far the best marker in defining murine 
NK cells (Koo et al. , 1986) . It is expressed on all CD3" NK 
cells capable of lysing the YAC-1 lymphoma cells, a prototypic 
target for both rat and mouse NK cells. 
NK cells possess the ability to kill certain tumor cells or 
normal cells which are infected by virus. The killing activity 
of NK is "natural" . It is not induced by specific antigen and 
is thus part of natural rather than specific immunity. These 
cells mediate cytolytic reactions even in the absence of class 
工 or class 工工 MHC antigens on the target cells. NK cells can 
lyse certain tumor cell lines, particularly of haematopoietic 
origin, but not of others . The killing mechanism of target cells 
by NK cells involves granule exocytosis and secretion of a 
cellular toxin (cytolysin). The cytolysin causes a channel or 
ring-like hole to. be introduced into the target structure. The 
cytolysin may alternatively make a channel which then allows a 
toxin to enter the target cell and kill it (Herberman et al., 
1986) . NK granules also contain cytotoxins, serine esterases and 
proteoglycans. NK cells also synthesize TNF-a but not 
lymphotoxin (LT) (Herberman et al. , 1986). There appears to be 
a degree of specificity in the tumor-killing activity of NK 
cells. Moreover, NK cells can be targeted to antibody — c o a t e d 
cells because they express low-affinity Fc receptors (CD16) for 
IgG molecules. The tumoricidal activity of NK cells is increased 
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by cytokines, including interferons, TNF-a and IIj-2. Therefore, 
their role in anti-tumor inunuiii.ty rna.y depend, on the concurrent 
stimulation of T cells and macrophages which produce these 
cytokines (Herberman et al., 1986). More recent studies found 
that the combination of 工 L 一 4 and IL一12 (cytotoxic lymphocyte 
maturation factor/NK cell stimulatory factor) resulted in a 
synergistic proliferative activity (8-fold) in the CD56+ NK cells 
(Naume et al., 1993) 
1.1.4 IiYMPHOKINE ACTIVATED KILLER CELLS 
The precursors of murine lymphokine-activated killers (LAK) 
can be divided into two major subsets : NK-like (CDS—, NK1.1+, 
asialo GM1+) and T-like (CD8+, NKl.l", asialo GM1+) • LAK 
effectors have generally been characterized as being either CD8+ 
or NK1.1+ (Ballas and Rasmus sen, 1990). It has been shown that 
in vitro cultivation of lymphatic cells including NK cells 
(CD16+) , T cells (.CD3 + ) and even B cells (CD20+) in the presence 
of IL_2 results in the formation of potent cytotoxic cells called 
LAK cells which are able to lyse a wide spectrum of target cells 
(Damle and Bradley, 1.988) . Unlike NK cells, the LAK cells also 
lyse normal cell types including epithelial cells. In clinical 
trial, LAK cell therapy involves the in vitro generation of LAK 
cells by culturing peripheral blood leukocytes removed from tumor 
patients in high concentrations of IL-2 • The LAK cells are then 
re-injected into the cancer patient (Rosenberg et al. , 1987). 
Adoptive therapy with autologous LAK cells, in combination with 
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in vivo administration of 工 L - 2 or chemotherapeutic drugs, has had 
impressive anti-tumor activities in mice bearing tumors (Yamasaki 
et al. , 1989) . Human LAK therapy trials have so far been largely 
limited to advanced cases of metastatic tumors, and the efficacy 
of this approach has not been fully elucidated (Rosenberg et al., 
1987). 
1.1.5 TUMOR-INFILTRATING LYMPHOCYTES 
The mononuclear cells derived from the inflammatory 
infiltrate in human solid tumors are called tumor-infiltrating 
lymphocytes (TILs) . TIL therapy involves the generation of LAK 
cells from mononuclear cells originally derived from the 
inflammatory infiltrate present in and around solid tumors 
obtained from surgical resection specimens. TILs include 
activated NK cells and CTLs, both of which appear to kill tumor 
cells nonspecifically. Unlike LAK cells, TIL can be expanded in 
large amount and .maintained for several weeks in culture. The 
following culture conditions to generate more effective TIL have 
recently been suggested : 1. Low dose of 工 L - 2 (5-20 U/ml)' 2. 
Increasing TIL efficacy by gene transfer of cytokines, 3. 
Repeated in vitro stimulation with irradiated autologous tumor 
cells, 3. Anti-CD3 and IL-2 stimulation to select for T cells, 
4 . Inclusion of TNF-a (100 U/ml) and 工 FN—gainma may enhance 
activation of T cells, 5. Inclusion of IL一4 in addition to 




TILS are 50 to 100 times more effective in their therapeutic 
potency than are LAK cells. Therefore the use of TIL was 
explored for the treatment in mice with large pulmonary and 
hepatic metastatic tumors that do not response to LAK cell 
therapy (Rosenberg et al. , 1986) . Human trials with TIL therapy 
are ongoing (Kariya et al. , 1991; Mizutani and Yoshida, 1991). 
Recently, modern molecular technology has been utilized to study 
the infiltration of lymphocytes into tumor sites and the local 
delivery of BRMs to enhance their anti-tumor efficacy. Active 
research is now being performed to transfect TILs with the cDNA 
of IFN-gamma or TNF-a to enable the TILs to deliver locally 
produced cytokines to kill the tumor cells directly (Hillman et 
al., 1992). 
1.2 BIOLOGICAL RESPONSE MODIFIERS : THE NEW IMMUNOTHERAPY 
The three traditional modalities used in cancer treatment 
are surgery, radiation therapy and chemotherapy. However, all 
of the above three modalities have their own limitations. An 
exciting new approach for the treatment of cancer is 
immunotherapy which aims at enhancing the anti-tumor immune 
response in cancer patients using biological response modifiers 
(BRMs). 
工 i n m u n o t h e r a p y is very effective in certain animal model 
systems and it has been used to treat human cancers for several 
decades (Terry and Rosenberg, 1982). Immunotherapy can be 
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divided into two overlapping categories, active and passive. The 
objective of active immunotherapy is the stimulation of the host 
cellular or humoral anti-tumor immunity. This can be achieved 
specifically by using tumor vaccines to generate an immune 
response to tumor-associated antigens. Nonspecific anti-tumor 
immunity can be accomplished by compounds such as BCG. Passive 
immunotherapy is based on the administration of biologically 
active agents with innate anti-tumor properties, e.g. antibodies 
which can react with growth factor receptors of tumor cells. 
BRM represent a new dimension in the immunotherapy of 
malignancy. The definition of BRM includes agents or approaches 
that alter interactions between tumors and host to achieve 
therapeutic advantages, through modification of host response to 
tumors. BRM can act in the following ways ： 
(1) increase the host's anti-tumor responses through augmentation 
and/or restoration of the immune defence mechanisms of the host; 
(2) augment the host ‘ s immune responses to modified tumor cells 
or vaccines； 
(3) increase the ability of the host to tolerate damages 
resulting from cytotoxic modalities of cancer treatment; 
(4) decrease the transformation and/or increase differentiation 
(maturation) of tumor cells； 
(5) increase the host's defence by acting as effectors or 
mediators of an anti-tumor response; 




BRMS can be classified into the following groups (Table 1.1). 
Table 1.1 Examples of biological response modifiers (Oldham, 
1984) 
Type of Examples 
BRM 
Bacterial BCG, C.parvum, Muramyl dipeptide, 
products Trehalase dimycolate. Endotoxin 
Synthetic Pyran copolymer, Malic anhydride-divinyl ether, 
molecules Poly 工•(：：, Pyrimidines 
Cytokines 工 F N - O C , 工 F N - S , 工 F N - g a i n m a , IL-2, TNF-a 
Hormones Thymosin, Thymulin, Thymopoietin 
Effector Macrophages, NK cells, T cell clones' 
cells Tumor-infi1trating lymphocytes 
Natural Glucan, Krestin, Lentinan' OK-432 
products 
Antigens Tumor-associated antigens, Vaccines 
Monoclonal Monoclonal antibodies to growth-promoting 
antibodies factors, Anti-T cell antibody, Anti-T suppressor 
cell antibody. Anti-tumor antibody 
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1 • 3 CYTOKINES AS BIOLOGICAL RESPONSE MODIFIERS IN CANCER THERAPY 
Cytokines ara a group of low molecular weight proteins or 
glycoproteins that are invloved in the regulation of cell 
proliferation and differentiation. They also act as important 
mediators in the coordination of immune and inflammatory 
responses (reviewed by Aral et al. , 1990； Aggarwal and Pocsik, 
1992). They are produced locally by a variety of diverse cell 
types and act in an autocrine or paracrine manner. Cytokines are 
pleiotropic and exert hormone-like actions both within and 
outside the immune system. A number of cytokines are known to 
be cytostatic and/or cytotoxic to tumors and are capable of 
modulating host's immunity to malignant cells. A brief overview 
of the current status of cytokines used as BRMS in cancer therapy 
is given as follows (Foon, 1989; Gutterman, 1988; Mihich, 1986; 
Oldham,1984; Parkinson, 1989): 
1.3.1 INTERFERONS - There are three major antigenic types of 
interferons (IFNs). The original leukocyte-derived IFN is called 
alpha (a) , and the f ibroblast-derived 工 F N is termed beta (S). 
These two IFNs share the same receptor. The T cell-derived 工 F N -
gamma is structurally quite different and binds to a distinct 
type of IFN receptor. 
工 n t e r f e r o n - o c is active in treating renal cell carcinoma 
(Kirkwood et al • , 1985), bladder cancer (Torti et al. , 1988), 
acquired iimunodeficiency syndrome-related Kaposi sarcoma (Krown 
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et al. , 1986), carcinoid tumor (Oberg et al. , 1983) and malignant 
melanoma (Hersey et al., 1985) . One major immunological activity 
of 工 F N - o c is the induction of HLA class 工 antigen expression on 
cell surface (Gutterman, 1988) • In addition to up-regulating HLA 
antigens, IFN_a also up—regulates other antigens on the surface 
of tumor cells (Quesada et al., 1984). 
工 n t e r f e r o n - g a m m a has exhibited little activity as a single 
agent in cancer therapy. Some reports indicated that it 
exhibited anti-tumor effect on melanoma (Ernstof f et al. , 1987). 
It is most likely that synergistic anti-cancer effect is found 
in combination with other cytokines such as TNF-a (Abbruzzese et 
al., 1989; Fiedler et al., 1991). 
1.3.2 TUMOR NECROSIS FACTOR-ALPHA - TNF-a is a growth factor for 
fibroblasts but it is responsible for cachexia in cancer 
patients. It is mainly released from macrophages and monocytes. 
Activated mouse . peritoneal macrophages (obtained from an 
inflainmatory exudate) release about 10 times more TNF-a than 
peritoneal "resident" or "elicited" macrophages. Lymphocytes, 
mast cells, polymorphonuclear leukocytes (PMN), keratinocytes, 
astrocytes, microglial cells, smooth muscle cells, intestinal 
paneth cells and tumor cells (reviewed by Vassalli, 1992) have 
also been reported to release TNF-a. Its anti-tumor effect was 
found to be very potent in animal systems (reviewed by Old, 1988, 
1990) . Fig.1.1 shows the possible mechanism of the endogenous 
production of TNF-a involving the primed and elicited stage at 
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the molecular level. The "primed stage" involves the 
transcription and translation of precursor TNF-a and the release 
) 
of the TNF-a with 17kD. The "elicited stage" involves the 
processing of the preformed precursor TNF-a by lysosomal enzyme 
such as protease which is released from lysosome by an eliciting 
agent. Usually the eliciting agent is a strong lysosome 
labilizer such as the lipopolysaccharide (reviewed b y Mizuno, 
1992). 
Normal stage No transcription or translation of TNF 
Transcription and translation of 
Nh precursor TNF as membrane 
Cytosol ( 2 integrated form 
Membmng |S| 
C O O H 
Processing of precursor TNF 
^ N H j and release of mature TNF 
Cytosol 
. Protease 
17 kD aNF-activity) 
C O O H 
Fig. 1.1 Possible mechanism of priming and triggering of TNF 
production in macrophage (Mizuno, 1992). 
Phase 工 and 工工 Clinical trials of cancer therapy with human 
recombinant TNF-a (Hr-TNF-a) have been disappointing for its low 
effectiveness but sever side effects. However, clinical studies 
for Hr-TNF-a in combination with chemotherapy or other cytokines 
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(e.g. IFN-gamma and IIj-2) have not been well established (Frei 
and Spriggs, 1989; Spriggs and Yates, 1992； Taguchi, 1990). More 
recent clinical studies indicated that intratumoral 
administration of Hr-TNF-a exhibited potent anti-tumor effects 
(Taguchi et al. , 1992). Kato et al (1990) reported an 
alternative approach of using rTNF-a as a primer to produce 
endogenous TNF-a and OK-432 as a trigger latter for endogenous 
production of TNF-a in cancer patients. This 
endogenous/exogenous TNF therapy was effective against metastatic 
lung or liver tumors as well as primary lesions. 
1 . 3 . 3 工 NTERLEUKIN-1 - IL-l is a proinflammatory molecule 
produced mainly by activated macrophages. It acts on target 
cells both directly and via the induction of other cytokines 
(e.g. ILi-6, TNF-a, GM-CSF, M-CSF, G-CSF) • Moreover, it 
synergizes with TNF-a in a wide variety of biological effects. 
The therapeutical potentials of IL-l may be attributed to its 
radioprotective .effect, enhancement of haematopoiesis and 
stimulation of T cells and NK cells (Haworth and Feldmann, 1991). 
IL-l has anti-tumor effect in several different ways: (1) by 
exhibiting direct cytostatic and cytotoxic effect on various 
murine syngeneic tumors (Lachman et al. , 1986; Nakamura et al.' 
1986; Onozaki et al. , 1985) ； (2) by increasing the production of 
other lymphokines, such as IL一2 and interferon; (3) by enhancing 
the effect of NK cells and cytotoxic T lymphocytes (CTL) and 
synergizing with IL一2 and interferon in promoting NK and CTL cell 
activities (Wilmott and Kaplan, 1990). In addition, IL-l had 
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also been shown to function as an adjuvant in specific 
immunotherapy resulting in enhanced host survival following 
subsequent tumor challenge (McCune et'al. , 1990). 
1.3.4 INTERLEUKIN-2 -工Ij-2 is produced by activated T cells, and 
its receptor is also found on T cells. 工 L - 2 activated killer 
cells recognized autologous tumor cells. The killer cells are 
called lymphokine-activated killer cells (LAK) with anti-tumor 
activities (Damle and Bradley, 1988)• Their anti-tumor 
activities can also be enhanced by TNF-a and IFN-gamma 
(Maghazachi, 1990). 工 L - 1 has been shown to synergize with IL-2 
in the generation of LAK cells (Crump et al. , 1989) . IL-2 can 
also synergize with 工 F N - a (Kim and Warnaka, 1991) or TNF-a (Agah 
et al, , 1988) for treating cancers. A potentially exciting 
approach to IL_2 therapy involves the application of 工 L - 2 fusion 
proteins . Genetic construction of a fusion protein involving the 
receptor binding domain of IL-2 and the toxin moiety of 
diphtheria toxin can selectively kill the cells bearing the high-
affinity IL-2 receptor (Murthy et al. , 1986) . Investigators are 
now also beginning clinical trials of IL_2 for the treatment of 
HIV infection by administrating IL-2 before overt 
immunodeficiency develops . It is because IL-2 activated T cells 
and NK cells which can kill the HIV-infected cells (reviewed by 
Smith, 1990). 
1.3.5 granulocytes /MACROPHAGES COLONY-STIMULATING FACTORS - CSFs 
are glycoprotein growth factors that control survival, 
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proliferation, and differentiation of hematopoietic progenitor 
cells in vitro (Metcalf, 1986). GM-CSF influences the 
functioning of mature cells .丨 belonging to the 
neutrophil/eosinophil and monocyte/macrophage lineages (Grabstein 
et al., 1986) . Since these cell types exhibit microbicidal and 
tumoricidal activities, the in vivo application of GM-CSF is 
expected to possibly increase resistance against infections and 
also to modulate tumor growth (Herrmann et al. , 1989). GM-CSF 
has been demonstrated to be active in leukopenic patients with 
various disease states to cause dose-dependent increase in 
circulating neutrophils, eosinophils, and monocytes (Brandt et 
al. , 1 9 8 8 ) .工 n addition, the murine WEH工-3B (D+) cells and human 
leukemic cells classified as M2, M3, M4 were induced by human G-
CSF to undergo terminal differentiation to macrophages and 
granulocytes (Souza et al•, 1986). 
1.3.6 EPIDERMAL GROWTH FACTOR - EGF is a common growth and 
differentiation factor. It has been investigated clinically for 
wound healing and corneal ulcers. However, it can also inhibit 
squamous cell cancers if the EGF receptor is up-regulated 
(reviewed by Gutterman, 1988). 
1.3.7 TRANSFORMING GROWTH FACTOR-BETA - TGF-S is an important 
immunoregulator as it suppresses the proliferation and function 
of B lymphocytes and T lymphocytes (Kehrl et al. , 1991). TGF-S 
produces marked inhibition of DNA sunthesis in normal B cells, 
an effect which is significantly less in chronic lymphocytic 
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leukemia (CLL) cells. This latter property may provide CLL cells 
with a growth advantage over normal lymphocytes in vivo (Israels 
et al. , 1993) . TGF-S was found to transform or allow unregulated 
growth of rat embryo kidney cells. However, an anti-
proliferative effect on chronic myelogenous leukaemia (CML) cells 
and immunosuppressive properties of TGF-S had also been reported 
(reviewed by Gutterman, 1988). 
The insertion of cytokine genes, including 工 L - 4 , IL-2, TNF-
a,工FN-gamma and GM-CSF in the tumor cells and transfer of these 
gene-modified cells to the patients could induce active 
immunotherapy and also beneficial in the induction of immune 
effector cells for adoptive immunotherapy (Rosenberg, 1991). 
1.4 BIOACTIVE POLYSACCHARIDES FROM CHINESE MEDICINAL HERBS ACT 
AS BIOLOGICAL RESPONSE MODIFIERS 
Traditional Chinese medicine (TCM) is primarily based on the 
experience accumulated during the course of several thousand 
years by the Chinese people. Chinese medicine is more patient-
oriented than disease-oriented. The main aim is to restore the 
equilibrium in the human body, and not merely to kill the 
pyrogens or cancer. The important idea of Chinese medicine is 
to mobilize the internal ability of the body to resist disease. 
The syndrome, known as the imbalanced condition in various 
aspects caused by various kinds of pathogenic factors, may be 
restored to a new level of balanced condition by the effects of 
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appropriate medication or acupuncture to mobilize the active 
factors in the body, strengthen the ability to resist diseases 
or remove the pathogenic agents, and raise the adaptability of 
the body. Western medicine puts emphasis on etiology and the 
treatment of local condition, but seems not to give enough 
attention to the general condition. Moreover, the toxic side-
effects after the treatment of malignant tumors with chemotherapy 
or radiotherapy are one of the drawbacks of Western medicine. 
It is hoped that greater effectiveness may be achieved by 
combining the features of the TCM and modern Western medicine. 
Thus, the administration of traditional Chinese herbal medicines 
simultaneously with chemical drugs in Western medicine may be 
more effective for the treatment of certain cases of cancer. 
Moreover, it can result in reducing or preventing the toxic side-
effects of chemotherapy. 
According to the basic theory of TCM, there is always some 
kinds of deficiency before and during the course of diseases, 
including infections and cancer. Fu-zheng (FZ) therapy is one 
of the basic principles of TCM. It means stimulating or 
modulating our immune system. Many traditional herbs from 
medicinal plants were found to act as BRMs in cancer patients 
(Sun, 1986) . These BRMs were used in combination with 
chemotherapy and radiotherapy during cancer treatment. It was 
found that patients receiving medicinal herbs as BRMs in 
combination with chemotherapy or radiotherapy survived longer 




However, the development of TCM is handicapped by its 
etiology, mechanism, diagnosis and analysis. It lacks objective 
data for quantification and characterization. Therefore, 
qualitative and quantitative concepts should be given to TCM 
objectively in order to bring about the modernization of Chinese 
medicine. TCM should be developed from a knowledge acquired by 
subjective perception to a science with experimental basis. A 
large number of biological and pharmacological testing systems 
are available today. They allow plant drugs or plant 
constituents of TCM to be selected and screened for potentially 
inununological and pharmacological activities before they are 
subject to detailed chemical and clinical trials. 
Certain glycoproteins, polysaccharides, nucleotides and 
proteins (peptides) of high molecular weights are among the 
dominant immunologically active compounds isolated from Chinese 
medicinal herbs. T〇- evaluate the immunopharmacological 
activities of bioactive substances in TCM, a series of 
immunological tests should be applied (Hong, 1987) . The 
immunological tests are divided into three levels. First level 
tests include (1) lymphocytes count, (2) lymphocyte morphology, 
(3) skin tests and (4) determination of immunoglobulin level. 
Second level tests include (1) histochemical analysis of lymphoid 
organs, (2) lymphocyte surface marker analysis, (3) mononuclear 
cell proliferation studies and (4) effector cells (e.g. NK' LAK 
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etc.) mediated cytotoxicity. Third level tests include (1) 
enzyme measurement (adenosine deaminase, purine nucleoside 
phosphorylase etc.), (2) cytokine measurement (e.g.工L-1, irj-2, 
TNF-a,工FN-gamma etc.), (3) Phagocyte studies (mobility, surface 
marker etc.), (4) complement tests, (5) cellular mixing 
experiments, (6) genetic analysis (e.g. Northern blotting of 
specific mRNA) and (7) carrier detection. 
There are several lines of evidence that some of the 
investigated plants, besides the high molecular weight compounds, 
contain other immunostimulating agents which belong to the class 
of terpenoids, alkaloids or polyphenolic compounds (reviewed by 
Wagner, 1985). Recently, various polysaccharides from higher 
plants have been isolated and their structures as well as 
pharmacological activities have been studied. 
A list of the procedures based on different principles for 
isolating polysaccharides is shown as follows (Pazur, 1986). 
(1) solubility : (a) fractional precipitation, (b) fractional 
solution, (c) distribution between immiscible solvents. 
(2) Ultracentrifugation : (a) model E ultracentrifugation, (b) 
density gradient techniques. 
(3) Membrane ultrafiltration. 
(4) Chromatography ： (a) adsorption, (b) ion-exchange, (c) 
partition chromatography. 




The analytical methods commonly used for the determination 
of the sequence of monosacharide residue and structure are 
methylation analysis, periodate oxidation, partial acid 
hydrolysis, acetolysis, alkaline degradation, enzymic assays and 
iiranunological reactivities. The methods utilize paper 
chromatography, gas liquid chromatography, mass spectrometry, 
polarimetry, circular dichroism adsorption, nuclear magnetic 
resonance spectrometry, affinity chromatography and antibody-
antigen complex formation (Carney, 1986)• The flow chart of the 
investigation of the immunopharmaco logical and ant i-tumor 
activities of bioactive polysaccharides adopted in my stuides is 
shown in Fig.1.2. 
Most of the polysaccharides from higher plants are 
heteroglycans with very complex structures. Some of them have 
secondary and tertiary structures stabilized by intra-molecular 
hydrogen bonds between adjoining sugar units (reviewed by Lien 
and Gao, 1990) • Many immuno stimulating polysaccharides have been 
isolated from various sources including fungi (Tsukagoshi et al.' 
1984), lichens (Wagner, 1985), seaweeds (Yamamoto et al., 1977) 
and higher plants (Haranaka et al • , 1985; Kumazawa et al. , 1985a,. 
Zhao et al., 1990) and they are summarized in Table 1.2. 
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T. 
Primary purification: 
e.g.hot water extraction and alcohol precipitation 
) 
NO 7 
- Screening : 
• Lymphocyte mitogenic assay 
YES 
Remove LPS or Bacterial LPS contamination 
use different fractions 
NO 
T 
Further purification and characterization 
T 
Anti-tumor activity in vitro and in vivo 
IN VITRO • IN VITRO + IN VITRO _ IN VITRO + 
IN VIVO • IN VIVO _ IN VIVO + IN VIVO + 
T 
Direct cytotoxic ^ 
effect on tumor cells 
• f ^ + 
Immunostimulating studies Immunotoxicological studies 
* Immunosuppression 
T cell deficiency 
W Y B cell deficiency 
Humoral immunity Cellular immunity d e S ™ ^ 
IL-l Lymphocytes Phagocytosis defects 
IL-2 Macrophages 
tisjf Cf ^ ^ NK * Hypersensitivity 
TN卜oc ^ • LAK . Antibody-mediated 
IFN-Y C T L (immediate) 
GM-CSF TILs 
Antibodies Bone marrow cells Cell-mediated 
(delayed) 
• —I * Autoimmunity 
T Altered self-antigen 
Immune 
Host-mediated anti-tumor activities dysregulation 
Fig 1 2 A flow chart of the investigation of immunopharmacological 
and anti-tumor activities of natural-occurring polysaccharides 
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Table 1.2 工 m m u n o s t i m u l a t i n g polysaccharides from fungi, lichens 
and higher plants (Wagner, 1985; Lien and Gao, 1990). 
； 
Polysaccharides Type Linkage M.W. 
FUNG工 Zymosan Glucan SI,3 50-12 0,000 
Mannozym Mannan SI, 3 5-2 0,000 
SI, 3 Sc 50-65, 000 
Lentinan Glucan SI,3 ca 500,000 
- 10 ' 
Schizophyllan Glucan SI, 3 & ca 400,000 
£ 1 , 6 
Krestin (PSK) Glucan SI, 4 & 50-100,000 





工 s o l i c h e n a n al,3 100-500,000 
al,4 
Laminaran SI, 3 
£1,6 
HIGHER Panax ^ 
PLANT notoginseng £(1,3) Gal 1.5 x 10 
Rice bran a(l, 6)Glu 10' 
The molecular weights of the compounds shown in Table 1.2 
range between 2 0,000 and 1,500,000 and the sugar chains 
primarily contain 1,3 and 1,6. occasionally also 1,4 and 1,2 
linkages. Most higher plant polysaccharides contain galactose, 
arabinose and glucose (Lien and Gao, 1990) • Some are acidic and 
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most belong to plant mucilages (Morrison 1988) . Most higher 
plant polysaccharides have complex structures characterized by 
many branch chains attached to main chains (Lien and Gao, 1990). 
Bioactive polysaccharides isolated from traditional Chinese 
medicinal herbs have been found to possess a wide variety of 
immunomodulating activities including the activation of 
macrophages (Adachi et al • , 1990), PMN (Kimura et al. , 1987; 
Morikawa et al. , 1985) , CTL (Hamuro, et al. , 1978) , NK cells 
(Tsukagoshi et al. , 1984) , LAK cells (Hayashida et al. , 1991), 
TILs (Kariya et al. , 1991; Mizutani and Yoshida, 1991), T 
lymphocytes (Izawa et al. , 1983 ； Kumazawa et al. , 1985a) , B 
lymphocytes (Kumazawa et al. , 1985b), antibody-dependent cell-
mediated cytotoxicity (Peter et al. , 1988), stimulation of 
production of 工 F N (Aoki, 1985; Sakagami et al. , 1988; Tsukagoshi 
et al. , 1984), production of TNF-a (Haranaka et al • , 1984； 
Haranaka et al., 1985; Takahashi et al. , 1988a), production of 
CSFs (Sakagami et al. , 1991) , anti-complementary activities (Gao, 
et al. , 1988; Yamada et al • , 1988; Yamada 1989； Yamada et al., 
1990) , the anti-tumor activities of macrophages from the bone 
marrow (Stimpel et al. , 1984) as well as the stimulation of bone 
marrow haematopoiesis (Rou and Renfu' 1983). 
Clinical studies have shown that many p l a n t - d e r i v e d 
polysaccharides possess anti-tumor activity (Kariya et al., 
1 9 9 1 ) . psK can prolong the disease-free intervals in colorectal 
cancer patients after curative surgery (Torisu et al. , 1990). 
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PSK can also increase the life span of recurrent stomach cancer 
patients combined with mitomycin C and 5-fluorouracil (Tsukagoshi 
et al. , 1984) . Moreover, some polysaccharides are capable of 
augmenting the host defence against bacterial (Takeda et al., 
1990; Tomioka et al. , 1992) and fungi (Uetsuka et al. , 1982) 
infection by activation of the macrophages in mice. PSK has been 
found to inhibit human immunodeficiency virus (HIV) infection 
(Tochikura et al. , 1987) and HIV reverse transcriptase in vitro 
(Hirose et al. , 1987) . It is apparent that the complex branched-
chain-polysaccharides with anionic structures and high molecular 
weight exert higher immuno s t imulat ing activities than linear 
glucans (Wagner, 1985) . None of the polysaccharides were found 
to be mutagenic or carcinogenic to animals (Wagner, 1985)• 
Polysaccharides may therefore be promising agents for future 
immunostimulatory medications. Because they are easily 
biodegradable, the polysaccharides can fulfill the requirements 
of ideal immunostimu 1 ating drugs set forth by the World Health 
Organization (Wagner, 1985) . The difficulties in reproducibility 
of the isolation procedures for isolating chemically well-defined 
polysaccharides of constant activity might be overcome in the 
future by producing them from tissue cultures under controlled 
conditions. 
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CHAPTER TWO 
AIM AND SCOPE OF INVESTIGATION 
The human immune system plays an important role in the 
iiraminosurveillance against many invasive microorganisms as well 
as tumor cells. However, in cancer or AIDS patients, in patients 
suffering from various kinds of immune deficiency, as well as in 
patients receiving radiotherapy and/or chemotherapy, the normal 
immune functions are severely suppressed. It is generally 
believed that the application of tonic medicinal herbs may 
enhance the immune system of the body and is likely to be 
beneficial to the anti—neoplastic therapy and infections. 
Traditional Chinese medicines (TCM) have widely been used in the 
Orient for thousands of years for the treatment of various 
diseases, especially those that are chronic, persistent or 
degenerative in nature. The roots of Pseudostellaria 
heterophylla is Oriental mild tonic herb. Its roots have been 
used to treat asthenia-syndrome cases. Although P. heterophylla 
has a long history of being used as a tonic herb, its 
immunomodulatory and anti-tumor activities have not been 
investigated. Therefore, purification, characterization, 
structural elucidation of the bioactive components and study of 
their immunopharmacological and anti-tumor activities are of 
great interest. 
In my thesis project, the bioactive components from the 
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roots of P. heterophylla will be extracted by hot water and then 
partially purified by step-wise alcohol precipitation. The 
alcohol-insoluble fractions will be 'further purified by gel 
filtration on Sephadex G-lOO columns followed by anion-exchange 
chromatography on DEAE Sephadex columns. The purity and 
molecular weight of the purified fractions will be determined by 
high performance liquid chromatography. The structural 
components of the purified fractions will be investigated by SDS-
polyacrylamide gel electrophoresis, paper chromatography and gas 
liquid chromatography. The immunomodulatory effects of the 
bioactive fractions on both non-specific and specific immunity 
will be studied, both in vitro and in vivo. In addition, the 
immunorestorative properties of P. heterophylla on tumor-bearing 
mice, aged mice and cyclophosphamide treated mice will also be 
investigated. Moreover, the in vitro and in vivo anti-tumor 
activities of P. heterophylla will be studied by using different 
tumor cell lines. Attempts will be made to dissect out the 
mechanisms whereby P. heterophylla can exert its anti-tumor 
activities through examining its effects on the induction of 
cytokines (e.g. TNF—oc, IFN-gamma and 工 L _ l ) , the activation of 
macrophages, natural killer cells, lymphokine activated killer 
cells and tumor infiltrating lymphocytes. Besides the 
traditional immunological techniques, the techniques of modern 
molecular biology will also be applied for the studies. 
Over the past few decades or so, there has been a worldwide 
research effort in the study of experimental and human cancers. 
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Although some progress has been made, it is still a long way from 
preventing and curing the disease effectively. Moreover, most 
of the anti-neoplastic drugs carry significant toxic and adverse 
side effects. Therefore, their clinical applicabilities and 
therapeutic efficacies are greatly limited. The present project 
is to try to understand the iiranunomodulatory and ant i-tumor 
properties as well as the structure-activity relationship of P. 
heterophylla • It is hoped that by studying the immunomodulatory 
and anti-tumor fractions derived from natural products and 
understanding of their structure-activity relationships, it may 
be possible to identify and obtain new and potent bioactive 
compounds with minimal side effects for clinical applications 
such as immunotherapy of cancer as well as treatment of various 
immunological, infectious and age-related diseases. 
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CHAPTER THREE 
MATERIALS AND METHODS 
3.1 MATERIALS 
1. Animals 
Inbred female BALB/c (H-2^) , C57BL/6J (H-2^) and outbred 
male ICR mice, were bred at the University Animal House, The 
Chinese University of Hong Kong. They were fed by animal diet 
(Chow 5001, Rodent Laboratory) and tap water ad libitum. Except 
additional indication, animals of the same age ( 6 - 8 weeks old) 
were used in each experiment. 
2• Pseudostellaria heterophylla 
The roots of Pseudostellaria heterophylla ( 太子| , 
Taizhishen) , (Miq. ) Pax ex Pax et Hoffm. [P. rhaphanorhiza 
(Hemsl.) Pax； Krascheninnikovia heterophylla Miq.; K. 
rhaphanorhiza (Hemsl, ) Kryl. ] - Caryophyllaceae, were brought 
from a local Chinese medicinal store (Hip Tak Wing Ginseng 
Co. , LTD. ) in Hong Kong, They were imported from Shan-dong of the 
People's Republic of China in dried form. 
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3. Cell lines 
Various cell lines used in the study were as follows ： 
(a) Fibroblast-like tumors : 
These include L929 (a transformed fibroblast cell line 
derived from C3H mice) and WEHI-164 (a methylcholanthrene-induced 
fibrosarcoma derived from BALB/c mice) . L929 cells were kept in 
RPMI medium supplemented with 5 % fetal calf serum (FCS) and 50 
units/ml penicillin, 100 |lg/inl streptomycin sulphate. 
(b) Livmphoid tumors ： 
These include MBL-2 (a Moloney leukaemia virus-induced T 
cell lymphoma of C57BL/6J mice) and YAC-1 (a Moloney virus-
induced T cell lymphoma of A/Sn mice). 
(c) Macrophaqe-like tumors ： 
These include PU5-1.8 (a spontaneous macrophage-like tumor 
derived from BALB/c mice) and P388Di (a methylcholanthrene-
induced macrophage-like tumor derived from DBA/2 mice). 
(d) Myeloid Tumor ： 
Ml is a spontaneous myeloid leukaemia derived from SL mice. 
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(e) Carcinoma ： 
EAT (Ehrlich ascites carcinoma) is an ascites derivative of 
a spontaneous murine mammary adenocarcinoma (tetraploid subline 
Ny Klein Strain). 
(f) Factor-dependent T cell line ： 
CTLL-2 is an IL一2 dependent cloned cytotoxic T cell line 
derived from C57BL/6J mice. It was maintained in exponential 
growth in RPMI medium supplemented with 10 % PCS and 40 % rat 
growth factor. 
With the exception of L929 and CTLL-2 cells, all the above 
cell lines were kept by continuous culture in RPMI medium 
supplemented with 10 % FCS and 50 units/ml penicillin, 100 jLig/ml 
streptomycin sulphate. Long term storage of the cells was 
achieved by cryopreservation in liquid nitrogen. 
4. Buffers, culture media and chemicals 
(a) Phosphate-buffered-saline (PBS) 
PBS was prepared by dissolving 8.00 g NaCl, 0.20 g KCl, 0.2 0 
g KH2PO4 and 1.15 g Na2HP〇4 in one litre double distilled water. 
The pH of the solution was adjusted to 7.4 before use. PBS was 
sterilized by autoclaving at 121°C for 15 min. 
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(b) Hank's balanced salt solution (HBSS) 
HBSS was prepared by dissolving 0.4 g KCl, 0.06 g KH2PO4, 
8.00 g NaCl, 0.35 g NaHCO〗，0 • 12 g Na^HPCVlS H^O, 1.00 g D-glucose 
in one litre double distilled water. The solution was adjusted 
to pH 7.2 and sterilized by filtration through a 0.22 jim 
millipore membrane filter. 
(c) Culture medium 
RPMI 1640 medium (Sigma Chem. Co., U.S.A. with 25 mM HEPES) 
was used. The powder medium was dissolved in double distilled 
water and buffered with 25 mM NaHCO] according to manufacturer's 
specification. The solution was sterilized by filtration through 
a 0.22 lim millipore membrane filter. The plain medium was stored 
at 4°C. During cell culture, the plain medium was supplemented, 
with 50 units/ml penicillin, 100 |lg/ml streptomycin and 10 % FCS 
(RPMI complete medium) or 5 % FCS (for L929 cells). 
(d) Fetal calf serum 
Fetal calf/bovine serum (Gibco, U.S.A.) was stored at -20°C 
as 50 ml aliquots. Heat-inactivated fetal calf serum (HIFCS) was 
prepared by heating the aliquots at 56°C for 30 min. 
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(e) Normal saline 
Normal saline was prepared by dissolving 9.00 g NaCl in one 
litre double distilled water and sterilized by autoclaving at 
121°C for 15 min. 
(f) 2-Mercaptoethanol solution (2-ME) 
A 5 X 10-3 M stock solution of 2-mercaptoethanol (Gibco, 
U.S.A.) was prepared in sterilized PBS and kept at 4^0. 
(g) Mounting- medium 
Mounting medium for microscopic slides was prepared by 
mixing an equal volume of PBS and glycerol. 
(h) L929 conditioned medium 
L929 cells were grown in RPMI medium supplemented with 5 % 
FCS for three days. The cell-free supernatant was collected and 
stored at -20oc until use. 
⑴ Scintilla_tion fluid 
Triton X-toluene scintillant was prepared by mixing 12.0 g 
PPO, 1.2 g POPOP, 2.0 litres toluene and 1.0 litre triton X-100. 
The suspension was stirred overnight until all PPO and POPOP were 
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completely dissolved. 
(j) Dye solutions 
Neutral red solution ： 
Neutral red (0.5 g, Sigma Chem. Co., U.S.A.) was dissolved 
in 100 ml normal saline. The insoluble dye was filtered through 
Whatman No.1 filter paper. 
Trypan blue solution ： 
Trypan blue (0.3 g' Sigma Chem. Co., U.S.A.) was dissolved 
in 100 ml sterilized PBS. The insoluble dye was filtered through 
Whatman No.1 filter. 
(k) Antibodies 
FITC-conjugated rabbit anti-rat IgG (whole molecule) 
antibody was purchased from Sigma Chem. Co., U.S.A. and used at 
a dilution of 1:32 in RPMI complete medium. 
Monoclonal rat anti—mouse interleukin—2 receptor antibody 
was purchased from Boehringer Mannheim (Germany) and used at a 
dilution of 1:40 in RPMI complete medium. 
Monoclonal rat anti-mouse B cell—antigen monoclonal antibody 
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(clone LR-1) was purchased from Serotec Co. (U.K.) and used at 
a dilution of 1:10,000 in RPMI complete medium. 
Monoclonal rat anti-mouse Thy 1.2 antibody (clone F7D5) was 
purchased from Serotec Co. (U.K. ) and used at a dilution of 
1:1000 in RPMI complete medium. 
(1) Lipopolysaccharide 
LPS {E. Coli. serotype 0127:B8, Sigma Co., U.S.A.) was 
dissolved in PBS at 125 jLlg/ml. It was freezed at -20^C 
until use. 
(m) Reagents and buffers for SDS-PAGE 
2 X SDS gel-loading buffer 
100 mM Tris.HCl (pH 6.8), 200 mM dithiothreitol, 4 % SDS 
(electrophoresis grade), 0.2 % bromophenol blue and 20 % 
glycerol. 
Electrophoretic buffer : 
0.025 M Tris, 0.192 M glycine and 0.1 % SDS. The pH of 
electrophoretic buffer was adjusted to 8.3 by HCl. 
Stacking gel ： 
3 % acrylamide, 0.125 M Tris and 0.1 % SDS. The pH of 
stacking gel was adjusted to 6.8 by HCl. 
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Separating gel ： 
9 % acrylamide, 0.375 M Tris and 0.1 % SDS. The pH of 
separating gel was adjusted to 8.8 by HCl. 
Staining solution ： 
0.1 % Coommassie Blue R-250 in 25 % methanol and 10 % acetic 
acid in water (v/v/v). 
STOCK SOLUTIONS 
Solution A : 
18.17 g Trizma Base, 4 ml 10 % SDS adjusted to pH 8.8 with 
conc. HCl and made up to 100 ml. 
Solution B ； 
2.4 g acrylamide, 0.064 g N,N'-methylene bisacrylamide and 
made up to 8 ml. 
Solution C : 
3.03 g Trizma base, 2 ml 10 % SDS adjusted to pH 6.8 with 
conc. HCl and make up to 50 ml. 
Solution D : 
10 % ammonium persulphate (w/v) 
Solution E ； 
-tetramethylethylene-diamine (TEMED) 
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(n) Reagents and buffers for Northern blott.inrj 
Formaldehyde gel-loading buffer ： 
50 % glycerol, 1 mM EDTA (pH 8.0), 0.25 % bromophenol blue, 
0.25 % xylene cyanol FF. 
Lysis buffer ： 
4 M guanidine thiocyanate, 25 mM sodium citrate, 0.5 % 
sarkosyl. Prior to use, 0.36 ml j^-mercaptoethanol was added 
to 50 ml of the above solution. 
5 X MOPS buffer ： 
0.1 M MOPS (pH 7.0), 40 mM sodium acetate, 5 mM EDTA (pH 
8 . 0 ) . 
Prehybridization buffer ： 
50 % formandde, 0.25 M NaHaPO* (pH 7.2), 0.25 M NaCl, 7 % 
(w/v) SDS, 1 mM EDTA. 
20 X SSC : 
3 M NaCl, 0.3 M Trisodium citrate. 
Solubilization buffer ： 
10 mM Tris (pH 7.5), 1 mM EDTA, 0.1 % SDS. 
TE buffer : 
10 mM Tris.HCl (pH 7.5) and 1 mM EDTA (pH 7.5). 38 
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STE solution ： 
0.1 M NaCl, 10 mM Tris.HCl (pH 8.0), 1 mM EDTA (pH 8.0). 
3.2 METHODS 
(I) EXTRACTION, FRACTIONATION AND CHARACTERIZATION 
OF PSEUDOSTELLARIA HETEROPHYLLA 
The procedure for the purification and characterization of 
the P. heterophylla was shown in Fig.3.1. 
3.2.1. Hot water extraction and stepwise alcohol precipitation 
The roots (200 g) were broken down into small pieces and 
soaked in one litre of water at 4°C overnight. One litre of 
water was then added and heated at 80°C for 4 h. The precipitate 
was removed by high speed centrifugation (10,000 g, 30 min) . The 
supernatant was lyophilized• The lyophilized powder, which was 
designated as the crude extract (PH fraction), was subject to 
stepwise alcohol precipitation. Briefly, the crude extract (PH) 
was dissolved in water (2.67 % w/v) and slowly added into an 
equal volume of 95 % ethanol with continuous stirring. The 
precipitate was then centrifuged down. The resulting 
supernatant was slowly added into an equal volume of 95 % 
ethanol. The precipitate was then centrifuged down and was 
designated as the PH-工 fraction. The supernatant was again added 
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Fig.3.1 A FLOW CHART SHOW THE PROCEDURES FOR THE 
PURIFICATION AND CHARACTERIZATION OF 
PSEUDOSTELLARIA HETEROPHYLLA 
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Stirring. The precipitate was then centrifuged down and was 
designated as the PH-II fraction. The supernatant was then 
evaporated to dryness and then lyophilized. The lyophilized 
powder was designated as the PH-III fraction. 
3.2.2 Determination of carbohydrate, protein and uronic acid 
contents 
Carbohydrate content of the isolated fractions was 
determined by phenol sulphuric acid method (Dubois et al. , 1956) • 
while protein content was determined by the Lowry method (Lowry 
et al. , 1951) and uronic acid content was determined by the 
carbazole method (Bitter and Muir, 1962). 
3.2.3 Gel filtration 
PH-I fraction was applied onto a Sephadex G-lOO (Pharmacia) 
column (2.5 x 90 cm) and eluted with water to obtain fractions 
PH-I A, PH-I B and PH-I C. Fractions of 12 ml were collected at 
a flow rate of 12 ml/h. The relative amount of carbohydrate in 
each fraction was determined by phenol sulphuric acid method 
(O.D.490) • 
3.2.4 Anion-exchange chromatography 
PH-I A, PH-I B or PH-I C fraction was applied onto a DEAE 
anion—exchange Sephadex column ( 2 . 5 x 6 cm) to fractionate into 
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PH-I Aa and PH-I Ab; PH-I Ba and PH-工 Bb or PH-工 Ca and PH-I Cb 
respectively. PH-工 Aa, PH-工 Ba and PH-I Ca were eluted with 10 
mM NaCl phosphate buffer (pH 8.0) while PH-工 Ab, PH-工 Bb and PH-I 
Cb were eluted with 500 mM NaCl phosphate buffer (pH 8.0). 
Fractions of 10 ml were collected at a flow rate of 100 ml/h. 
PH—工 Aa and PH—工 Ab were dialysed against distilled water with 
Spectra/POR dialysis tubing (membrane pore size of 6,000-8,000) 
to remove salts. PH-I Ba, PH-工 Bb, PH-工 Ca and PH-I Cb were 
dialysed against distilled water with benzolated dialysis tubing 
with membrane pore size of 1,200. The relative carbohydrate and 
protein contents of each fraction were determined by phenol 
sulphuric method (O.D.490) and Lowry method (O.D.650) respectively. 
3.2.5 Paper chromatography 
The method of Partridge (1948) was adopted. Various samples 
with 1 mg/ml in 4 M HCl were heated at 100°C for 2 h. Each 
standard or acid hydrolysed sample was applied drop by drop 
followed by air drying onto a Whatman No. 1 filter paper. Paper 
chromatography was developed overnight using descending method 
in a closed glass tank. The developing solvent for the neutral 
sugars consisted of ethyl acetate, pyridine and water in a volume 
ratio of 8 : 2 : 1. The developing solvent for the acidic sugars 
consisted of ethyl acetate； acetic acid, formic acid and water 
in a volume ratio of 18 : 3 ： 1 : 4. Method of detection of 
Trevelyan et al (1950) was attained by immersing the filter paper 
first in acetone solution saturated with silver nitrate and then 
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the paper was air dried for 10 min. The filter paper was then 
immersed in ethanol with 1 % NaOH for development and air dried 
for 1 h. Finally, the background colour was removed by washing 
in 2 % Na2S2〇3 several times and air dried. 
3.2.6 Gas liquid chromatography 
Preparation of volatile alditol acetates 
Sugar standards and acid hydrolysed samples were converted 
into volatile derivatives by reduction and acetylation 
(Sawardeker et al • , 1965). Firstly, samples from P. 
heterophylla (1 mg/ml) in 4 M HCl were heated at lOO^C for 2 h. 
After the HCl was removed by evaporation, 5 mg sample was 
dissolved in 5 ml water and 10 mg sodium borohydride (NaBH^) was 
added. The solution was incubated at room temperature for 30 
min. Afterward, glacial acetic acid was added dropwise into the 
solution to react with excess NaBH^ until no gas was evolved. 
The solution was then co-evaporated with methanol until complete 
dryness. Acetylation was done by adding 2 ml of acetic anhydride 
to the samples and heated at 90°C for 15 min. The solution was 
then C O - e v a p o r a t e d with methanol to complete dryness. Finally, 
5 ml of chloroform was added to dissolve the sample. 
Runnincf conditions and detection by GLC 
The sample (1 jil) was injected into a DB-17 column (30 m) 
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(J & W) in a HP5890 A gas chromatography (Hewlett Packard). The 
operating conditions are shown as follows ： detector temperature 
二 250。C, injector temperature = 250°C, initial column temperature 
=170°C, initial time = 3 min, column temperature increasing rate 
=2oc/niin, final temperature 二 220°C, final time 二 7 min, helium 
flow rate 二 14 ml/min, total helium flow rate including auxiliary 
helium flow rate = 24 ml/min. The signal was detected by a flame 
ionization detector. The peak areas and retention times were 
calculated by a HP3393A integrator. The sugar components of the 
samples were determined by comparing their retention times with 
the sugar standards. 
3-2.7 Determination of molecular weight by high performance 
liquid chromatography 
The purity and the molecular weight of different fractions 
were determined by analytical HPLC (Bio-Gel TSK-20 column. Bio— 
Rad) at a flow rate 1 ml/min and compared with dextran standards . 
3.2.8 SDS-polyacrylamide gel electrophoresis 
Preparation of gel 
The method was adopted from Laemmli (197 0). The vertical 
gel slab apparatus was used. The gel system was a discontinuous 
SDS-PAGE. To prepare the 9 % polyacrylamide separating gel, 10.8 
ml distilled water was mixed with 6 ml solution A and 7 ml 
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solution B. It was filtered and deaerated. The gel solution was 
casted into the vertical gel glass plates of sizes 15 x 13 x 0.11 
cm (h X w X d) after the addition of 6 i^l TEMED and 72 |il 10 % 
ammonium persulphate. A layer of water saturated 1-butanol was 
laid on the top to assist the formation of a straight line 
interphase. After the separating gel was set, the 3 % 
polyacrylamide stacking gel was made by mixing 5.2 ml distilled 
water with 2 ml solution C and 0.8 ml solution B. It was 
filtered and deaerated. The gel was casted after the addition 
of 6 TEMED and 24 |Lll 10 % ammonium persulphate with comb to 
form wells of sizes 2 x 0.7 x 0.11 cm (h x w x d). 
Electrophoresis 
Different fractions (5 mg) were dissolved in 20 |Xl 2 x SDS 
loading buffer and heated in a 100°C water bath for 3 min. The 
ppt. was then spun down at 11, 000 rpm for 15 min. After the 
supernatants were loaded into wells, electrophoresis was started 
(with cathode on the top) at a constant voltage of 200 V for 1 
h. The current was 108 mA at the beginning. The current was 
dropped to 68 mA when the bromophenol dye reached to the bottom. 
The gel was fixed in the destaining solution for 1 to 2 h. 
Protein staining was performed by placing the gel in Coomassie 
Blue staining solution at 37°C for 2 h. Destaining was carried 
out at room temperature (r. t. ) and assisted with the addition of 
mixed bed resin AG 501-X8 (Bio-Rad) to absorb the excess stain 
in the destaining solution. Periodate Schiff reagent was used 
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for carbohydrate staining (Laemmli, 1970). After the gel was 
fixed, carbohydrate staining was performed by placing the gel in 
0.2 % aqueous periodic acid and storing at for 45 min. The 
gel without rinsing was then placed in Schiff's reagent (BDH) at 
40c for 45 min. Destaining was carried out at r.t. with 2 or 3 
changes of 10 % acetic acid. 
3.2.9 Determination of the bio-toxicity of samples 
The bio—toxicity of different fractions was determined by 
the brine shrimp assay (Anderson et al. , 1991； Meyer et al., 
1982) . Ten shrimp per vial (30 shrimp per dilution) was counted. 
Individual fraction at 1000, 100, I6 )Llg/ml was mixed with the 
brine shrimp {Artemia salina LEACH), the volume of solution was 
adjusted to 5 ml/vial with sea water. The number of shrimps 
being killed was counted 2 days later and the toxicity (LC50) was 
determined. LC50 is defined as the concentration of sample 
(|lg/ml) which causes 50 % of the total shrimps death in the brine 
medium. Berberine chloride and hippuric acid were used as 
positive controls. 
3.2.10 Treatment of samples with sodium periodate or acetic acid 
Samples (2 mg/ml) were either oxidized with 0.02 M sodium 
periodate at 4°C for 24 h or boiled in 1 % (v/v) acetic acid at 
lOQoc for 90 min.. In the case of acetic acid treatment, lipid 
A was removed by centrifugation. Both treated samples were 
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dialysed (with Spectra/POR dialysis tubing) in distilled water 
at 40c for 18 h to remove the salts. The remaining solution was 
then lyophilized. 
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(11) ASSAYS OF IMMUNOMODULATORY ACTIVITIES OF 
PSEUDOSTELLARIA HETEROPHYLLA ON LYMPHOCYTES 
3.2.11 Isolation and preparation of cells 
Human cord blood lymphocytes 
Human heparinized cord blood was obtained from the Prince 
of Wales Hospital. Human cord blood lymphocytes were prepared 
according to Boyum (1968)• Blood was diluted 1 ： 1 with plain 
RPMI medium and then layered onto a 50 ml centrifuge tube 
containing an equal volume of Ficoll-paque solution (Pharmacia, 
Sweden) and centrifuged at 2000 x g for 15 min at 20^C. The cord 
blood lymphocytes collected at the interface were washed three 
times with plain RPMI before use. 
Murine spleen lymphocytes 
Spleen cell suspensions were prepared from the spleens of 
BALB/c mice. The spleens were removed aseptically, gently cut 
into small pieces with a pair of fine scissors and pressed gently 
through a 2 0 0-gauge stainless steel sieve, and washed with RPMI 
medium (3 00 x g, 2 min) . Viable lymphocytes were obtained by 
Ficoll-paque (Pharmacia Fine Chemicals, Sweden) gradient 
centrifugation (400 x g, 15 min) of spleen cell suspension. The 
lymphocytes were then washed twice with RPMI medium and 
resuspended in RPMI medium supplemented with 10 % FCS. 
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Murine thymocvtes 
Thymocytes were prepared from the thymuses of BALB/c mice. 
The thymuses were pressed gently through a 200-gauge stainless 
steel sieve and washed twice with RPMI medium (400 x g, 2 min) • 
The thymocytes were suspended in RPMI medium supplemented with 
10 % FCS. 
Murine peritoneal exudate cells (PEC) 
Mice were killed by cervical disloca_tion. The skin was 
cleaned with 70 % ethanol. The skin of the abdomen was cut and 
pulled apart. Ice-cold HBSS (5 ml) was injected i . p . . 
Peritoneal fluid was collected by using a 5 ml syringe fitted 
with a 20-gauge needle. The peritoneal cavity of mouse was 
lavaged three times. The cells were spun down at 300 x g for 5 
min at 4^0 and washed with cold HBSS twice before use. 
Bone marrow cells 
The femurs were removed and put into a petri dish containing 
cold RPMI complete medium. Using a 2 ml syringe with 25 G 
needle, the marrow plugs were flushed into RPMI complete medium. 
The cells were spun down at 300 x g for 5 min and red cells were 
removed by Ficoll-paque gradient centrifugation. The bone marrow 
cells were washed twice with plain RPMI medium and resuspended 
in complete RPMI medium. 
49 
Materials and methods 
3.2.12 In vitro lymphocyte transformation assay 
Murine spleen lymphocytes were cultured in the presence or 
absence of samples in 96-well flat-bottomed microtiter plates 
(Nunc, Denmark) at a cell density of 5 x 10^ cells/well in a 
total volume of 0.2 ml. Microtiter plates were incubated at 37oc 
in a humidified atmosphere with 5 % C〇2-95 % air for 2 days. In 
the last 6 h of incubation, 0.5 microcurie (jlCi) tritiated 
thymidine (^H-TdR) (Amersham, U.K.) in 50 jil volume was added 
into each well. Lymphocytes were collected on glass fibre 
filters by a Titertek cell harvester (Flow Lab., U.K.). 
Incorporation of ^H-TdR into cells was determined by a liquid 
scintillation counter (Beckman, LS-1801, U.S.A.). Results were 
expressed as the arithmetic mean stimulation index (S.I.) 土 S.D. 
of triplicate cultures (S.I. 二 cpm in test cultures per cpm in 
control cultures). 
3.2.13 Mixed lymphocyte culture 
BALB/c lymphocytes at a concentration of 5 x 10"^  cells/ml 
were incubated with 25 jO^g mitomycin C per ml cell suspension for 
3 0 min. at 37°C with occasional shaking. The cells were then 
washed three times with RPMI medium and resuspended in complete 
RPMI medium. The mitomycin C treated BALB/c splenocytes were 
thus inhibited to respond to allogenic stimulation. They were 
used as the allogenic stimulator in the mixed lymphocyte reaction 
using C57BL/6J lymphocytes as the responder. Mitomycin C treated 
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BALB/c spleen cells (5 x 10^) were co-cultured with an equal 
number of C57BL/6J lymphocytes in a final volume of 0.1 ml 
complete RPMI medium in each well of a flat-bottomed 96-well 
microtiter plate. After incubation for 72 h in a humidified 
atmosphere with 5 % CO? — 95 % air at 37°C, the cells were pulsed 
with 0.5 |lCi 'H-TdR in 50 RPMI for 20 h. The incorporation of 
^H-TdR into cells was determined by a liquid scintillation 
counter. Results were expressed as the arithmetic mean S.I. 土 
S.D. of triplicate cultures. 
3.2.14 Depleting mouse T cells by anti-Thy-1.2 antibody plus 
complement treatment 
Monoclonal anti-Thy 1.2 antibody (40 jil) was added to 2 ml 
spleen cell suspension (2 x lO? cells/ml) at a final antibody 
dilution of 1 ： 1,000. The rrdxture was then incubated at r.t. 
for 3 0 min. The cells were spun down and resuspended in 2 ml 
guinea pig complement (diluted 1 ： 5 with RPMI medium) for 45 min 
at 37°C to lyse the T cells. The viability of the remaining 
cells was measured by trypan blue dye exclusion method. The 
cells were then washed two times with RPMI ajid resuspended to 5 
X 106 cells/ml in RPMI complete medium. 
3 .2.15 Depleting mouse B cells by anti-mouse B cell antibody plus 
complement treatment 
Monoclonal anti-mouse B cell-antigen antibody was added to 
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2 ml spleen cell suspension (2 x 10' cells/ml) at a final 
antibody dilution of 1 ： 10,000. The mixture was then incubated 
at r.t. for 30 min. The cells were spun down and resuspended in 
2 ml guinea pig complement (diluted 1 ： 5 with RPMI medium) for 
45 min at 37^0 to lyse the B cells. The viability of the 
remaining cells was measured by trypan blue dye exclusion method. 
The cells were then washed two times with RPMI and resuspended 
to 5 X 106 cells/ml in RPMI complete medium. 
3.2•16 Haemolytic plaque assay 
The method of Cunningham and Szenberg (1968) was adopted 
with slight modification. Briefly, BALB/c mice, either untreated 
or treated with samples, were immunized i .p. with 2 x 10® sheep 
red blood cells (SRBC) (Serotec, U.K.). Four days after SRBC 
immunization, spleen cells were prepared and suspended at 3 x lO? 
and 6 x l O V m l in complete RPMI medium. SRBC (20 % in PBS) in 50 
\il and 50 |ll of Hemo-Lo guinea pig complement (diluted 1 ： 2.5) 
were added to 100 [ll of the above spleen cell suspensions. A 
measured volume (about 45 |Lll) of this splenocytes-SRBC-complement 
mixture was added to each micro-chamber formed between two glass 
slides adhered together by strips of double-sided Scotch tape. 
The open edges of the microchambers were sealed with melted 
paraffin wax. Microchambers containing the cell mixture were 
laid flat and incubated for 1 h at SV^C. IgM plaques were 
counted under an inverted microscope. A true plaque-forming cell 
(PFC) possesses a central cell, a circular plaque and visible red 
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cell ghosts within the plaque. Results were expressed as the 
number of PFC per 10^ spleen cells. 
3.2.17 Delayed-type hypersensitivity (DTH) 
The procedure described by Leung et al (1986) was followed. 
On day 0, BALB/c mice in groups of 3 were given an i.v. injection 
of 1 X 106 SRBC in 0.2 ml PBS for sensitization. On day 1 and 2, 
2 mg of each fraction in 0.2 ml PBS was injected i.v.. Control 
mice were injected i.v. with an equal volume of PBS. On day 4, 
the left and right hind footpad thickness of mice were measured 
using a Schnelltaster caliper (Kroplin, Germany) and their mean 
footpad thickness was determined. Each mouse was then challenged 
with 10® SRBC in 50 |Lll of PBS, injected subcutaneously (s.c.) 
into each right hind footpad. An equal volume of PBS was 
injected into the left hind footpad as self-control. Footpad 
swelling was measured at 24, 48 and 72 h after antigen challenge 
and results were expressed as the percentage mean increase in 
footpad thickness (Leung et al, 1980) which was calculated as 
follows : 
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Tr - T1 
% mean increase in footpad thickness = x 100 % 
Ta 
where 
Tr : Thickness of right hind footpad 
Tl : Thickness of left hind footpad 
Ta ： Mean thickness of left and right footpad of all 
experimental animals before challenge 
3.2.18 Immunofluorescent assay for interleukin-2 receptor 
expression 
BALB/c mouse lymphocytes (10^) in 1 ml RPMI complete medium 
were added into the wells of a 24-well plate in the presence of 
Con A (1 jiig/ml) or various concentrations of PH-I. The culture 
was incubated for 3 days at 37^0 in a humidified atmosphere 
containing 5 % C02-95 % air. Lymphocytes (10^) were mixed with 
0.1 ml of diluted (1:40) rat anti-mouse IL-2 receptor IgG and 
incubated in ice for 3 0 min with once agitation during the 
incubation. After incubation, the mixture was washed twice with 
plain RPMI medium to remove unbound first antibody. The cell 
pellet was then resuspended in 100 |ll of diluted (1:32) FITC-
conjugated rabbit anti-rat IgG. After 1 h incubation at 37°C in 
a shaking water bath, cells were washed twice with plain RPMI 
medium to remove unbound second antibody. Finally, the cells 
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were resuspended in 100 mounting medium and examined under an 
incident UV light microscope. The % of fluorescing (IL-2 
receptor positive) cells were counted. 
3.2.19 Assay of murine interleukin~2 
IL一2 activity in the culture medium was determined by the 
proliferation of IL-2 dependent CTLL-2 cells (Leung et al., 
1986) • CTLL-2 cells were harvested from in vitro culture, washed 
with plain RPMI medium and resuspended in complete RPMI medium 
at a density of 2 x 10' cells/ml. Test samples (50 [il) with 
serial two fold dilutions were mixed with 1 x 10^ CTLL-2 cells in 
50 |ll in triplicates. The culture was incubated for 24 h at 37°C 
in a humidified atmosphere of 5 % C〇2 in air. The cells were 
then pulsed with 0.5 jlCi ^H-TdR per well for 6 h and harvested 
onto glass fibre filter by a semi—automatic Titertek cell 
harvester. The incorporated radioactivity was determined by a 
liquid scintillation counter. Murine recombinant IL-2 (Genzyme, 
U.S.A.) was used as standard. 
(工工工） A S S A Y S OF IMMUNOMODULATORY ACTIVITIES OF 
PSEUDOSTELLARIA HETEROPHYLLA ON MACROPHAGES 
3.2.20 Assay of murine interleukin-1 
The method of Falk et al (1987) was used. BALB/c thymocytes 
(5 X lOVwell) were cultured with MurIL-2 (25 or 50 U/ml), 2-ME 
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(5 X 10-5 ⑷ and different IL-l samples in serial two fold 
dilutions. The mixtures were incubated at 37^0 for 3 days before 
harvest. Four hours prior to harvest, 0.5 |LlCi of ^H-TdR was 
added to each well. The incorporation of ^H-TdR into cells was 
determined by a liquid scintillation counter. The data represent 
the mean of triplicate cultures given as cpm. 
3.2.21 In vivo migration of macrophages 
The method described by Gervais et al• (1984) was followed 
with minor modification. C57BL/6J mice in group of four were 
either injected i.p. with different fractions or an equal amount 
of PBS on day 0. Picolinic acid (PLA) (2.5 mg in 0.5 ml PBS) was 
injected i .p . on day 2. Peritoneal exudate cells (PEC) of 
individual mouse were harvested and counted on day 5. 
3-2.22 Assay of phagocytic activity of peritoneal macrophages 
The spectrofluorometric method of Ragsdale and Grasso (1989) 
was used with slight modification. PEC (2 x 10^) in 1 ml RPMI 
complete medium were added to each well of 24-well plate and 
incubated at 37^0 with 5 % C02-95 % air for 4 h. The non-
adherent cells were washed away with RPMI mediuni. The 
macrophages were then incubated with 0.5 ml Zymosan A 
Bioparticles {R} {S. cerevisiae) , B〇DIPY{R} FL conjugate 
(Molecular Probes) (16 jLlg/ml in RPMI complete medium) at 37°C 
with 5 % CO2-95 % air. After different periods of time, the 
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macrophages were washed three times with PBS and lysed by 
addition of 0.5 ml of 1 % SDS. The lysate was mixed with 1.5 ml 
water and its fluorescence was measured by a Luminescence 
Spectrometer LS50 (Perkin Elmer) with an excitation of wavelength 
of 488 run and an emission wavelength of 515 nm. The protein 
concentration of the lysate was determined by the Lowry method. 
The phagocytic activity of macrophages was expressed as 
fluorescence per jilg protein of macrophages. 
3.2.23 Northern blotting of mRNA of iS-actin gene extracted from 
peritoneal exudate cells 
RNA extraction 
Peritoneal exudate cells (5 x 10” harvested from ICR mice 
were lysed with l&O jLll lysis buffer. Seven volume of 4 M lithium 
chloride was added to the lysate and incubated overnight at . 
The cells debris was spun down at 1,000 rpm for 5 min. at 4°C. 
The supernatant was collected and then centrifuged at 9000 rpm 
for 25 min at 4°C . The supernatant was discarded and the pellet 
was resuspended in 1 ml 3 M lithium chloride. The sample was 
centrifuged at 9000 rpm for 20 min at 4°C and the pellet obtained 
was resuspended in 0.7 ml solubilization buffer. The above 
sample was freezed with liquid nitrogen and then thawed. The 
pellet was vortexed v\7hile it thawed. The freezing and thav\7ing 
processes were repeated twice. The sample was extracted once 
with an equal volume of phenol and spun at 10, 000 rpm for 5 min 
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at room temperature. The upper aqueous layer was collected and 
extracted once with an equal volume of phenol-chloroform-isoamyl 
alcohol (25 : 24 : 1). The sample was spun at 10,000 rpm for 3 
min at room temperature. The upper aqueous layer was collected 
and extracted once with an equal volume of chloroform-isoamyl 
alcohol (24 : 1) . The sample was spun at 10, 000 rpm for 3 min 
at room temperature and the upper aqueous layer was collected. 
Sodium acetate (3 M) with 1/10 volume was added to the upper 
aqueous layer and then ice cold ethanol (2.5 volume) was added. 
The RNA was precipitated out at -70°C for 1 h and spun down at 
9,000 rpm for 10 min. at 4°C. The supernatant was discarded. 
The pellet was washed with 1 ml 70 % ethanol and centrifuged at 
9,000 rpm for 10 min. . The supernatant was discarded and the 
ethanol was evaporated out. The extracted RNA was resuspended 
in 10 - 20 [ll TE buffer (pH 7.5). One |ll RNA sample was taken 
out and diluted with 400 jlll TE buffer for O.D.260 and O.D.280 
determination. The RNA concentration (^ig/ml) 二 〇.D.26o x 400 x 
40. The RNA was stored at -70°C. 
Mini-gel electrophoresis 
Electrophoresis of the RNA was done in a 1 % agarose gel 
containing 18 % formaldehyde. MOPS buffer was used as the 
running buffer. RNA (5 }lg) was dissolved in loading buffer 
containing 1 jig EtBr in a final volume of 20 {ll. The RNA sample 
was applied onto the gel and run for 1.5 h at 50 V. RNA bands 
were observed under variable-intensity transilluminator (312nm 
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UV). 
Northern blotting 
After mini—gel electrophoresis, the gel was cut and washed 
with water followed by 20 x SSC. A sheet of Whatman 3 MM paper 
was placed on an inverted gel casting tray and its two ends were 
immersed in a steel tank containing 20 x SSC. The gel was then 
put on the Whatman 3 MM paper bridge which was soaked with 20 x 
SSC. The nylon membrane (Zeta-probe, Bio-Rad) was first soaked 
in water and then in 20 x SSC before putting onto the gel. Two 
pre-cut sheets of Whatman 3 MM papers were placed on the 
membrane. A plastic wrap was spread over the gel and the 3 MM 
paper stack. A window was cut with a razor blade so that only 
the gel was allowed to emerge from the window. Two 20 x SSC 
soaked sponges followed by two dry sponges were placed over the 
Whatman paper. The sponges were pressed by putting a plastic 
plate on top of them. The transfer was continued for 24 h. 
After the transfer was completed, the nylon membrane was washed 
with 2 X SSC. The RNA on the nylon membrane was then UV 
crosslinked in a XL-1000 UV crosslinker (Spectronics 
corporation). 
Mecraprime DNA labelling 
Amersham's Megaprime DNA labelling system was used for the 
cDNA probe labelling with ^^ P. Firstly, cDNA probe was dissolved 
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in TE buffer to 25 ^g per ml. Two cDNA probe and 10 primer 
was added into 55 |Lll DEPC-treated distilled water and heated at 
lOOoc for 5 min. Megaprime reaction buffer (20 叫 ， [ a - ^ ' P ] d C T P 
with 102 in 10 |Lll (PB 10205, 3000 Ci/mmol, Amersham) and 
enzyme (50 ng in 4 pi) were then added and incubated at 37^0 for 
10 min. The reaction was stopped by the addition of 10 \il of 0.2 
M EDTA. The unincorporated nucleotides were separated from the 
32p—labelled cDNA probe by a Sephadex G—50 column in STE buffer. 
Briefly, 100 |ll of the mixture was applied to a Sephadex G-50 
column (1 ml) and spun at 3000 rpm for 5 min. Afterwards, STE 
I ‘ 
solution (100 |Lll) was used to rinse the column by spinning at 
3 000 rpm for 5 min. The 200 )J.l eluate which contained the ^^p. 
labelled cDNA probe was used for hybridization. 
Prehvbridization and hybridization 
Prehybridization buffer (12.5 ml) was added into a 
hybridization bottle containing the nylon membrane. The 
hybridization bottle was incubated in a 42°C incubator for at 
least 3 h with rotation. The prehybridization buffer was then 
discarded. Prehybridization buffer (12.5 ml) was again added to 
the hybridization bottle. ^^P-labelled cDNA probe (200 |LLl) was 
added to the hybridization bottle and hybridized for 18 h at 42°C 
with rotation. After hybridization, the hybridization buffer 
and excess ^^P-labelled cDNA probe was discarded. The nylon 
membrane was washed twice with 2 x SSC at r.t.. The nylon 
membrane was then washed by 0.5 x SSC, 0.1 % SDS solution 
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followed by 0.1 X SSC, 0.1 % SDS solution at 42。C with rotation 
for 15 min. Autoradiography was carried out by exposing the 
nylon membrane with the Amersham Hyperfilm-MP for 5 h at -VQoc. 
The film was then developed and the signals on the film could be 
obtained. The signals on the film were semi-quantitated with 
optical densitometry using 2202 Ultroscan Laser Densitometer and 
222 0 Recording integrator (LKB). 
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(IV) ASSAYS OF ANT工-TUMOR ACTIVITIES OF 
PSEUDOSTELLARIA HETEROPHYLLA 
3 -2 .24 Assay of anti-tumor activity in vitro 
To study the effect of different fractions on the growth of 
different tumor cells in vitro, tumor cells were cultured in 
microtiter plates in a total volume of 0.2 ml RPMI medium 
supplemented with 10 % HIFCS in the presence or absence of 
samples. Microtiter plates were incubated at 37°C in a 
humidified atmosphere with 5 % CO〗一95 % air for 2 days. In the 
last 6 h of incubation, 0.5 |LLCi ^n-TdR was added into each well. 
Cells were collected on glass fibre filters by a Titertek cell 
harvester. Incorporation of ^H-TdR into cells was determined by 
liquid scintillation counting. In case of adherent cells, 50 |il 
of 1 M NaOH was added to each well so as to detach the adherent 
cells from the plastic surface before the normal harvesting 
procedure was performed. Results were expressed as % suppression 
士 S.D. of triplicate cultures. % Suppression = [100 x (Control— 
treatment)/control] %, where "control" is the ^H-TdR 
incorporation in the absence of samples and "treatment" is the 
^H-TdR incorponration in the presence of samples. LC50 is defined 
as the concentration of different fractions which gives a 50 % 
suppression of tumor cell proliferation. 
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3.2.25 Assay of anti-tumor activity in vivo 
To Study the effect of different fractions on the growth of 
EAT tumor in vivo, ICR mice in groups of five were injected 
intraperitoneally (i.p.) with 500 [ig samples in 0.2 ml PBS for 
five consecutive days (day 0 - 4) . The control group was 
injected with PBS only. On day 2, 1 x 10^ EAT cells were 
inoculated i.p. into each mouse. On day 9, EAT cells in the 
peritoneal cavity of each mouse were harvested by exhaustive 
drainage. Cells were counted with a haemocytometer and viability 
was determined by the trypan blue exclusion method (Philip, 
1973). 
3-2.26 Priming effect of different fractions for the induction 
of TNF-a in mice 
On day 0, 5 mg zymosan or samples in 0.5 ml PBS was injected 
i.p. in groups of three ICR mice. On day 6, 25 jig LPS or 
different doses of samples in 0.2 ml PBS was injected 
intravenously (i.v.) into the primed mice. Two hours later, 
serum was obtained and tumor necrosis factor (TNF) titre in mouse 
serum was determined by the mouse tumor necrosis factor ELISA 
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3.2.27 In vitro stimulation of TNF-a release from resting 
peritoneal macrophages 
Individual fractions at different concentrations were 
incubated with adherent peritoneal macrophages from ICR mice 
(106/ml) for 24 h at 37°C in a humidified atmosphere of 5 % CO。 
in air. The supernatants were harvested and their TNF-a titers 
were determined by a mouse TNF-a ELISA test kit (Genzyme) using 
the recombinant murine TNF-a as the standard. 
3.2.28 Effects of P. heterophyl1a polysaccharides on TNF-a 
and IFN-gamma production as well as EAT growth in vivo 
Male ICR mice, about 3 0 — 3 5 g, were used in all experiments. 
eat was maintained by weekly i.p. implantation in mice. Mice in 
groups of ten were inoculated i .p. with 1 x 10^ EAT cells 
harvested from 7 day-old tumors in 0.2 ml PBS on day 0. On day 
6, each mouse was injected i.v. with 2 mg P. heterophylla 
fractions in 0.2 ml PBS. Three to four mice from each group were 
bled from subclavian vessels to obtain the serum while ascitic 
fluid was collected from the peritoneal cavity 2 h after the 
injection. TNF-a and 工 F N - g a m m a titers in the pooled sera and 
ascitic fluids were determined by the mouse TNF-a and IFN-gamma 
ELiISA test kits (Genzyme, U.S.A. ) using recombinant mouse TNF-a 
and recombinant IFN-gamma as the standard respectively. The 
remaining 6-7 mice in each group were scarified on day 7, EAT 
cells in each mouse were harvested from the peritoneal cavity and 
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counted. Pooled cells were washed once with half-isotonic 
solution to remove the erythrocytes. The final cell suspension 
was prepared in PBS. Cells were counted with a haemacytometer 
using 0.3 % trypan blue. 
3.2.29 Macrophage-mediated cytostatic activity 
Different fractions were injected i.p. into each C57BL/6J 
nvouse on day 0. Control mice were injected with PBS only. As 
cytostatic peritoneal exudate cells (PEC) were obtained in vivo 
by activation with picolinic acid (PLA) (Ruffmann et al. , 1984), 
so on day 2, freshly prepared solution of PLA in PBS at a 
concentration of 5 mg/ml was injected i .p . into each mouse (2.5 
mg per 25 g body weight) . Three days later, the PEC were 
harvested with cold HBSS. After washing two times with HBSS, the 
cells were resuspended in complete RPMI medium at 2.5 x l O V m l . 
PEC suspension in 0.1 ml was added into each well of a flat-
bottomed 96— •well microtiter plate. After 6 h of incubation at 
370c, non-adherent cells were removed by three washes with warm 
RPMI medium. MBL-2 cells (10” and LPS (2 ng/ml) were added to 
each well in a final volume of 0.2 ml. After incubating for 48 
h at 37°C in a humidified atmosphere containing 5 % C02-95 % air, 
the cells in each well were pulsed with 0.5 jllCi ^H-TdR and then 
harvested 5 h later using a Titertek cell harvester. Results 
were expressed as percentage growth suppression of MBL-2 cells 
induced by the activated macrophages as follows ： 
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^H-TdR incorporation of MBL-2 
cells in the presence of 
macrophages 
% Suppression = 1 — x 100 % 
^H-TdR incorporation of MBL-2 
cells in the absence of 
macrophages 
1 
3.2.30 Assay of lymphokine-activated killer cell activity 
A modification of the colorimetric assay (Mullbacher et al., 
1984) was used to determine the lymphokine—activated killer (LAK) 
cell-mediated cytotoxicity. WEHI-164 cells, which are known to 
be LAK-sensitive but NK-resistant, were used as target cells. 
WEHI-164 cells (4 x 10” was seeded onto each well of a 96-well 
microtiter plate and incubated at 37^0 overnight. The medium was 
flicked off and the cells were washed with RPMI. Effector cells 
were generated from splenocytes which had been pretreated with 
recombinant IL-2 (50 U/ml) and/or different fractions (100 |Xg/ml) 
for 3 days at 37°C. Effector cells (10^) in 0.1 ml volume were 
added to the target cells (4 x lOVwell) so that the 
effector/target ratio was 2 5 : 1 . After 24 h incubation at 37°C, 
the cell mixtures were washed once gently with warm PBS. Fifty 
microliters neutral red solution (0.5% w/v in normal saline) was 
added to each well and the mixtures were incubated at 37°C for 
30 min. Excess neutral red was washed away with warm PBS and the 
plate was completely dried in an oven at 60 — 70°C. Finally, 100 
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1 % SDS was added to each well and mixed at a titertek 
microplate shaker (Flow Lab., U.K.) until all the dye was 
completely dissolved. The absorbance in each well was read at 
540 run using a microplate reader (Bio—Rad Model 3550, U.S.A.) and 
the results were expressed as the % cytotoxicity on WEHI—164 
cells which was calculated as follows ： 
C - T 
% cytotoxicity on WEHI-164 cells 二 x 100 % 
C 
Where C = O.D.540 of control (without effector cells) and 
T 二 O.D.540 of test culture (with effector cells) 
3.2.31 Assay of natural killer cell activity 
NK activity was measured by the ^^Cr release method as 
described previously (Leung et al. , 1981) . Briefly, 5 x 10^ YAC-
1 cells were labelled with 1 mCi Na2^^Cr04 (Amersham, specific 
activity : 250-500 mCi/mg) for 1 h at 37^0 with occasional gentle 
shaking. The cells were then washed twice with RPMI medium and 
cell concentration was adjusted to 2 x l O V m l in RPMI medium 
supplemented with 10 % HIFCS. Different concentrations of 
effector cells in RPMI medium supplemented with 10 % HIFCS (0.1 
ml) were added onto a 96-well plate and mixed with 2 x 10^ ^^Cr-
labelled YAC-1 target cells (0.1 ml) so that the effector to 
target cell ratios were 50 ： 1 and 100 : 1. After 4 h incubation 
at 370c, 0.1 ml of supernatant was sucked up and counted for 
radioactivity in a gamma counter (Kontron). For determination 
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Of spontaneous releasable ^^Cr determination, 0.1 ml RPMI medium 
supplemented with 10 % HIFCS was added to 0 .1 ml labelled target 
cell. For determination of maximum releasable ^^Cr 
determination, 0.1 ml 10 % triton x-100 was added to 0.1 ml 
labelled target cells. The percentage specific cytolysis was 
calculated as follows ： 
% Specific cytolysis 
Test culture counts — Spontaneous release counts 
— X 100 % 
Maximum release counts - Spontaneous release counts 
3.2.32 Assay of tumor-infiltrating lymphocytes 
The method of Mizutani and Yoshida (1991) was adopted with 
slight modification. Briefly, 2 x 10^ WEHI-164 in 0.2 ml PBS was 
inoculated s.c. into the back of each BALB/c mice on day 0. 
Fraction from P. heterophylla was injected i .p. on day 16 to day 
22 . On day 23, TILs were isolated from the sarcoma. Sarcoma was 
dissected out and finely minced in RPMI medium. Cell suspension 
was prepared by treating tumor tissue in 5 ml HBSS supplemented 
with collagenase (0.06 mg/ml, Sigma), DNase (0.1 mg/ml, Sigma) 
and Dispase I (0.168 mg/ml, Boehringer) at 37^0 for 1.5 h with 
occasional shaking. The various cell components were loaded onto 
discontinuous gradients consisting of 10 ml of 100 % and 15 ml 
of 75 % Ficoll-paque in 50 ml plastic centrifuge tubes and was 
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centrifuged at 3000 rpm for 30 minutes. Lymphocytes-rich 
mononuclear cells were concentrated in the 100 % interface, tumor 
cells and mesothelial cells in the 75 % interface, and 
erythrocytes, polymorphonuclear cells and aggregated tumor cells 
at the bottom of the tube. The lymphocytes were collected and 
washed with RPMI medium. Monoclonal anti-Thy 1.2 antibody (at 
a final dilution of 1 ： 1,000) was added to 1 ml lymphocyte 
suspension (2 x 10' cells/ml) • The mixture was then incubated at 
r.t. for 30 min. The cells were spun down and resuspended in 1 
ml guinea pig complement (diluted 1 ： 5 with RPMI medium) for 45 
min at SV^C. The % of TILs of the cell population was determined 
by trypan blue dye exclusion method. 
(V) ASSAYS FOR THE EFFECTS OF 
PSEUDOSTELLARIA HETEROPHYLLA ON THE PROLIFERATION AND 
DIFFERENTIATION OF MURINE BONE MARROW 
CELLS AND MYELOID LEUKAEMIC Ml CELLS 
3.2.33 Assay of proliferation of murine bone marrow cells 
Murine bone marrow cells were cultured in the presence or 
absence of samples in 96-well flat-bottomed microtiter plates at 
a density of 1 x 10^ cells/well in a total volume of 0.2 ml. 
Microtiter plates were incubated at 37°C in a humidified 
atmosphere with 5 % CO2 —95 % air for 3 days. Tritiated thymidine 
(0.5 |lCi) in 50 |Lll volume was added into each well. One day 
later, the culture was freezed and then thawed once. DNA of bone 
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marrow cells were collected onto glass fibre filters by a 
Titertek cell harvester. Incorporation of ^H-TdR into cells was 
determined by a liquid scintillation counter. Results were 
expressed as the arithmetic mean S.I. 土 S.D. of triplicate 
cultures. 
3.2.34 Assay of differentiation of murine bone marrow cells 
Murine bone marrow cells (10^ cells per well) were seeded 
onto a 96-well microtiter plate. They were treated with 
recombinant mouse interleukin , or different fractions in 0 .2 
ml RPMI complete medium for 3 days at 37^0 in a humidified 
atmosphere with 5 % 00^-95 % air. The differentiation—inducing 
activity of different samples was evaluated by morphological 
staining using Hemacolor Rapid Blood Smear staining set (Merck). 
Briefly, 0.1 ml cells was taken out and fixed on a slide by a 
cytospin (500 rpm, 5 min) . The slide was firstly immersed five 
times for one second each time into solution 1 of the staining 
set. Then the slide was immersed three times for one second into 
solution 2. Afterwards, the slide was immersed six times for one 
second into solution 3 . The excess dye was rinsed by the buffer 
solution (pH 7.2). The morphology of bone marrow cells on the 
slide was examined and photographed under a light microscope 
(Olympus). 
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3.2.35 Assay of differentiation of Ml cells 
Mouse myeloid leukaemic Ml cells (1.5 x lOVwell) were 
seeded onto a 24-well plate. They were either treated with 
different fractions (250 jUg/ml) or recombinant mouse leukaemia 
inhibitory factor (LIF) (500 U/ml) in 1 ml RPMI complete medium 
for 3 days at 37oc in a humidified atmosphere with 5 % C〇2-95 % 
air. The differentiation-inducing activities of LIF and 
different fractions were evaluated by morphological staining 
using Hemacolor Rapid Blood Smear staining set (Merck). 
3-2.36 Induction of GM-CSF from bone marrow cells and Ml cells 
Murine bone marrow cells (10^ cells per well) were seeded 
onto a 96-well microtiter plate. They were treated with MurIL_3, 
L929 conditioned medium or different fractions in 0.2 ml RPMI 
complete medium for 3 days at 37°C in a humidified atmosphere 
with 5 % C〇2-95 % air. In the case of Ml cells. Ml cells (1.5 x 
104 cells per well) were seeded onto a 24 well plate. They were 
treated with MurIL-3 or different fractions in 1 ml RPMI complete 
medium for 3 days at 37^0 in a humidified atmosphere with 5 % 
CO2-95 % air. GM-CSF in the culture supernatants of bone marrow 
cells and Ml cells was assayed by a murine GM-CSF ELISA kit 
(Endogen, U.S.A.) using murine recombinant GM-CSF as the 
standard. 
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(VI�ASSAYS FOR THE IMMUNORESTORATIVE PROPERTIES OF 
PSEUDOSTELLARIA HETEROPHYLLA 
3.3.37 Immunorestoration in tumor-bearing mice 
〇n day 0, ICR mice in groups of five were either untreated 
(Group A) or inoculated i.p. with 10^ EAT in 0.2 ml PBS (Group B 
and C). Group B mice were injected i .p . with 500 ^g of PH-I in 
0.2 ml PBS while Group C mice were injected with an equal volume 
of PBS on day -2, -1, 0, 1, 2. On day 7, splenic lymphocytes 
were prepared from these 3 different groups of mice and assayed 
for the. Con A or LPS induced lymphocyte proliferation. 
3-2.38 Immunorestoration in aged mice 
C57BL/6J mice of three different age groups (7 weeks, 5 
months and 18 months) were used in the present experiment. Mouse 
in each group was either injected i.p. with PH—工 A (200 |ig in 0.2 
ml PBS) or an equal volume of PBS on day 0 to 5. On day 6, 
lymphocytes were prepared and added onto the wells (5 x lOVwell) 
of the 96—well plate. Mitogens at predetermined sub-optimal 
concentrations (1 |lg/ml of Con A, 10 |Llg/ml of LPS, 4 jLlg/ml of PHA 
and 20 |Llg/ml of DS) were then added. The cultures were incubated 
at 370c for 48 h and pulsed for 6 h with 0.5 |LlCi 3H-TdR per well. 
Incorporation of ^H-TdR into cells was determined by a liquid 
scintillation counter. Results were expressed as the arithmetic 
mean S.I. 土 S.D. of triplicate cultures. 
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3.2.39 工 i r a n u n o r e s t o r a t i o n in cyclophosphamide (CY)-treated mice 
〇n day 0 to day 2, 2 mg CY in 0.2 ml PBS was injected i .p. 
into BALB/c mice. On day 1 to day 5, 200 jig PH—工 A, PH-I B or 
PH—工 C in 0.2 ml PBS was injected i .p . into groups of three mice. 
〇n day 6, the number of splenic lymphocytes and the ratio of 
spleen weight to body weight in each group were determined. 
3.2.40 STATISTICAL ANALYSIS 
All results were expressed as the arithmetic mean 土 standard 
deviation (S.D.). The differences between control group and 
treatment groups were determined by the Student's t-test. P < 




EXTRACTION, FRACTIONATION AND CHARACTERIZATION 
OF MITOGENIC FRACTIONS FROM 
PSEUDOSTELLARIA HETEROPHYLLA 
INTRODUCTION 
There is increasing interest in the search for novel and 
effective compounds with immunomodulatory activities. Recently, 
various immunomodulating polysaccharides have been isolated from 
a number of Chinese medicinal plants (Gonda et al. , 1989； Haruki 
and Hiroaki, 1989; Lien and Gao, 1990) . These bioactive 
polysaccharides have been shown to be capable of stimulating or 
modulating the immune system, thus enhancing the immune 
surveillance against cancers (Ebina and Kohya, 1988) and bacteria 
(Tomioka et al. , 1992) in vivo. Besides polysaccharides, a small 
immunopotentiating polypeptide isolated from the crude extraction 
of polysaccharide peptide of Coriolus vesicalor was found to 
possess potent cytotoxic effect on human tumor cell lines (Yang 
et al., 1992). 
Although many Chinese medicinal herbs have been reported to 
display iiranunomodulatory activities, yet in most cases the 
bioactive- ingredients have not been unequivocally identified, 
thoroughly investigated and validated by modern 
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immunopharmacological m e t h o d s .工 have screened for several kinds 
of traditional Chinese herbs, Aconitum carm土chaeU, Cinnamomum 
cassia, Polygonum multiflorum, Pseudostellaria heterophylla and 
Salvia miltiorrhiza. Pseudostellaria heterophylla is chosen for 
my studies because its crude hot water extract showed the most 
potent mitogenic effect on murine lymphocytes in vitro. 
Pseudostellaria heterophylla is an Oriental mild crude drug with 
tonic effects. Its roots have been used to treat asthenia-
syndrome cases which manifest as insufficiency of vital energy. 
In view of the importance of P. heterophylla as a tonic drug, the 
isolation and characterization of the bioactive fractions from 
P. heterophylla might help to understand its mode of actions. 
Previous studies showed that many polysaccharides could 
activate the proliferation of B cells (Kumazawa et al. , 1982； 
Kumazawa et al. , 1985a； Kumazawa et al. , 1985b； Xie et al. , 1989) 
〇r T cells (Hamuro et al., 1978; Kumazawa et al., 1985a； Li et 
al•‘ 1990) in vitro. Besides polysaccharides, potent mitogenic 
activities for both human and/or mouse lymphocytes were found in 
the protein fractions of four crude drugs, namely, Bupleuri 
radix, Pinelliae tuber, Sophorae radix and Zedoariae rhizoma 
(Tachibana and Kawanishi, 1991). More recently, a protein—bound 
polysaccharides (PSP) isolated from Coriolus versicolor has been 
shown to stimulate IL-2 production from mouse splenocytes and 
activate the Con A—st imul a. ted. T lymphocyte proliferation in vi tiro 
(Li et al. , 1990) . Kumazawa et al (1985b) , on the other hand, 
showed that Angelica immunostimulating polysaccharide (AIP) could 
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Significantly activate the 工 g M and 工 g G antibody response against 
sheep erythrocytes (SRBC) in SRBC immunized mice. In addition, 
AIP could also induce the in vivo differentiation of murine B 
lymphocytes polyclonally into functionally matured antibody-
forming cells (Kumazawa et al • , 1985b). In this chapter, the 
extraction, fractionation and characterization of bioactive 
fractions from P. heterophylla will be reported. In addition, 
the effects of different fractions on the proliferation of T and 
B lymphocytes will be studied, both in vitro and in vivo. 
RESULTS 
4.1 Extraction and fractionation of Pseudostellaria heterophylla 
The roots of P. heterophylla (Fig. 4.1) were extracted by hot 
water (SO^C) to obtain the crude fraction designated as PH which 
gave a yield of 35.90 % by stepwise alcohol precipitation. Three 
distinct fractions with decreasing molecular weight were obtained 
and they were designated as PH-I, PH-II and PH-工工工 respectively. 
The fraction PH-工工工 showed a large yield (30.06 %). In contrast, 
a relatively low yield was seen in fractions PH-I (0.20 %) and 
PH-11 (0.24 %). 
4 .2 Gel filtration and anion-exchange chromatography 
As shown in Fig.4.2, PH—工 was size fractionated into PH—I 
A (15.0 %), PH-I B (31.0 %) and PH-工 C (36.3 %) by Sephadex G—100 
chromatography in descending order of molecular weights. Using 
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Fig.4.1 A diagram showing the roots of P. heterophylla. 
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Fig.4.2 Gel filtration of PH—I. PH-I (400 mg) was dissolved in 
4 ml distilled water and applied on to a Sephadex G-lOO column 
(2.5 X 90 cm) . Fractions were eluted with water. Fractions of 
12 ml were obtained at a flow rate 12 ml/h. Fractions 11 to 19 
were collected as fraction PH-I A. Fractions 20 to 30 were 
collected as fraction PH-I B. Fractions 31 to 38 were collected 
as fraction PH-I C. The relative amount of carbohydrate in each 




DEAE-Sephadex anion-exchange chromatography, PH-工 A was further 
purified into PH-I Aa (25.0 %) and PH-I Ab (75.0 %) (Fig.4.3 
(a)), PH-工 B was further purified into PH-I Ba (41.6 %) and PH-I 
Bb (35.6 %) (Fig.4.3 (b)) and PH-I C was further purified into 
PH-I Ca (40.1 %) and PH-I Cb (30.4 %) (Fig.4.3 (c) ) respectively. 
4.3 Characterization of bioactive fractions from 
Pseudostellaria heterophylla 
The carbohydrate and protein contents of various fractions 
are shown in Table 4.1. All fractions were found to contain 
mainly carbohydrate, a small amount of protein and some uronic 
acid. From the results, it seems obvious that the bioactive 
fractions are polysaccharides or proteoglycans. 
The purity of each fraction was analyzed by high performance 
liquid chromatography (HPLC)• The elution profiles of various 
fractions are shown in Fig.4.4. The molecular weights of the 
purified fractions which showed a single peak were determined by 
comparison with dextran standards. It was found that fractions 
PH-I A, PH-工 C, PH-I Ab and PH-工 Cb showed single peak in the 
elution profile. The molecular weights of PH-I A, PH-工 C, PH-I 
Ab and PH-I Cb were found to be 40000, 5000, 40000 and 5000 
respectively (Table 4.2) . PH—I A showed a single peak but PH-I 
Aa showed two peaks because PH-1 A and PH-工 Aa may be broken down 
into two fractions. 
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Fig .4.3 (a) Anion—exchange chromatography of PH-I A . PH—工 A (143 
mg) was dissolved in 1,5 ml of 10 mM NaCl phosphate buffer (pH 
8.0) and applied onto a DEAE Sephadex column (2.5 x 6 cm) . PH_I 
A a was eluted with 10 mM NaCl phosphate buffer (pH 8.0) and PH-I 
A b was eluted with 500 niM NaCl phosphate buffer (pH 8.0). 
Fractions of 10 ml were collected at a flow rate of 100 ml/h. 
Fractions 1 to 8 were collected as fraction PH—工 A a . Fractions 
15 to 23 were collected as PH-工 Ab. The fractions were then 
dialysed against distilled water with benzolated dialysis tubing 
having a cut off value of 6,000-8,000 to remove salts. The 
relative carbohydrate and protein contents of each fraction were 
determined by the phenol sulphuric acid method {$) (O.D.490) and 
the Lowry method (•) (O.D.gs。） respectively. 
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Fig. 4. 3 (b) Anion-exchange chromatography of PH-I B. PH-I B (101 
mg) was dissolved in 1.5 ml of 10 mM NaCl phosphate buffer (pH 
8.0) and applied onto a DEAE Sephadex column ( 2 . 5 x 6 cm) • PH-1 
Ba was eluted with 10 mM NaCl phosphate buffer (pH 8.0) and PH-I 
Bb was eluted with 500 m M NaCl phosphate buffer (pH 8.0). 
Fractions of 10 ml were collected at a flow rate of 100 ml/h. 
Fractions 1 to 10 were collected as PH—工 Ba. Fractions 13 to 22 
wer〒 collected as PH-I Bb. The fractions were then dialysed 
against distilled water with benzolated dialysis tubing having 
a cut off value of 1,200 to remove salts. The relative 
carbohydrate and protein contents of each fraction were 
determined by the phenol sulphuric acid method (•) (O.D.490) and 
the Lowry method (•) (O.D.550) respectively. 
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FIF.4.3 (C) Anion-exchange chromatography of PH-I C. PH_I C (150 
mg) was dissolved in 1.5 ml of 10 m M NaCl phosphate buffer (pH 
义 • • ) and applied onto a DEAE Sephadex column (2.5 x 6 cm) . PH 二工 
^ ^ was eluted with 10 mM NaCl phosphate buffer (pH 8.0) and PH-I 
gt) was eluted with 500 mM NaCl phosphate buffer (pH 8.0). 
Fractions of 10 ml were collected at a flow rate of 100 ml/h. 
Fractions 1 to 7 were collected as PH-I Ca. Fractions 14 to 20 
wer，collected as PH-I Cb. The fractions were then dialysed 
against distilled water with benzolated dialysis tubing having 
a cut off value of 1,200 to remove salts. The relative 
carbohydrate and protein contents of each fraction ‘ were 
determined by the phenol sulphuric acid method (•) (O.D.490) and 
the Lowry method (•) (O.D.sso) respectively. 
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工，巧 4 1 Protein, carbohydrate and uronic acid contents in 
different fractions. 
PROTEIN CARBOHYDRATE URONIC ACID 
⑷ （％) ( % ) 
PH-I 7.60 56.80 4.45 
PH-I A 5.20 53.15 6.37 
PH-工 B 4.90 40.00 3 . 4 9 
PH-工 C 9.07 43.00 9.43 
PH-I Aa 4.10 47.82 9.35 
PH-I Ab 5.03 39.29 31.39 
PH-I Ba 3.21 33.23 7.54 
PH-工 Bb 7.53 16.01 14.41 
PH-工 Ca 2.50 50.21 18.50 
PH-工 Cb 4.77 61.46* 21.75* 
Bovine serum albumin (BSA), dextran (M.W. 72,200) and a-D-
galacturonic acid were used as standards for the assays of 
protein, carbohydrate and uronic acid respectively. •In the case 
of PH-I Cb, heparin containing glucuronic acid was used as a 
standard for carbohydrate and uronic acid determinations. 
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Fig.4.4 Analytical HPLC of different fractions from P. 
heterophylla. Each fraction (1 mg in 20 |ll distilled water) was 
injected to a TSK-20 column (Bio-rad) . The flow rate was 1 
ml/minute. The carbohydrate content was monitored by refractive 
index detector. The molecular weight of each fraction (except 
PH-I) was determined by comparing with dextran standards . (a) PH-
I, (b) PH-I A, (c) PH-I B, (d) PH-I C, (e) PH-I Aa, (f) PH-I Ab, 
(g) PH-I Ba, (h) PH-I Bb, (i) PH-I Ca, (j) PH-I Cb. 
* « • 
92 
Chapt:er four 
Table 4.2 Determination of the molecular weights of different 
fractions using HPLC by comparing with dextran standards. 
Fractions Molecular weight 
一工 A 40000 
PH-I C 5000 
PH-I Ab 40000 
PH-工 Cb 5000 
Only the molecular weight of the purified fraction which showed 




Using paper chromatography to determine the sugar 
components, PH-I Ab was found to contain arabinose, galactose and 
galacturonic acid whereas PH—工 Cb was found to contain galactose, 
glucose and glucuronic acid. 
The sugar composition of various purified fractions was 
further analyzed by gas liquid chromatography. It was found that 
PH—工 Ab contains arabinose (48 %), galactose (34 %) and mannose 
(18 %), PH-I Ba contains galactosamine (28 %), glucosamine (38 
%) and glucose (34 %) . PH—工 Bb contains arabinose (20 %), 
galactose (16 %) , glucose (10 %) , glucosamine (31 %) and 
galactosamine (23 %) and PH—工 Cb contains galactose (12 %), 
glucose (44 %) and an unknown component (44 %). 
Various fractions isolated from P. heterophylla were also 
analyzed by SDS-PAGE. Fig. 4.5 (a) and (b) show that PH-I A 
contained a high M.W. carbohydrate component carrying negative 
charge and a protein with low M.W. The carbohydrate component 
of PH-I A was concentrated in the PH-I Ab fraction carrying 
negative charge. A small amount high M.W. carbohydrate moiety 
could be found in PH-I Aa. PH-工 B was found to be a protein 
bound carbohydrate at relative low M.W. because the positions of 
its carbohydrate and protein bands were in the same position. 
The carbohydrate part of PH-I C could not be stained by periodate 
schiff reagent due to its resistance to the oxidation of 
periodate reagent. PH-I C contained two minor protein bands at 
low M.W.. The carbohydrate part PH-I Ca and PH-I Cb could not 
be stained by periodate schiff reagent due to.their structural 
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Fig.4.5 (a) SDS-polyacrylamide gel electrophoresis of different 
fractions of P. heterophylla. The protein bands of each fraction 
were stained by coomassie blue. 
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Fig.4.5 (b) SDS-polyacrylamide gel electrophoresis of different 
fractions of P. heterophylla. The carbohydrate bands of each 
fraction were stained by periodate schiff reagent. 
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resistance to the oxidation by periodate reagent. 
4.4 Mitogenic activity of fraction PH-I 
on murine lymphocytes in vitro 
£ 
Spleen lymphocytes from BALB/c mice were cultured with 
different fractions separated from P. heterophylla. The results 
in Fig. 4.6 show that fractions PH, PH—I, PH—工工 but not PH—工工工 
caused the stimulation of tritiated thymidine incorporation into 
murine lymphocytes in a dose-dependent manner. Among these 4 
fractions, PH-I was found to exhibit the most potent mitogenic 
activity on murine lymphocytes. PH-I also stimulated the 
tritiated uridine incorporation and the synthesis of RNA of 
muirine lymphocytes (Fig.4.7). Moreover, PH—工 was found to be a 
polyclonal murine B cell mitogen because it only stimulated the 
proliferation of murine B cell but not T cell in vitro (Fig.4.8). 
Similarly, PH—I could not stimulate the proliferation of 
thymocytes which mainly composed of pre—matured T cells in vitro 
(Fig.4.9). These results, when taken together, suggest that PH-I 
alone cannot stimulate the transformation and proliferation of 
murine T cells in vitro. 
The possible co-mitogenic activity of PH-I was tested by co-
culturing murine splenic lymphocytes with different 
concentrations of PH—工（0 — 250 jlg/ml) and various mitogens (Con 
A, PHA, LPS) at their sub—optimal concentrations. As shown in 
Fig. 4.10, PH-I at 250 |lg/ml was co—mitogenic with the T cell 
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Fig.4.6 The mitogenic effect of different fractions PH, PH—工,PH— 
工工 PH_工工工 from P. heterophylla on murine lymphocytes. PH (•), 
PH二工（•） PH-工工（•), PH_工工工（•) in different concentrations were 
c o - c u l t u U d with 5 X 105 B A L B / C lymphocytes. After an incubation 
period of 48 h, cultured cells were pulsed with 0.5 |iCi/wel丄 H_ 
TdR and radioactivity incorporated was determined. Results were 
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Fig. 4.7 The effect of PH—工 on RNA synthesis of murine 
lymphocytes. PH 
-工 in (different concentrations were co-cultured 
with 5 X IQS BALB/c lymphocytes. After an incubation period of 
48 h, cultured cells were pulsed with 0.5 |ICi/well -^H-uridine and 
radioactivity incorporation was determined. Results were 
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[ig.4 8 The mitogenic effect of PH-I on murine T lymphocytes and 
B lj^^ghocy^s. PH-I in different concentrations were co-cultured 
二ith 5 X 105 BALB/c total lymphocytes (•) ' B lymphocytes (!) and 
T lymphocytes (•) . After an incubation period of 48 h, cultured 
cells were pulsed with 0.5 |LiCi/well ^H-TdR and radioactivity 
incorporation was determined. Results were expressed as mean 
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Fig-4.9 The mitogenic effect of PH-I on murine thymocytes. PH-I 
in different concentrations were co-cultured with 5 x 10^ BALB/c 
thymocytes in the absence (•) or presence of 2 jig/ml Con A (•) 
or 4 }lg/ml PHA (•) • After an incubation period of 48 h, cultured 
cells were pulsed with 0.5 jlCi/well ^H-TdR and radioactivity 
incorporation was determined. Results were expressed as mean 
S.I. 土 S.D. 
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Fig.4.10 The co-mitogenic effects of PH-I on murine lymphocytes. 
PH-I in different concentrations were co-cultured with 5 x 10^ 
BALB/c lymphocytes in the absence (•) or presence of 1 |xg/ml Con 
A (•)' 4 |Lig/ml PHA (•) or 10 }lg/ml LPS (!) . After an incubation 
period of 48 h, cultured cells were pulsed with 0.5 jiCi/well ^H-
TdR and radioactivity incorporation was determined. Results were 




at 15.6 ^ig/ml and 62.5 时/ml also exerted c o -mitogenic effect on 
murine lymphocytes with another T cell mitogen PHA (4 |Lig/ml) • 
However, PH-I did not show any co-mitogenic effect with the B 
cell mitogen LPS (10 |Llg/ml). 
i 
The effect of PH-I on the proliferation of human lymphocytes 
was also examined. It was found that PH-工 alone exhibited little 
stimulation on human cord blood lymphocytes (Fig.4.11)• However, 
PH—I exerted strong synergistic effect with Con A (1 jLlg/ml) in 
the proliferative response of human lymphocytes. 
4.5 Mitogenic effect of PH-I on murine lymphocytes In vivo 
Table 4.3 shows that the ratio of spleen weight to body 
v^reight was significantly increased after i .p . injection of PH—工. 
The enlargement of spleen could be due to the induction of spleen 
cell proliferation by PH-I, as shown by increased ^H-TdR 
incorporation in splenocytes from PH—工一treated mice. These 
results indicate that PH_I is also mitogenic to mouse splenocytes 
in vivo. 
4.6 Effect of PH-I on polyclonal B cell activation 
To determine whether B cells could be differentiated into 
antibody—secreting cells by polyclonal activation with PH—I, 
lymphocytes from BALB/c mice were incubated with control medium, 
PH-I or LPS for two days. The direct PFC response to SRBC was 
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Fig.4.11 The co-mitogenic effects of PH-工 on human lymphocytes. 
PH-工 in different concentrations were co-cultured with 1 x 10^ 
human lymphocytes in the absence (•) or presence (•) of 1 fig/m] 
Con A . After an incubation period of 72 h, cultured cells were 
pulsed with 0.5 |lCi/well ^H-TdR and radioactivity incorporated 
was determined. Results were expressed as mean S.I. 土 S.D. 
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Table 4.3 Mitogenic effect of PH—工 iia vivo. 
Mice 
i ^ g c t e d Ratio of spleen/body weight ^H-TdR incorporation 
(cpm) 
# 
PBS 0.0038 土 8.4 x 10- 2362.55 土 131.28 
PH-I 0.0055 土 2.2 X 10—4* 7683.38 土 721.00* 
^n day 0 5 mg PH-I was injected into each BALB/c mouse i p 
9n day 3, the ratio of spleen to body weight and the ^H-TdR 
incorporation into the splenocytes were determined. The 
splenocytes were isolated and seeded into a 96-well plate at 5 
^ ” cpl^s per well i _ e d i a t e l y after the ratio of spleen to 
？fY "Ttght was determined. The splenocyte cultures were pulsed 
二i^ h。..5 3H-TdR for 6 h and radioactivity incorporated was 
determined. The difference between the control group and 






Table 4.4 Polyclonal B cell activation by PH-工. 
Treatment of Number of PFC / 1 x 10^ splenocytes 
lymphocytes Without 2-ME with 2-ME 
with (5 X 10-5 M) 
：F 
Nil 0 0 
PH-I 6 ± 9 9 土 4 
LPS 18 ± 9 52 ± 30 
PH-I (250 M-g/ml) or LPS (10 |Llg/ml) was added to cultures 
containing 5 x 10® BALB/c lymphocytes/ml/well. Two days later, 
spleen cells were prepared and suspended at 6 x l O V m l in 
complete RPMI medium. The number of plaque-forming cells (PFC) 
of each group was determined by haemolytic plaque technique. 




increased the number of PFC, either in the presence or absence 
of 2-ME, indicating that PH-I is a direct polyclonal activator 
of murine B lymphocytes. 
4.7 Adjuvant effect of PH-I on antibody response to SRBC in 咖。 
Table 4.5 shows that i .p. injection of PH-I markedly 
augmented the anti-SRBC IgM PFC response in mice immunized with 
SRBC, indicating that PH-工 could act as an adjuvant for the 
primary antibody response to SRBC in vivo. 
4.8 Evidences to support the mitogenic activity of PH-工 is due 
to its polysaccharide rather than due to the contamination by LPS 
Lipid A has been known to be the toxic and immunostimulating 
part in LPS (Burrell, 1990). Treatment of LPS with 1 % acetic 
acid at 100°C for 90 min could completely abolish the mitogenic 
effect of LPS (Fig.4.12 (a)) because acetic acid could deplete 
lipid A from LPS (Ha et al. , 1985) . On the other hand, the 
mitogenic effect of PH—工 was not affected by acetic acid 
treatment (Fig.4.12 (b)), indicating that the mitogenic effect 
of PH-I was unlikely to be due to contamination by LPS. 
In contrast, the mitogenic effect of PH-I was completely 
abrogated by the oxidation with sodium periodate (Fig. 4 .13) . The 
result indicates that the mitogenic activity in PH-I was due to 




Table 4.5 Adjuvant effect of PH-I on 
antibody response to SRBC in vivo. 
Mice Number of PFC / 1 x U ” splenocytes 
Treated 
with 3 X lO'Vml 6 x l O V m l 
SRBC 29.0 土 10.0 12.0 土 0.0 
PH"•工 & SRBC 153.0 土 29.0* 245.0 土 47.0"" 
Group of three BALB/c mice were injected i.p. with PII—I (!5.0 mg) 
into each mouse on day 0, day 2, day 4. On day 2, 2 x 10" sheep 
red blood cells (SRBC) were injected i.p.. On‘day 6, the number 
of plaque—forming cells (PFC) was determined by haemolytic plaque 
technique. Results were expressed as mean 士 S.D. The difference 
between the control group (SRBC) and treatment group (Pii-l and 
SRBC) was determined by the Student's t~test. 1)<0 005 
•*P<0 . 002 . 
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Fig.4.12 (a) The mitogenic effect of LPS on murine lymphocytes 
after acetic acid treatment. LPS at different concentrations was 
either untreated (•) or treated with 1 % acetic acid for 90 min 
(•) were co-cultured with 5 x 10^ BALB/c lymphocytes. After an 
incubation period of 48 h, culture cells were? pulsed with 0.5 
jlCi/well ^H~TdR and radioactivity incorporated was determined. 
Results were expressed as mean S.I. ± S.D. 
(b) The mitogenic effect of PH-工 on murine lymphocytes after 
acetic acid treatment. PH-I at: different concentrations either 
untreated ( 參 ） o r treated with 1 % acetic acid for 90 min (_), 
were co - cultured with 5 x 10^ BALB/c lymphocytes. After a a 
incubation period of 48 h, cultures eelIs were pulsed with 0.5 
|lCi/well ^H-TdR and radioactivity incorporated was determined. 
Results were expressed as mean S.I. 土 S.D. 
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Fig.4.13 The mitogenic effect of PH—I on murine lymphocytes after 
sodium periodate treatment on murine lymphocytes. PH—工 at 
different concentrations was either untreated ) or treated with 
0.02 M sodium periodate (•) were co-cultured with 5 x 10^ BALE/c 
lymphocytes. After an incubation period of 48 h' cultures cells 
were pulsed with 0.5 jlCi/well ^H-TdR and radioactivity 




The absence of LPS in PH-工 was further supported by the fact 
that polymyxin B showed no inhibitory effect on the mitogenic 
activity of PH-I whereas the mitogenicity of LPS was strongly 
inhibited (Fig.4.14). It is because the cationic PMB may bind 
to the anionic polysaccharide of PH-I, PMB show little inhibitory 
effect on mitogenic effect of lymphocytes at 250 )ig/ml of PH—I. 
4.9 The effects of PH-I on IL-2 production and IL-2 receptor 
expression on murine lymphocytes in vitro 
Table 4.6 shows that PH-I neither inducing ILi-2 production 
by murine lymphocytes nor augmenting Con A-induced 工 L - 2 
production by murine lymphocytes. On the other hand, PH-I (15.6 
jig/ml) slightly enhanced the expression of IL —2 receptors on 
murine lymphocytes (Table 4.7) whereas it had no enhancing effect 
on Con A-induced receptor expression at all concentrations 
tested. 
4.10 The mitogenic activity of the purified fractions on 
murine lymphocytes in vitro 
Fig.4.15 shows that PH-I A exerted the strongest mitogenic 
effect on murine lymphocytes among fractions PH—I, PH—工 A, PH-I 
B and PH-工 C. On the other hand, PH-工 C failed to exhibit any 
mitogenic activity at higher concentration (250 - 500 jig/ml). 
Fig.4.16 shows that PH-I Ab exerted the strongest mitogenic 
effect on murine lymphocytes among fractions PH-I, PH—工 A, PH-I 
Aa and PH-I Ab. The stimulation index was about 100 at a PH-I 
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Fig.4.14 (a) The effect of polymyxin B (PMB) on the mitogenic 
effect of LPS. LPS in different concentrations in the absence 
of PMB («) or in the presence of PMB 1 ^ig/ml (•), or 5 fig/m丄（a) 
w e r e co-cultured with 5 x 10^ BALB/c lymphocytes. After an 
incubation period of 48 h, cultured cells were given a pulse with 
0.5 |ici/well ^H-TdR and radioactivity incorporated was 
d e t e r m i n e d . Results were expressed as mean S.I. 土 S.D. 
(b) PH-I in different concentrations in the absence of PMB (®) 
or in the presence of PMB 1 Hg/ml (•), 5 ^ig/ml (B) we^e co~ 
c u l t u r e d with 5 x 10^ BALB/c lymphocytes, After，n 丄：^。二bat^芸 
iDeriod of 48 h, cultured cells were given a pulse witn u ：3 
5 c i / w e l l ' H-TdR and radioactivity incorporated was determinea, 
R e s u l t s were expressed as mean S.I. 土 S.D. 
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Table 4.6 Induction of IL一2 production from lymphocytes in vitro. 
Treatment of IL-2 titer (U/ml) 
lymphocytes 
with 24 h 48 h 
Con A 0.100 0.018 
PH-I U.D.* U.D. 
Con A Sc PH-I 0.150 0.019 
Murine lymphocytes (lO” were incubated with Con A (2 |lg/ml) and 
PH-I (5〇0 |ig/ml) for 24 h or 48 h. Test samples (50 jil) with 
serial two fold dilutions were mixed with 1 x 10^ CTLL-2 cells in 
50 \il volume in triplicates. The culture was incubated for 24 
h at 3 7 i n a humidified atmosphere of 5 % C〇2 in air. The 
cells were then pulsed with 0.5 |LlCi ^H-TdR per well for 6 h and 
harvested onto glass fibre filter by a Titertek cell harvester. 
The incorporated radioactivity was determined by a liquid 
scintillation counter. Murine recombinant was used as 
standard. 
*U.D. = undetectable 
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Table 4.7 Determination of IL一2 receptor expression on mouse 
lymphocytes by indirect immunofluorescence 
Treatment Concentration 工Lj-2 receptor positive 
of lymphocytes 
with (jlg/ml) cells (%) 
Nil 35.4 土 0.9 
Con A 1.0 58.8 ± 0.2* 
15.6 49.9 土 4.9** 
PH-I 62.5 41.0 土 13.2 
2 5 0 . 0 4 9 . 2 土 1 1 . 7 
1 5 . 6 4 2 . 7 土 7 . 8 
Con A 8c PH-I 62 .5 53.6 ± 1.3* 
2 5 0 . 0 6 5 . 7 土 8 . 3 … 
BALB/c mouse lymphocytes of 10^ in 1 ml RPMI complete medium were 
added into the wells of a 24-well plate in the presence of Con 
A (1 |xg/ml) or various concentrations of PH-I. The culture was 
incubated for 3 days at 37°C in a humidified atmosphere 
containing 5 % C〇2-95 % air. The % of IL-2 receptor positive 
cells was determined by indirect immunofluorescence. The 
differences between the control group and treatment groups were 
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Fig.4.15 The mitogenic effect of PH-I, PH-I A, PH-I B, PH-I C 
from P. heterophylla on murine lymphocytes. PH-I (•) ' PH-I A 
(•) , PH-I B (•) , PH-I C (•) in different concentrations were co-
cultured with 5 X 105 BALB/c lymphocytes. After an incubation 
period of 48 h, cultured cells were pulsed with 0.5 ！ x C i / w e l l ^H-
TdR and radioactivity incorporated was determined. Results were 
expressed as mean S:工.土 S.D. 
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Fig.4.16 The mitogenic effect of PH-I, PH-I A, PH-I Aa, PH-I Ab 
from P. heterophylla on murine lymphocytes. PH-I (•) ' PH-I A 
(•) , PH-I Aa (!) and PH-I Ab (•) in different concentrations were 
co-cultured with 5 x 10^ BALB/c lymphocytes . After an incubation 
period of 48 h, cultured cells were pulsed with 0.5 flCi/well ^H-
TdR and radioactivity incorporated was determined. Results were 
expressed as mean S.I. 土 S.D. 
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A b concentration of 500 |lg/ml. Fig.4.17 shows that PH—工 Ba was 
weakly mitogenic whereas PH—工 Bb was virtually n o n-mitogenic up 
to a concentration of 500 jig/ml. Fig. 4.18 shows that both PH-I 
Ca and PH-I Cb demonstrated maximal mitogenic activity at a 
concentration of 62.5 jlg/ml and the mitogenic activity reached 
a plateau (PH-I Ca) or declined (PH-I Cb) thereafter. From the 
above results, it can be seen that the mitogenic effect of PH-I 
was mainly concentrated in PH-I Ab fraction. Moreover, PH-工 Ab 
was found to be a murine B cell mitogen because it only 
stimulated the proliferation of murine B cells but not T cells 
in vitro (Fig.4.19). Similar to PH-I, PH-I Ab alone could not 
stimulate the proliferation and transformation of murine T cells 
in vitro. 
4.11 Adjuvant effect of PH-I Ab on antibody response 
to SRBC in vivo 
Table 4.8 shows that i.p. injection of PH-I A b markedly 
augmented the anti-SRBC 工 gM PFC response in mice iininunized with 
SRBC, indicating that PH-I A b could also act as an adjuvant for 
the primary antibody response to SRBC. 
4.12 Mitogenic effect of PH-工 C on murine lymphocytes in vivo 
Table 4.9 shows that the ^H-TdR incorporation of splenocytes 
was significantly increased after the i.p. injection of PH-I 
indicating that PH-工 C could activate the proliferation of 
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Fig. 4.17 The mitogenic effect of PH-I Ba and PH-I Bb from P. 
heterophylla on murine lymphocytes. PH-I Ba (•) , PH-I Bb (S) in 
different concentrations were co-cultured with 5 x 10^ BALB/c 
lymphocytes. After an incubation period of 48 h, cultured cells 
were pulsed with 0.5 jlCi/well ^H-TdR and radioactivity 
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Fig 4 18 The mitogenic effect of PH-I Ca and PH-I Cb from P. 
heterophylla on murine lymphocytes. PH-I Ca (1 ) and PH-I Cb (•) 
in different concentrations were co-cultured with 5 x 10 BALB/c 
lymphocytes . After an incubation period of 48 h, cultured cells 
were pulsed with 0.5 ^iCi/well ^H-TdR and radioactivity 
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Fig.4.19 The mitogenic effect of PH-I Ab on murine T lymphocytes 
and B lymphocytes. PH-I Ab in different concentration were co-
cultured with 5 X 105 BALB/C total lymphocytes (〇）'B lymphocytes 
(•) and T lymphocytes (A) • After an incubation period of 48 h, 
cultured cells were pulsed with 0.5 jlCi/well ^H-TdR and 
radioactivity incorporation was determined. Results were 
expressed as mean S.I. 土 S.D. 
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Treated Number of PFC / 1 x 10^ splenocytes 
with 
SRBC 65.3 土 17.0 
PH-工 Ab 8c SRBC 117.3 土 5.7* 
, 
Group of three BALB/c mice were injected i.p. with PH-I Ab (2.0 
mg) into each mouse on day 0, day 2 and day 4. On day 2, 8 x ICT 
sheep red blood cells (SRBC) were injected i .p. . On day 6, 
spleen cells were prepared and suspended at 3 x lO'^/ml in 
complete RPMI medium. The number of plaque-forming cells (PFC) 
were determined by haemolytic plaque technique. Results were 
expressed as mean 士 S.D. The difference between the control 
group (SRBC) and treatment group (PH-I Ab and SRBC) was 
determined by the Student's t-test. *P<0.01. 
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Table 4.9 Mitogenic effect of PH-I C in vivo. 
Mice ‘ 
injected ^H-TdR incorporation (cpm) 
with 
PBS 1031.60 土 73.18 
PH-工 C 3758.48 土 368.64* 
PH-工 C (200 |lg/0.2 ml PBS) was injected into group of three CSV 
mice i.p. for 6 days. On day 7, splenocytes were isolated and 
seeded into a 96-well plate at 5 x 10^ cells per well. The 
splenocyte cultures were pulsed with 0.5 |lCi ^H-TdR for 6 h and 
radioactivity incorporated was determined. The difference 
between control group and treatment group was determined by the 
Student's t-test. *P<0.001. 
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4.13 Evidences to support the mitogenic activity of PH-工 Ab is 
due to its polysaccharide rather than due to the contamination 
by LPS 
The mitogenic effect of PH-I Ab was unlikely to be due to 
the contamination by bacterial LPS, since acetic acid treatment 
only slightly suppressed the mitogenic effect of PH-I Ab 
(Fig.4.20). 
In contrast, the mitogenic effect of PH-I Ab was completely 
abrogated by the oxidation with sodium periodate (Fig.4.21), 
indicating that the mitogenic activity in PH-I A b could be 
attributed to its carbohydrate component since periodate 
specifically damaged the structure of carbohydrate. 
DISCUSSION 
Several immunomodulatory activities have been observed in 
the high-molecular-weight fractions of the hot-water extracts 
from the Chinese herbs but less observed in the low-molecular 
weight fractions (Yamada, 1989)• The immunopotentiating 
fractions have been shown to possess anti-neoplastic activity 
(Chihara et al., 1970a,b; Ebina and Kohya, 1988; Ebina and 
Murata, 1990; Lien and Gao, 1990; Miyazaki et al. , 1979; 
Takahashi et al. , 1988a,b), induction of TNF-a (Haranaka et al., 
1984； Haranaka et al. , 1985), anti-inflammatory activity (Satomi 
et al., 1989), enhancement of antibody production (Zhao et al., 
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Fig.4.20 The mitogenic effect of PH-工 Ab after the ^treatment of 
acetic acid on murine lymphocytes. PH-工 Ab in different 
concentrations, without (O) or with (•) the treatment of 1 ^ 
acetic acid for 90 min., were c o - c u l t u r e d with 5 x 10 B A L B / c 
lymphocytes. After an incubation period of 48 h cultures ce.ls 
w ^ e given a pulse with 0.5 ^iCi/well ^H-TdR and radioactivity 
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Fig.4.21 The mitogenic effect of PH-I Ab after sodium periodate 
treatment on murine lymphocytes. PH-I Ab in different 
concentrations, without (〇）or with (•) the treatment of 0.02 M 
sodium periodate, were co-cultured with 5 x 10^ BALB/c 
lymphocytes. After an incubation period of 48 h, culture cells 
were pulsed with 0.5 jlCi/well ^H-TdR and radioactivity 




1982; Vacheron et al., 1989). 
P- heterophylla has been widely used as a mild tonic herbal 
medicine in China. A single batch of raw materials of P. 
heterophylla was used for the whole project to maintain the 
standardization of the purified products. Three alcohol-
insoluble fractions PH-I, PH—工工 and PH—工工工 in descending order 
of molecular weights have been separated from the roots of P. 
heterophylla by hot water extraction followed by stepwise alcohol 
precipitation. 
The in vitro lymphocyte transformation assay was employed 
for the screening assay for the detection of the bioactive 
component (s) in the P. heterophylla extract. It is a typical 
non-specific immune reaction and the mechanism of which has been 
well understood. Moreover, this assay has frequently been used 
as an immune parameter to investigate lymphocyte responsiveness 
due to its high sensitivity. The present results show that a 
macromolecular fraction (PH-I) displayed a dose dependent 
mitogenic activities on splenic B cells but not on T cells in 
vitro (Fig.4.6, 4.7, 4.8, 4.9) by the stimulation of DNA and RNA 
synthesis. PH-I is believed to consist of polysaccharides as it 
is found to have a high carbohydrate content (56.8 %) . The 
mitogenic activity of PH—工 could be attributed to the 
polysaccharides rather than due to contamination by LPS. This 
is because it is heat and mild acid stable (Fig.4.12 (a) and 
(b) ) . Moreover, its activity was completely abrogated by the 
treatment with periodate (Fig. 4.13) . It has been shown that the 
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antibiotic polymyxin B can bind specifically to lipid A and at 
the same time reduce endotoxin lethality in chick embryos (Teuber 
and Bader, 1976) . The absence of LPS in PH-I is further 
evidenced by the fact that polymyxin B showed no inhibitory 
effect on the mitogenic activity of PH-I while it strongly 
inhibited the mitogenicity of LPS (Fig. 4.14) . It is because the 
cationic PMB may bind to the anionic polysaccharide of PH-I, PMB 
show little inhibitory effect on mitogenic effect of lymphocytes 
at 250 |lg/ml of PH-I. 
In vi tro experiments show that PH-I exhibited a synergistic 
effect on the proliferative response of murine lymphocytes to T 
cell mitogens such as Con A and PHA (Fig.4.10) and enhanced the 
lymphocyte blastogenesis at sub-optimal concentrations of the Con 
A and PHA. Similarly, PH-I also exhibited a co-mitogenic effect 
on Con A-induced proliferation of human lymphocytes (Fig.4.11). 
This may provide a scientific basis for its therapeutic actions 
on human beings. However, PH-工 could not augment the Con A-
induced 工L-2 release from murine lymphocytes (Table 4.6). On the 
other hand, PH-I (15.6 |lg/ml) significantly increased the 
expression of 工L-2 receptors on murine lymphocytes (Table 4.7). 
Whether this upregulation of IL-2 receptors expression by PH-I 
is at the transcriptional or translational level requires further 
investigation. The mechanism whereby PH-I can exert its co-
mitogenic activity on T lymphocytes is as yet unclear. Results 
in Table 4.6 and 4.7 suggest that this is not mediated by the up-
regulation of 工L-2 receptor gene expression nor due to increase 
in IL一2 production. Therefore, further experiments are required 
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to determine whether PH-I can affect the production of other 
cytokines such as 工L-1 and 工L-4 which are also involved in T cell 
activation and proliferation. Although PH-I is a polyclonal B 
cell mitogen, it also exerts co-mitogenic activity on T cells 
with T cell mitogens such as Con A and PHA. Therefore, it is 
conceivable that PH-I may play an indirect role in the activation 
of T cell functions in vi tro. Whether PH-I has any effect on the 
activation of various T cell subsets such as Tc, Th and Ts needs 
further investigation. 
Data in this chapter show that PH-I not only could activate 
the proliferation of splenocytes in vitro but also in vivo 
(Fig.4.6 and Table 4.3) . In addition, PH-I could induce the 
polyclonal activation of murine B cells, even if 2-ME was absent 
from the culture medium (Table 4.4). However, the activity of 
PH-I was weaker than that of LPS. It was found that reduced 
glutathione is an essential component in FCS in order for 2-ME 
to produce its enhancing effect. 2-ME can concomitantly reverse 
the inhibitory effect of oxidized glutathione in FCS and increase 
the availability of reduced glutathione which can scavenge 
oxygen-derived radicals, thus protecting lymphocytes from the 
deleterious effects of oxygen - d e r i v e d free radicals and enhancing 
the antibody response (Hoffeld and Oppenheim, 1980). Moreover, 
the polyclonal activation of B cells by PH-I was not due to the 
contamination by bacterial LPS due to the reasons explained 
before. The adjuvant activity of PH—工 was shown by the marked 
augmentation of IgM PFC response in mice which had been immunized 
i.p. with 2 X 10® SRBC and given concomitant injection of PH—工 
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(Table 4.5). From the above results, the marked augmentation of 
antibody response to a T cell dependent antigen (SRBC) by PH-I 
is mediated not only through the activation of the proliferation 
of splenocytes but may also be resulting from the activation of 
Th and B cells in vivo. It may also be possible that suppressor 
T cells were relatively inactivated by PH-I. 
The carbohydrate contents of fraction PH-I and its 
subfTactions were considered to be lower than expected. It may 
be due to the fact phenol sulfuric acid method is not sensitive 
enough for determining these types of polysaccharides. Many 
previous studies indicated that the activity of the 
imimnopotentiating fractions from Chinese herbs was strongly 
related to its carbohydrate structure (Gonda et al., 1990; Lien 
et al,, 1990; Miyazaki et al., 1979). The structural components 
of PH-I and its subfractions appear to be polysaccharide or 
proteoglycan in nature because all of them except PH-I Bb were 
found to contain mainly carbohydrate in addition to a small 
amount of protein. The stepwise alcohol precipitation was found 
to be ineffective in removing the protein, as the protein amount 
was similar in all P. heterophylla fractions. These results 
suggest that the protein portion may tightly bound to the 
carbohydrate moiety in P. heterophylla extracts, possibly in the 
form of proteoglycans or heteroglycan-protein conjugates. The 
acidic fractions such as PH-I Ab and PH-工 Cb contained a 
relatively large amount of uronic acid (over 20 %) whereas the 
uronic acid contents of the less acidic fractions such as PH—工 
Aa and PH-I Ba were found to be less than 10 %• 
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The murine B cell mitogenic activity of PH-工 was shown to 
be concentrated in the fraction PH-I Ab (Fig.4.15, 4.16, 4.17, 
4.18). PH-I Ab was found to exhibit a very potent mitogenic 
activity on murine B cells but not T cells in vi tro. The 
adjuvant effect of PH—工 Ab for the augmentation of the number of 
PFC cells in vivo appears to result from increased induction of 
Th cells in mice injected with PH-I Ab. It is, however, the in 
vivo Th cell activation is stimulated by the increase of antigen-
presenting cells such as macrophages and B cells. 
From the results of analytical HPLC, the fractions which 
show the single peak did not imply the pure fraction. It is 
because the single peak found in HPLC column may be due to 
several components with similar size. Moreover, some single 
peaks are very broad, idicating the fractions may not be very 
pure. More better HPLC columns should be used to improve the 
purification. In the structural analysis, PH-I Ab is a highly 
purified fraction which gave a single peak in the HPLC profile 
with molecular weight of approximately 40,000. The sugar 
components of PH-I Ab were found to include galactose, arabinose 
and galacturonic acid as determined by paper chromatography. GLC 
of alditol acetates also indicated that PH-1 Ab contained mainly 
galactose and arabinose. PH-I Ab carried negative charge at pH 
8 . 3 and contained a large amount of uronic acid (over 30 %) • The 
SDS-PAGE showed that PH-I Ab contained mainly high molecular 
weight carbohydrate. Similar to that of PH-I, the potent B cell 
mitogenic activity of PH-I Ab could be attributed to the 
carbohydrate moiety rather than the contamination by bacterial 
129 
Chapter four 
LPS. It was because PH-I Ab was heat and acetic acid stable 
(Fig.4.20) . Moreover, its activity was completely destroyed by 
the treatment with periodate (Fig.4.21). It suggested that the 
overall structure of the mitogenic polysaccharide in PH-I Ab was 
important for the mitogenic activity. Finally, PH-I Ab did not 
contain any detectable amino sugar such as glucosamine determined 
by GLC, which is a maj or component of lipid A . 
The small protein moiety in PH-I Ab may play a role on its 
mitogenic activity in vitro• A previous study showed that 
trypsinisation of the peptide moiety in the macromolecular 
fraction from Ginseng could abolish its mitogenic activity (Song 
et al. , 1989) . Whether the small protein moiety in PH-I Ab may 
play a role in its potent mitogenic activity or just stabilizing 
the structure of polysaccharide awaits further investigation. 
For example, trypsinization of protein moiety can be used to test 
for its contribution in mitogenic activity. The trypsin can be 
removed by centrifugation. 
Preliminary studies indicated that the intracellular calcium 
level of a single B cell measured by confocal microscope 
increased immediately after the addition of PH-I Ab (data not 
shown) . Previous reports indicated that the combined use of 
ionophore and phorbol ester could stimulate the proliferation and 
DNA synthesis of B cell (Lindsberg et al. , 1991; Planelles et 
al. , 1992; Van Endert and Moldenhauer, 1992) . Therefore, the 
signal transduction of the proliferation of B cell was believed 
to depend on the increase of intracellular calcium, activation 
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of protein kinase C and breakdown of membrane inositol bis-
phosphates (PIP?) • The experiment of intracellular calcium 
signal transduction of PH-I Ab induced DNA synthesis in murine 
B cells in vitro is in progress. 
〇n the other hand, fraction PH—工 C and PH-I Cb showed a 
decrease or loss of mitogenic activity at higher concentrations 
(500 lig/ml) (Fig.4.15, 4.18) . It is probably due to the release 
of inhibitory mediators (such as prostaglandins) from the 
lymphocytes (Vacheron et al. , 1989) or due to the stimulation of 
suppressor cells in the culture (Wang et al. , 1989) . This 
phenomenon needs further detail examinations. 
In conclusion, the B cell mitogenic activity of P. 
heterophylla was found to be associated primarily with a high 
molecular weight (40000) and negatively charged polysaccharide 
fraction (PH-I Ab) which contains large amount of uronic acid and 
a small amount of protein moiety. It is highly unlikely that PH-
I Ab contains 1,3 linkages because the carbohydrate component of 
PH-工 Ab can be oxidized by periodate solution. The mitogenic 
activity was found to increase with the purity in different 
fractions (PH, PH-1, PH-I A, PH-I Ab) • It is due to the 
increase of % amount of mitogenic substance in different 
fractions with the increasing degree of purity. 
The in vitro and in vi vo activation of B cells by P. 
heterophylla can enhance the humoral or cellular immunity by 
augmenting specific antibody formation or activation of the 
131 
Chapter four 
antibody-dependent cell-mediated cytotoxicity (ADCC) which play 
a role in the host defence against bacterial infection and 
cancerous cell invasion. Therefore, P. heterophylla is a 
naturally-occurring immunostimulating agent with therapeutic 
potentials in both murine and human system. The activation of 
T cells function of P. heterophylla is also important for the 
other immuno stimulating activities such as the activation of 
cell-mediated immunity (e.g. activation of macrophages, NK, LAK, 
TILs etc.). The details of the cell-mediated immunity will be 




IMMUNOMODULATING AND ANTI-TUMOR ACTIVITIES OF 
ALCOHOL-INSOLUBLE FRACTION (PH-I) FROM 
THE HOT WATER EXTRACT OF PSEUDOSTELLARIA HETEROPHYLLA 
INTRODUCTION 
Recently, it has been reported that polysaccharides from 
many Chinese herbal medicines with tonic effects have 
immunomodulatory and anti-tumor activities (Ebina and Murata, 
1990; Kumazawa et al. , 1982; Sone et al. , 1985; Yamasaki et al., 
19 89; Zhao et al. , 1990) . Although many Chinese herbs have been 
demonstrated to serve as an inhibitor or killer of the tumor 
cells (Ebina and Kohya, 1988; Kumazawa et al. , 1982; Miyazaki et 
al. , 1979), nevertheless, in most cases the anti-tumor activities 
of Chinese herbs are mediated by the immunological system of the 
host (Lien and Gao, 1990) . For example, many anti-tumor natural 
polysaccharides were reported to induce tumor necrosis factor 
(Haranaka et al., 1985; Takahashi et al. , 1988a,b) or activate 
macrophages (Luettig et al., 1989) in vivo. 
Since the discovery of tumor necrosis factor-alpha (TNF-a) 
by Carswell and colleagues, bacteria were usually used as the 
priming agents for the release of TNF-a (Carswell et a!., 1975). 
Not until 1984, zymosan, a yeast polysaccharide, was found to be 
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an effective priming agent for the release of TNF-a (Haranaka et 
al., 1984) . In chapter 4, hot water extracts from the roots of 
P. heterophylla were found to have mitogenic effect on murine 
lymphocytes. Mitogenic activity was observed in the alcohol-
insoluble and macromolecular fractions prepared from hot water 
extracts. One of these fractions, PH-I, exhibited the most 
potent mitogenic activity on mouse splenocytes among all 
fractions being tested. The mitogenic activity of PH-I was found 
to be concentrated in the highly purified fraction PH-I Ab. In 
this chapter, the effects of PH-工〇n cytokine ( 工 L - 1 and TNF-a) 
production and activation of murine macrophages were examined. 
In addition, the effects of PH-工 on the in vitro growth of 
various murine tumor cell lines (EAT, PU5-1.8, P388Di and MBL-2) 
will also be studied. 
A number of investigators have shown that Traditional 
Chinese Medicines have immunorestorative activities. For 
example, Toko and Fujimoto (1989) showed that BCG cell wall 
skeleton, OK43 2 or lentinan could augment the anti-tumor immunity 
in low-responder mice. On the other hand. Astragalus 
memhranaceus (Chu et al. , 1988a) and PSK (Mizushima et al, , 1982) 
were found to be capable of reversing the cyclophosphamide-
induced iinmunosuppression in vivo. Therefore, in this chapter, 
the possible immunorestorative properties of PH-I in EAT-bearing 
mice will be investigated. 
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RESULTS 
5.1 EFFECT OF PH-I ON CYTOKINE PRODUCTION 
Fig.5.1 (a) , (b) show that PH-I at a concentration of 250 
ug/ml significantly augmented the release of IL-l-like substance 
from resting peritoneal macrophages in vitro after incubating the 
mixtures for 24 h and 48 h culture. Plowever, the IIj — 1-inducing 
activity of PH-I on murine peritoneal macrophages was relatively 
weak when compared to that induced by LPS which was used as a 
positive control in the experiments. 
Table 5.1 shows that PH-I could act as a priining agent with 
subsequent challenge with LPS for the induction of TNF-a In vivo • 
However, PH—I could not act as an eliciting agent for TNF-a 
induction in zyrriosan-primed mice. AiRong the fractions PH-I A' 
PH-I B and PH-I C that had been tested, PH-I C was found to be 
the most potent priming agent for the induction of TlSTF-a In vI"o 
(Table 5.2). Fig. 5 .2 shows that 40 % of the zymosaii-pirimed EAT-
bearing mice died on day 11 after LPS injection. However, none 
of the PH-I primed EAT-bearing mice died at the same time. 
5.2 IN VIVO ACTIVATION OF MACROPHAGES BY PH-工 
The ability of PH_I t〇 activate peritoneal macrophages 112 
j^ivo was examined. Results in Fig.5.3 show that ？ H - I 
administrated in vi-fo (500 ug or 5 mg per mouse) could 
significantly enhance the cytostatic activity of the picolinic 
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Fig.5.1 (a) In vitro induction of 工 L - l - l i k e substance from 
resting peritoneal macrophages. LPS or PH-I at different 
concentrations were incubated with resting peritoneal macrophages 
for 1 day. The supernatant was harvested and tested for IL一 1 
activity. Briefly, C57BL/6J thymocytes (5 x l O V w e l l ) were 
cultured for 3 days in the presence of 25 U/ml of MurIL-2 and 5 
X 10"^ M 2-ME. Different 工 L _ l - l i k e substance containing culture 
supernatants in serial two fold dilutions were added to the 
cultures. Four h prior to harvest, 0.5 jiCi of ^H-TdR was added 
to each w e l l . Results were expressed as mean stimulation index 
士 S.D.. Control (〇），fraction PH-I 250 jig/ml ( 參 ） ， 1 2 5 jlg/ml (•)' 
62.5 jig/ml (•) , 31.2-5 |lg/ml (•) and 1 jlg/ml LPS (•). 
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Fig.5,1 (b) In vitro induction of IL一1一like substance from 
resting peritoneal macrophages. LPS or PH—工 at different 
concentrations were incubated with resting peritoneal macrophages 
for 2 d a y s . The supernatant was harvested and tested for IL-l 
activity. Briefly, C57BL/6J thymocytes (5 x l O V w e l l ) were 
cultured for 3 days in the presence of 25 U/ml of MurIL-2 and 5 
X 10_5 M 2 - M E . Different 工 L - l - l i k e substance containing culture 
supernatants in serial two fold dilutions were added to the 
cultures. Four h prior to harvest, 0.5 ^iCi of ^H-TdR was added 
to each w e l l . Results were expressed as mean stimulation index 
土 S.D.’ Control (〇），fraction PH—工 250 |lg/ml (⑩),125 jlg/ml (•), 
62.5 |ig/ml (•) , 31.25 |ig/ml (•) and 1 ^ig/ml LPS (•)• 
137 
Chapter four 
Table 5.1 Induction of TNF-a by PH-I and zymosan in mice. 
DAY 0 DAY 6 TNF-a TITER 
PRIMING ELICITING (ng/ml) 
5 mg Zymosan PBS U.D. * 
5 mg PH-工 PBS U.D. 
PBS 25 |lg LPS 0.97 土 0.49 
5 mg Zymosan 25 |lg LPS 22.68 ± 0.04 
5 mg PH-I 25 |lg LPS 15.45 士 0.45 
5 mg Zymosan 25 [ig PH-I U.D. 
5 mg Zymosan 50 |ig PH-I U.D. 
5 mg Zymosan 100 jig PH-I U.D. 
5 mg Zymosan 200 \ig PH-I U.D. 
5 mg Zymosan 400 |lg PH-I U.D. 
Nil 500 |ig PH-I U.D. 
Nil 2 mg PH-I U.D. 
On day 0, 5 mg zymosan or PH-工 were injected i.p. into ICR mice 
in groups of three. On day 6, 2 5 |lg LPS or different doses of 
PH-I were injected intravenously (i.v.) into the primed mice. 
Two hours later, serum was obtained and tumor necrosis factor 
(TNF) titer in mouse serum was determined by the murine TNF-a 
ELISA test kit (Genzyme) . Murine recombinant TNF-a was used as 
standard. 
U.D. ： undetectable 
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Table 5.2 Induction of TNF-a by PH-I A, PH-I B and PH-I C in 
m i c e . 
！ 
DAY 0 DAY 6 TNF-a TITER 
PRIMING ELICITING (ng/ml) 
PH-I A LPS 1.46 土 0.38 
PH-I B LPS 0.71 土 0.49 
PH-工 C LPS 4.14 士 0.66 
On day 0, 5 mg PH-I A, PH-I B, PH-I C were injected i.p. into ICR 
mice in groups of three. On day 6, 2 5 i^g LPS were injected 
intravenously (i.v.) into the primed mice. Two hours later, 
serum was obtained and tumor necrosis factor (TNF) titer in mouse 
serum was determined by the murine TNF-a ELISA test kit (Genzyme) 
using recombinant TNF-a as standard. 
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Fig.5.2 Survival test of EAT-bearing mice after the ^^ jivo 
production of TNF-a. Group of 10 mice were inoculated wxth 2 x 
10^ EAT on day 0. .On day 1, 5 mg zymosan or PH-I was injected 
into each mouse i.p. On day 7 , mice were in]ected j v 二 ^ j g 
ng LPS The percentage survival were monitored on the indicate、 
days. (•) EAT, PH-I, LPS; (•) EAT, zymosan, LPS. 
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Fig.5.3 The cytostatic effect of macrophages on MBL-2 cells in 
vitro. On day 0, 50 0 jig or 5 mg PH-I was injected i .p. into each 
mouse. Control mice were injected with PBS. On day 2, all mice 
were injected i.p. with 3 mg picolinic acid (PLA). On day 5, 
peritoneal macrophages of each mouse were harvested. Peritoneal 
macrophages (2.5 x 10^/well) were incubated with 1 x 10^ MBL-2 
cells. The % suppression of the murine macrophages was measured 
by their ability to suppress the growth of MBL-2 cells, as 
determined from the ^H-TdR incorporation of the MBL-2 cells 
growth in the presence or absence of the peritoneal macrophages 
after two days incubation period. Vertical bars represent one 
S.D. The difference between control and treatment was determined 
b y the Student's t-test. •PcO.OOl. 
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acid-activated macrophages towards MBL-2 tumor cells in vitro. 
5-3 EFFECT OF PH-I ON THE ACTIVATION OF K-ACTIN GENE 
TRANSCRIPTION IN PERITONEAL MACROPHAGES 
Northern blotting experiments, using a ^^P-labelled S-actin 
cDNA probe for hybridization indicated that i.p. injection of 
zymosan or PH-I could augment the transcription of the S-actin 
gene in resting peritoneal macrophages in vivo (Fig.5.4 (a), 
(b) ) . Semi-quantitative analysis of the hybridization signals 
in the autoradiogram by optical densitometry showed that the 
ratio of peak areas of control ： zymosan ： PH-I : LPS was 1.00 
: 6 . 3 7 : 5.63 : 4.30. 
5.4 EFFECT OF PH-I ON THE IN VITRO GROWTH OF 
VARIOUS TUMOR CELL LINES 
The cytostatic activity of PH-I on various culture tumor 
cell lines was assessed by a standard ^H-TdR incorporation assay. 
It was found that PH-I expressed strong dose-dependent 
suppressive effect on the growth of PU5-1.8 cells in vitro (ICs。 
二 86 jig/ml) (Fig. 5.5, Table 5.3) but less effective on P388Di 
cells (IC5o > 500 llg/ml) (Fig.5.5, Table 5.3) and MBL-2 cells in 
vitro (ICso > 500 jig/ml) (Fig.5.5, Table 5.3) . On the other 
hand, PH—工 exhibited potent anti-tumor activities against EAT 
cells in vivo (Table 5.4) but not In vitro (IC^o > 500 |ig/ml) 
(Fig.5.5. Table 5.3). 
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Fig.5.4 (a) Formaldehyde gel electrophoresis of the mRNA 
extracted from the peritoneal exudate cells of different groups 
of mice. On day 0, 5 mg of zymosan or PH-I was injected i.p. 
into groups of four ICR mice. On day 6, 25 |Llg LPS was injected 
i.v. into another group of mice. Two hours later, peritoneal 
macrophages from all groups were harvested and mRNA was extracted 
from macrophages. Total RNA (5 jig) was electrophoresed and 
photographed. 
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Fig 5 4 (b) Expression of S-actin gene in peritoneal macrophages. 
After the RNA was electrophoresed and transferred to a nylon 
membrane, the membrane was then hybridized with a P-l^belled 
1^-actin cDNA probe. Autoradiograph was exposed at —/U L r〇r 
h, and signals were assessed with optical densitometry. 
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Fig.5.5 The suppressive effect of PH-I on the growth of PU5-1.8, 
P388Di, EAT and MBL-2 cells in vi tro. PU5-1.8 , P388 D^ (•) 
E A T (•) cells were cultured at a cell density of 1 x 10 
cells/well and MBL-2 cells (•) was cultured at a cell density of 
2 X 104 in a total volume of 0.2 ml in the absence or presence of 
different concentrations of PH—工.After an incubation period of 
48 h, cultured cells were given a pulse with 0.5 jlCi/well H-TdR 
and radioactivity incorporated was determined. Results were 
expressed as mean % suppression 士 S.D. 
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Table 5.3 Determination of ICg。 of PH-工 fraction from P. 








Different cells were cultured at a cell density of 1 x 10^ (PU5-
1.8, EAT, P388Di) or 2 xlO^ (MBL-2) cells/well in a total volume 
of 0.2 ml in the absence or presence of different concentrations 
of PH-I. After an incubation period of 48 h, cultured cells were 
given a pulse with 0.5 |lCi/well ^H-TdR and radioactivity 
incorporated was determined. ICg。 is the concentration of 




Table 5.4 Suppression of EAT growth by PH-I in vivo, 
TREATMENT EAT NUMBER SUPPRESSION (%) 
(X 10-8 cells) 
PBS 7 . 1± 0 . 8 0.0 土 11.2 
PH-I 2.1 土 0.2 69.8 土 6.6* 
BALB/c mice in groups of five were injected i.p. with PH-I (500 
jig/mouse) for five consecutive days (day 0 - 4) . Control mice 
were injected with an equal volume of PBS. On day 2, all mice 
were injected i.p. with EAT (10^ cells/mouse) . The tumor cell 
number recoverable from the peritoneal cavity of each mouse was 
determined on day 9. The difference between control and 
treatment was determined by the Student's t-test. *P<0.001. 
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5.5 工 M M U N O R E S T O R A T I V E EFFECT OF PH-I ON 
THE MITOGENIC RESPONSE IN EAT-BEARING MICE 
Fig. 5.6 (a), (b) show that the i.p. injection of PH-I could 
partially restore the suppressed T and B cell mitogenic responses 
in EAT-bearing mice. These results suggest that PH-I can exhibit 
an immunorestorative effect on depressed immune functions in 
tumor-bearing mice. 
DISCUSSION 
Nakamura et al (1986) were able to demonstrate direct anti-
tumor effects of 工L-l against various murine syngeneic tumors. 
Other investigators showed that 工 L-1 could mediate direct 
cytostatic and cytotoxic activities against certain tumors 
(Lachman et al. , 1986; Onozaki et al, , 1985) . More recently, IL-
1 had been shown to function as an adjuvant in specific 
iiranunotherapy resulting in enhanced host survival following 
subsequent tumor challenge (McCune et al. , 1990) . Hornung et al • 
(1992) , on the other hand, demonstrated that systemic 工L-1 
administration with conjunction of local adjuvant such as C. 
parvum could augment specific immune protection for the host in 
the resistance of rechallenge with tumor. In this chapter, PH-I 
was found to enhance the release of IL一1一like substance from 
resting peritoneal macrophages in vitro. Similarly, a 1^-1,3-
glucan (Lentinan) isolated from Lentinus edodes was found to 
stimulate macrophages to produce IL一1 (Izawa et al•, 1983). It 
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Fig 5.6 (a) The mitogenic effect of Con A on murine lymphocytes. 
ICR mice in groups of four were injected i.p. with PH-工（5〇0 
|lg/mouse) for 5 consecutive days (days 0 - 4) . Control mice were 
injected with an equal volume of PBS. On day 2, all mice were 
injected i.p. with EAT (1 x 10^ cells/mouse) • On day 9, Con A at 
different concentrations were co-cultured with 5 x 10: 
lymphocytes from untreated mice (〇)，lymphocytes from PBS-treated 
EAT-bearing mice (A) and lymphocytes from PH-I-treated EAT-
bearing mice (•). After an incubation period of 48 h, cultured 
cells were pulsed with 0.5 jiCi/well 'H-TdR and radioactivity 
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Fig.5.6 (b) The mitogenic effect of LPS on murine lymphocytes. 
工CR mice in groups of four were injected i .p. with PH-I (500 
jig/mouse) for 5 consecutive days (days 0 - 4) . Control mice were 
injected with an equal volume of PBS. On day 2, all mice were 
injected i .p. with EAT (1 x 10^ cells/mouse) . On day 9, LPS at 
different concentrations were co-cultured with 5 x 10^ 
lymphocytes from untreated EAT-bearing mice (•) , lymphocytes from 
PBS-treated EAT-bearing mice (•) and lymphocytes from PH-工-
treated EAT-bearing mice (!). After an incubation period of 48 
h, cultured cells were pulsed with 0.5 }lCi/well ^H-TdR and 
radioactivity incorporated was determined. Results were 




beneficial to the host by augmenting its anti-tumor responses in 
vivo. Previous studies indicated that i.p. injection of an a-
glucan RBS could augment the host defense against bacterial 
infection by increasing the expression of IL-loc mRNA in C. parvum 
activated peritoneal macrophages (Takeda et al. , 1990) . The 
present results show that i.p. injection of PH-工 not only 
enhanced the cytostatic activity of picolinic acid activated 
macrophages but also augmented the transcription of S-actin gene 
in peritoneal macrophages in vivo. Therefore, PH-I is not only 
a polyclonal B cell mitogen but also an activator of peritoneal 
macrophages in vivo. 
Priming agents for TNF-a production are mostly from 
bacteria. A non-bacterial priming agent, zymosan, had been 
described in 1984 (Haranaka et al. , 1984) . Many well-recognized 
priming agents such as zymosan can be used to induce TNF-a with 
subsequent challenge with LPS in mice (Haranaka et al • , 1984； 
Wong et al. , 1992) . In a previous study, traditional Chinese 
medicines (e.g. Angelica radix, Cinnamomum cortex) were given 
orally as reticuloendothelial stimulating agents to induce TNF-a 
production in vivo and prolonged the survival time of Meth A 
bearing mice (Haranaka et al•, 1985). The above crude Chinese 
herbs offer the advantages of low toxicity and ease of 
administration while comparing with other bacterial priming 
agents such as BCG (Carswell et al., 1975) and Listeria 
monocytogenes (Ha et al • , 1987) . The results in Table 5.1 show 
that TNF-a could also be induced in the serum of P H - I - p r i m e d mice 
with subsequent challenge with LPS six days later. In contrast, 
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TNF-a could not be detected in the serum of zymosan-primed mice 
following challenge with PH-I. These results indicate that PH-I 
could act as a priming agent rather than an eliciting agent for 
the release of TNF-a in mice. However, the TNF-a titer induced 
by PH-I was lower than that of using zymosan as the priming 
agent. Among fractions PH-I A, PH-I B and PH-I C, PH-I C was 
found to be the most potent priming agent for the induction of 
TNF-a in vivo. The difference in the producibility of TNF-a 
might depend on the degree of stimulation of the 
reticuloendothelial system by the priming agent. The 
mechanism(s) whereby PH-I and its subfractions could exert its 
effect on the reticuloendothelial system will be discussed in 
Chapter 6. Moreover, PH-I was found to be better than zymosan 
in the treatment of tumor-bearing mice. It is because the 
zymosan-primed EAT-bearing mice died more easily after LPS 
injection than PH-工 primed EAT-bearing mice (Fig.5.2). 
In this chapter, the effect of PH-I on the in vitro growth 
of various tumor cell lines was also examined. The data show 
that PH-工 could suppress the growth of PU5-1.8 cells but had 
little or no effect on the proliferation of EAT or MBL-2 cell 
growth in vi tro. The basis for this differential sensitivity of 
the tumors to the cytostatic action of PH-I in vitro is not well 
understood. This could be due to the fact that macrophage - l i k e 
tumors such as PU5-1.8 cells do exhibit some properties of 
macrophages such as phagocytosis. It is possible that 
phagocytosis facilitates the internalization of PH-I into the 
cell interior which is considered to be necessary for its 
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cytostatic action. It could be possible that the observed 
cytostatic effect on tumor cells of PH-I might be principally due 
to the inhibition of protein synthesis and/or RNA synthesis. 
However, PH-I could suppress EAT growth in vivo and stimulate the 
picolinic acid activated peritoneal macrophages to suppress the 
growth of MBL-2 cells in vitro. This would indicate that the 
anti-EAT or anti-MBL-2 activity of PH-I was mediated through the 
activation of the immune system of the host rather than resulting 
from direct killing of the tumor cells. This is supported by the 
findings that PH-I could activate the reticuloendothelial system 
to release cytokines such as IL-l and TNF-a which may kill the 
tumor cells in vivo. More detailed studies on the effects of PH-
工 in activating host-mediated immunity against tumor cells will 
be discussed in chapter 6. 
It was found that i.p. injection of PH-工 could partially 
restore the suppressed mitogenic response of splenic lymphocytes 
in EAT-bearing mice (Fig.5.6 (a), (b)). In chapter 4, the i.p. 
injection of PH-I had been shown to activate the mitogenic 
activity of lymphocytes in vivo. This is consistent with the 
present results that PH-I could partially restore the suppressed 
mitogenic response in EAT-bearing mice. The immunorestorative 
activity of PH-工 in tumor-bearing mice has important implications 
in cancer therapy. Thus, PH-工 having i m m u n o s t i m u l a t i n g and 
immunorestoring activities could be used as an adjunctive agent 
in the treatment of cancer, especially in combination with other 
anti-cancer drugs (such as 5-flurouracil, methotrexate, 
cyclophosphamide) or radiotherapy in order to restore the 
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Chapter six 
CHAPTER SIX 
IMMUNOMODULATING AND ANTI-TUMOR ACTIVITIES 
OF PURIFIED FRACTIONS 
SEPARATED FROM PSEUDOSTELLARIA HETEROPHYLLA 
INTRODUCTION 
Anti-tumor polysaccharides from Traditional Chinese Medicine 
(TCM) have many immunomodulating activities including activation 
of the cell mediated immunity. They have been shown to cause the 
activation of various types of effector cells including T 
lymphocytes (Kumazawa et al. , 1985a) , B lymphocytes (Kumazawa et 
al., 1985b), macrophages (Adachi et al•, 1990), PMN (Kimura et 
al., 1987; Morikawa et al., 1985), NK cells (Tsukagoshi et al., 
1984), LAK cells (Hayashida et al., 1991), TILs (Kariya et al., 
1991; Mizutani and Yoshida, 1991) and macrophages (Wang et al., 
1993) . Besides the activation of cell-mediated immunity, many 
anti-tumor polysaccharides can also stimulate the production of 
cytokines in vivo with anti-tumor activities. One of the 
important cytokines is tumor necrosis factor-alpha (TNF-a). 
TNF-a was first discovered in 1975 by Carswell and her 
colleagues (Carswell et al, , 1975) in the serum of mice infected 
with BCG and challenged subsequently with LPS. TNF-a is capable 
of inducing necrosis of certain tumors in experimental animals 
(Carswell et al• , 1975) and exerted cytotoxic or cytostatic 
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effects on many tumor cell lines in vitro (Haranaka and Satomi, 
1981; Watanabe et al. , 1985) . However, when recombinant TNF-a 
was injected into human patients, many side effects including 
fever and cachexia were observed (Spriggs et al. , 1987). 
Therefore, a.nti — tunioir therapy by the induct ion of endogenous TNF-
a is a possible alternative. 
Results in Chapter 5 show that endogenous TNF-a could be 
induced in zymosan-primed mice bearing EAT cells with subsequent 
challenge with LPS. The in vivo production of TNF-a was found 
to suppress the proliferation of EAT cells simultaneously. A 
previous study showed that TNF-a could be induced in the solid 
MH134 hepatoma by systemic administration of an anti-tumor 
polysaccharide, MGA, in mice (Takahashi et al. , 1988). 
Therefore, the endogenous induction of TNF-a has been proved to 
be an effective method to suppress the growth of certain tumors 
in mice. In chapter 4,5, it has been shown that an alcohol-
insoluble fraction (PH-I) extracted from the roots of P. 
heterophylla possesses potent mitogenic and anti-tumor 
activities. In addition, PH-I was found to act as a priming 
agent for TNF-a release in vivo. In this chapter, purified 
fractions derived from PH-工 will be investigated for the 
induction of TNF-a as well as other anti-tumor cytokines' 
including 工FN-gamma and 工L-1. 
Moreover, the anti-proliferative effect of different 
purified fractions on various tumor cell lines in vitro will be 
examined. The therapeutic efficacy of these fractions on the 
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growth of EAT cells in vivo will also be discussed. In this 
chapter, attempts will be made to dissect out the underlying 
mechanisms by which P. heterophylla can exert its anti-tumor 
activities in vivo. In particular, the effects of the purified 
fractions from P. heterophylla on the activation of various 
effector cell types will be evaluated. 
Since PH-I has been shown to be capable of partially 
restoring the suppressed mitogenic response of lymphocytes in 
tumor-bearing mice (Chapter 5) . It will be also of interest to 
examine the immunorestorative effect of the purified fractions 
from P. heterophylla in immunodeficient or immunosuppressed mice 
as a result of aging or cytotoxic drug treatment. Many previous 
reports claimed that combined treatment with anti-tumor 
polysaccharides (with immuno s t imu1at ing activities) and 
chemotherapy or with other cytokines gave more promising results 
in anti-cancer therapy (Akiyama et al., 1977； Yamasaki et al., 
19 89) . Therefore, the effect of combined treatment of EAT-
bearing mice with purified fractions and cytokine such as TNF-a 




6.1 In vitro anti-tumor activities of P. heterophyl 1 a 
PH-I A, PH-工 B and PH-I C were found to be non-toxic to 
normal organisms in vivo as determined by the Brine shrimp assay 
(Table 6.1). Various fractions purified from P. heterophyl1a 
were studied for their in vitro anti-tumor activities. It was 
found that PH-工 A, PH-I B, PH-工 C, PH-工 Aa, PH-I Ab, PH-工 Ca and 
PH-I Cb (ICso > 500 flg/ml) could not suppress the proliferation 
of EAT cells in vitro (Fig.6.1, Table 6.2) whereas the 
proliferation of PU5-1.8 cells (Fig.6.2, Table 6.2) was 
suppressed. With the exception of PH-I Aa and PH-I Ca, all other 
fractions even enhanced the proliferation of EAT cells in vitro 
(Fig. 6.1) . On the other hand, among all fractions that had been 
tested, PH-I B (IC^q = 300 |lg/ml) and PH-I C (ICso 二 300 |Xg/ml) 
exhibited the greatest suppression on PU5-1.8 cells (Fig.6.2' 
Table 6.2). Moreover, both PH_I Ca and PH-I Cb fractions 
suppressed the proliferation of the MBL-2 cells (Fig.6.3, Table 
6.2) and WEH工-164 cells (Fig.6.4, Table 6.2) in a dose-dependent 
manner. However, in both cases, the anti-tumor activity of PH-I 
Cb was found to be more potent than that of PH—工 Ca. Finally, 
PH-工 A, PH-工 B, PH-工 C and PH-I Ca were found to suppress the 
proliferation of YAC-1 cells in vitro with PH-I C (ICso = 442 




Table 6.1 Determination of the toxicity (LC50) of different 
fractions from P. heterophylla by brine shrimp assay. 
lAo 
(jlg/ml) 
Berberine chloride 50.0 
Hippuric acid 310.0 
PH-工 >1000.0 
PH-工 A >1000.0 
PH-I B >1000.0 
PH-I C >1000.0 
P. heterophylla fractions at 1000, 100, 10 jlg/ml were mixed with 
the brine shrimp {Artemia salina LEACH). The number of shrimps 
being killed was counted 2 days later and the toxicity (LC50) was 
determined. Berberine chloride and hippuric acid were used as 
positive controls. LC50 is defined as the concentration of 
sample (|ig/inl) which causes 50 % of the total shrimps death in 
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Fig.6.1 The suppressive effect of different fractions on EAT 
cells in vi tro. EAT cells were cultured at a cell density of 1 
X 1〇5 cells/well in a total volume of 0.2 ml in the absence or 
presence of different concentrations of samples. (a) PH-I A (O)‘ 
PH-I B (•) , PH-I C (V) ； (b) PH-I Aa (•) , PH-I Ab (•) ' PH-I Ca (H) 
and PH-工 Cb (A)• After an incubation period of 48 h, cultured 
cells were given a pulse with 0.5 ilCi/well 'H-TdR and 
radioactivity incorporated was determined. Results were 
expressed as mean % suppression 土 S.D.. 
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Fig 6 2 The suppressive effect of different fractions on PU5-1.8 
cells 'in vitro, PUS-1.8 cells were cultured at a cell density 
of 1 X 105 cells/well in a total volume of 0.2 ml in the absence 
or p r e s e n c e of different concentrations of samples. (a) PH—工 ^ 
( 。 ） ， P H - I B (•), P H - I C (•); (b) P H - I A a (•) , P H - I A b (•j、『H:工 
Ca (A) a n d PH-I Cb (•)• After an incubation period of 48 N,^  
cultured cells were given a pulse with 0.5 [iCi/well H-TdR ana 
r a d i o a c t i v i t y incorporated was determined. Results were 
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Fig.6.3 The suppressive effect of different fractions on ^MBL-2 
cells‘in vitro. MBL-2 cells were cultured at a cell density of 
2 X 104 cells/well in a total volume of 0.2 ml in the absence or 
p r e s e n c e of d i f f e r e n t c o n c e n t r a t i o n s of PH—工.Aa (•), PH—工 A b 
(•) ； PH-工 Ca (•) and PH-I Cb (!) . After an incubation period of 
48 h, cultured cells were given a pulse with 0.5 |lCi/well ^H-TdR 
and radioactivity incorporated was determined. Results were 
expressed as mean % suppression 土 S.D.. 
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Fig.6.4 The suppressive effect of different fractions on WEHI-
164 cells in vi tro. WEH工-164 cells were cultured at a cell 
density of 1 x 10^ cells/well in a total volume of 0.2 ml in the 
absence or presence of different concentrations of samples. (a) 
PH-I A (〇），PH-I B ( 參 ） ， P H - I C (V) ； (b) PH-I Aa (•) ' PH-I Ab (B)' 
PH-I Ca (A) and PH-I Cb (•)• After an incubation period of 48 
h, cultured cells were given a pulse with 0.5 |iCi/well ^H-TdR and 
radioactivity incorporated was determined. Results were 
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Fig.6.5 The suppressive effect of different fractions on YAC-1 
cells in vitro. YAC-1 cells were cultured at a cell density of 
1 X 104 cells/well in a total volume of 0.2 ml in the absence or 
presence of different concentrations of PH-工（•），PH-工 A (•), PH-
工 B (•) , PH-工 C (•), PH-I Ca (〇）and PH-I Cb (A) . After an 
incubation period of 48 h, cultured cells were given a pulse with 
0.5 |lCi/well ^H-TdR and radioactivity incorporated was 
determined. Results were expressed as mean % suppression 土 S.D.。 
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^able 6.2 Determination of ICs。 of different fractions from P 
heterophylla on different tumor cells in vitro. 
Tumor jn 
1 1 50 
cell (|ig/ml) 
PH-I A PH-I B PH-I C PH-工 Aa PH-I Ab PH-I Ca PH-1 Cb 
EAT >500 >500 >500 >500 >500 >500 >500 
MBL-2 N.D.* N.D. N.D. >500 >500 >500 385 
PU5 >500 300 300 >500 >500 >500 >500 
WEHI164 >500 >500 >500 >500 >500 366 200 
YAc-i >500 >500 442 >500 >500 >500 >500 
Different tumor cells were cultured in a total volume of 0.2 ml 
in the absence or presence of various concentrations of different 
fractions of P. heterophylla. After an incubation period of 48 
h , cultured cells were given a pulse with 0 .5 |lCi/well ^H-TdR and 
radioactivity incorporated was determined. ICsq is the 
concentration of different fractions which gives a 50 % 
suppression of tumor cell proliferation. 
*N. D . = not determined 
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6.2 In vivo anti-tumor activities of P. heterophylla 
Although all P. heterophylla fractions tested failed to show 
any anti-proliferative effect on EAT cells in vitro (Fig.6.1), 
however, with the exception of PH—工 Cb, i.p. injection of P. 
heterophylla fractions significantly suppressed the growth of EAT 
cells in vivo (Table 6.3, 6.4). Among all the fractions being 
tested, PH-I C was found to exhibit the greatest anti-tumor 
activity in vivo. 
S.3 Effect of P. heterophyl 1a fractions on induction of 
delayed-type hypersensitivity 
Table 6.5 shows that the i.v. injection of PH-I A, PH-I B 
and PH-I C could not augment the DTH response to SRBC in vivo. 
In fact, PH-I C slightly suppressed the DTH response to SRBC at 
24 h after challenge with SRBC. 
6.4 Effect of PH-I fraction on the cytotoxic alloreactive T 
lymphocyte in vitro 
In Fig.6.6, PH-I has not exhibited any synergistic effect 
with Con A on the proliferation of alloreactive cytotoxic T 
lymphocytes in vi tro. Therefore, PH-I could not stimulate the 
Con A activated alloreactive cytotoxic T lymphocytes in vitro. 
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Table 6.3 Suppression of EAT growth in mice by different 
fractions of P. heterophylla. 
TREATMENT EAT NUMBER SUPPRESSION (%) 
(X 10-8) 
PBS 7.1 土 2.6 0.0 
PH—I A 5 . 0± 1 . 3 2 9 . 6±7 . 7 
PH-I B 2.5 ±0.3 64.8 ±7.7* 
PH-I C 0.1 ± 0.1 98.6 ± 12.0" 
ICR mice in groups of five were injected i.p. with different 
fractions (500 jig per mouse) for 5 consecutive days (days 0-4). 
Control mice were injected with an equal volume of PBS. On day 
2, all mice were injected i.p. with EAT (1 x 10^ cells/mouse). 
The tumor cell number recoverable from the peritoneal cavity of 
each mouse was determined on day 9 . The differences between the 
control group and treatment groups were determined by the 
Student's t-test. *P < 0.005, **P < 0.001. 
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Table 6.4 Suppression . of EAT growth in mice by different 
fractions of P. heterophylla. 
) 
TREATMENT EAT NUMBER SUPPRESSION (%) 
(X 10-7) 
PBS 6.9 ± 1.7 0.0 
PH—工 iVa 5.2 ± 0.9 27.8 土 
PH-I Ab 2.6 土 1.9 62.6 土 46.0“ 
PH-I Ca 2.9 ± 2.1 59.7 ± 44.3** 
PH-I Cb 5 . 5± 1 . 7 19.5土 5.8 
ICR mice in groups of seven were injected i .p. with different 
fractions (500 jig per mouse) for 5 consecutive days (days 0-4). 
Control mice were injected with an equal volume of PBS. On day 
2, all mice were injected i .p. with EAT (1 x 10^ cells/mouse). 
The tumor cell number recoverable from the peritoneal cavity of 
each mouse was determined on day 9. The differences between the 
control group and treatment groups were determined by the 
Student's t-test. < 0.02, **P < 0.01. 
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Table 6.5 DTH response against SRBC in BALB/c mice by different 
fractions of Pseudostellaria heterophylla. 
Mean increase in footpad thickness (%) 
Group 
24 h 48 h 72 h 
CONTROL 43.0 ± 10.5 28.7 ± 15.4 10.1 土 13.4 
PH—I A 38.7 土 8.9 16.9 土 16.2 6.7 士 5.8 
PH-I B 43.0 土 4.4 28.6 土 14.6 24.4 土 8.1 
PH-I C 15.2 土 14.1 29.5 土 6.4 6.7 士 5.8 
On day 0, BALB/c mice in groups of 3 were given an i.v. injection 
of 1 X 106 SRBC in 0.2 ml PBS for sensitization. On day 1 and 2, 
2 mg samples in 0 .2 ml PBS was injected i.v.. Control mice were 
injected i.v. with an equal volume of PBS. On day 4, the left 
and right hind footpad thickness of mice were measured and their 
mean footpad thickness was determined. Each mouse was then 
challenged with 10® SRBC in 50 jll of PBS, injected subcutaneous ly 
(s . c. ) into each right hind footpad. The same volume of PBS was 
injected into the left hind footpad as self-control. Footpad 
swelling was measured at 24, 48 and 72 h after the antigen 
challenge and results were expressed as the percentage mean 
increase in footpad thickness. 
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Fig 6.6 The co-mitogenic effect of PH—工 on alloreactive cytotoxic 
T lymphocytes. Mitomycin C treated BALB/c splenocytes (5 x 10 
in 50 LLl) were c o - c u l t u r e d with an equal number of C57BL/6J 
splenocytes (5 x 10^ in 50 ^1) in a final volume of 0 • 1 ml 
complete RPMI medium in the presence of different concentration 
of PH—工（•） or in the presence of different concentration of H^了工 
and con A (1 ^Lg/ml) (•) . After an incubation Period for 72 h in 
a humidified atmosphere with 5 % CO,-95 % air at 37^0 the cells 
were pulsed with 0.5 ^Ci ^H-TdR in 50 RPMI for 2 0 h The 
incorporation of ^H-TdR into cells was d e t e ^ i n e d by a ^ l i ^ i d 
scintillation counter. Results were expressed as the arithmetic 
mean S I ± S.D. of triplicate cultures (S.I. = cpm in test 
cultures per cpm in control cultures). 
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6.5 Effect of P. heterophylla on the production 
of TNF-a and IFN-gamma 
Table 6.6 shows that PH-I A, PH-工 B, PH-I C, PH-I Ca and PH_ 
工 Cb could stimulate TNF-a release from peritoneal resident 
macrophages in vitro. Table 6.7 shows that intravenous injection 
with PH-I A, PH-I B, PH-I C, PH_I Ca and PH-I Cb induced the 
production of TNF-a in the serum as well as IFN-gamma production 
in both the serum and peritoneal ascitic fluid of EAT-bearing 
mice. Moreover, PH-I C, PH-I Ca and PH-I Cb could also induce 
TNF-a release in peritoneal ascitic fluid of EAT-bearing mice. 
In view of the ability of PH-I Cb to induce production of high 
titers of TNF-a on EAT-bearing mice, the effect of PH-I Cb on the 
survival rate of EAT-bearing mice was also examined. It was 
found that the survival rate of PH-I Cb treated EAT-bearing mice 
was higher than that of the untreated EAT-bearing mice or 
zymosan-primed EAT-bearing mice after the injection of LPS 
(Fig.6.7) . There were 40 % EAT-bearing mice or zymosan-primed 
EAT-bearing mice died on day 11 after LPS injection. However, 
only 10 % PH-工 Cb treated EAT-bearing mice died at the same time. 
Table 6.8 shows that i.v. injection of heparin but not 
galacturonic acid alone could induce the production of TNF-a in 
vivo. Moreover, acetic acid treatment could not decrease the 
TNF-a inducing activities of PH-I A, PH-I B and PH-I C (Table 
6.9). Therefore, the TNF-a inducing activity of these fractions 
was unlikely due to the contamination by LPS. It is because 
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Tab+e 6.6 In vitro stimulation of TNF-a release from resident 
peritoneal macrophages by P. heterophylla. 
！ • ‘ 
V 
SAMPLE CONCENTRATION OF TNF-a 
(l^g/ml) (ng/ml) 
MEDIUM 0.140 土 0.032 
1 0 0 0 . 3 3 0 土 0 . 0 3 1 
PH-I A 200 0.330 土 0.013 
500 0.340 土 0.029 
100 0.570 土 0.020 
PH-I B 200 0.670 士 0.020 
500 0.830 士 0.002 
100 0.250 土 CK035 
PH-I C 200 0.300 土 0.013 
5 0 0 0 . 3 1 0 士 0 . 0 1 6 
100 0.280 士 0.040 
PH-I Ca 200 0.290 土 0.047 
. 500 0.280 土 0.035 
1 0 0 0 . 2 8 1 土 0 . 0 1 4 
PH-工 Cb 200 0.430 土 0.008 
5 0 0 0 . 5 0 0 土 0 . 0 6 4 
Different fractions (PH-工 A, PH-工 B, PH-工 C, PH-I Ca and PH-I Cb) 
at various concentrations were incubated with peritoneal 
macrophages from ICR mice (1 x lOVml) for 24 h. The 
supernatants were harvested and the TNF titers were determined 
by a mouse TNF-a ELISA test kit (Genzyme) using recombinant 
murine TNF-a as the standard. 
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Table 6.7 Effects of P. heterophylla fractions on the TNF-a and 
工 F N — g a m m a production as well as EAT growth in vivo. 
！ 
TREATMENT TNF-a TITER 工 F N — g a m m a TITER % SUPPRESSION OF 
(ng/ml) (ng/ml) EAT GROWTH 
SERUM ASCITIC SERUM ASCITIC 
FLUID FLUID 
PBS U . D. * U.D. U.D. U.D. 0.00 土 13.70 
ZYM, LPS+ 6.86 8.85 3.76 1.77 50.50 土 17.30* 
LPS+ 0.97 1.28 0.61 3.02 11.80 土 15.80 
PH-工 U.D. U.D. 3.85 0.70 16.75 土 28.77 
PH-工 A 0.05 U.D. 0.63 2.52 50.94 土 47.53** 
PH-I B 0.97 U.D. 0.22 1.90 38.00 土 20.67* 
PH-工 C 0.54 1.15 0.70 0.90 47.44 土 11.34" 
PH-工 Ca 0.29 0.45 0.30 2.79 49.30 士 19.58** 
PH-I Cb 12.00 3.16 1.30 0.49 83.91 土 18.49** 
ICR mice in groups of four were inoculated i.p. with 10^ EAT 
cells in 0.2 ml PBS on day 0. On day 6, each mouse was injected 
i.v. with 2 mg samples in 0.2 ml PBS. The mice were bled from 
subclavian vessels to obtain the serum, and the ascitic fluid was 
collected from the peritoneal cavity 2 h. after the injection. 
TNF-a and IFN-gamma titers in the pooled sera and ascitic fluids 
were determined by the mouse TNF-a and IFN-gamma ELISA test kits 
(Genzyme) using recombinant murine TNF-a or IFN-gamma as the 
standard respectively. The suppression of EAT growth was 
determined with the remaining mice (6-7 mice) on day 7. 
+〇n day 0, each mouse was inoculated with 10^ EAT cells. On day 
1, 5 mg zymosan or PBS was injected i.p. . On day 7' each mouse 
was injected i.v. with 25 \ig LPS. The sera and ascitic fluids 
were collected 2 h after LPS injection. On day 9' the 
suppression of EAT cells were determined. The differences 
between control group and treatment groups were determined by the 
Student's t-test. •PcO.Ol. •*?<〇.001. 
#U.D. = undetectable 
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Fig. 6.7 Effect of PH-I Cb on the survival rate of EAT-bearing 
m i c e . ICR mice in groups of ten were inoculated with 2 x 10^ EAT 
cells on day 0. In one group of mice, 5 mg zymosan was injected 
into each mouse i.p. on day 1. On day 7, each mouse was injected 
i.v. w i t h 25 jig LPS. In a second group of mice, each mouse was 
injected with 2 mg PH-I Cb i.v. on day 6. The percentage 
survival in these two groups of mice was monitored over a period 
of 18 days and compared with the control EAT-bearing mice. 
Control (〇），zymosan and LPS treated (•) , PH-I Cb treated (•)• 
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Table 6.8 Effect of heparin and a - D - g a l a c t u r o n i c acid on TNF-a 
induction in vivo. 
！ 
TREATMENT TNF-a TITER 
(ng/ml) 
SERUM ASCITIC FLUID 
HEPARIN 0.39 土 0.02 
GALACTURONIC ACID U.D.* 
HEPARIN+ 0.36 士 0.07 0.05 土 0.01 
GALACTURONIC ACID+ U.D, 0.04 ± 0.05 
Each ICR mouse was injected i.v. with 2 mg sample in 0.2 ml PBS. 
Three to four mice were bled from subclavian vessels to obtain 
the serum 2 h after the injection. +ICR mice in groups of four 
were inoculated i.p. with 1 x 10^ EAT cells in 0.2 ml PBS on day 
0. On day 6, each mouse was injected i.v. with 2 mg samples in 
0.2 ml PBS. Three to four mice were bled from subclavian vessels 
to obtain the serum and the ascitic fluid was collected from the 
peritoneal cavity 2 h. after the injection. TNF-a titers in the 
pooled sera and ascitic fluid were determined by the mouse TNF-a 
ELISA test kit (Genzyme) using recombinant murine TNF-a as the 
standard. 
*U.D. : Undetectable 
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Table 6.9 Effect of acetic acid treated or periodate treated 
fractions on the TNF-a induction in vivo. 
TREATMENT TNF-a TITER 
(ng/ml) 
PBS U.D.* 
PH-I A 0.44 ± 0.16 
PH-I B 0.36 士 0.04 
PH-I C 0.51 ± 0.14 
Acetic acid 
treated fractions 
PH-工 A 0.30 土 0.06 
PH-工 B 0.32 土 0.02 
PH-工 C 1.38 土 1.07 
Sodium periodate 
treated fractions 
PH-I C 1.77 土 0.01 
Different fractions were treated with acetic acid or sodium 
periodate as described in materials and methods. Each mouse was 
injected i.v. with 2 mg samples in 0.2 ml PBS. Three to four 
mice were bled from subclavian vessels to obtain the serum 2 h 
after the injection. TNF-a titers in the pooled sera were 
determined by the mouse TNF-a ELISA test kit (Genzyme) using 
recombinant murine TNF-a as the standard. 
•U.D. 二 Undetectable 
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sodium periodate treatment could not decrease the TNF eliciting 
activity of PH-I C, indicating that the TNF eliciting activity 
of PH-工 C is most likely due to a periodate resistant 
carbohydrate. The ability of PH-I C to act as an eliciting agent 
for TNF-a release in EAT-bearing mice was also examined. As 
shown in Table 6.10, TNF-a could be induced in the serum and 
ascitic fluid of zymosan or PH-I primed EAT-bearing mice with 
subsequent i.v. injection with PH-I C. 
6.6 Effect of P. het erophyl 1 a on the activation of macrophages 
Since macrophages play an important role in innate and 
acquired immunity and are one of the ma j or effector cell types 
involved in the host's defence against tumor invasion, therefore, 
the ability of various purified fractions from P. heterophylla 
to activate macrophages was examined, both in vitro and in vivo. 
Table 6.11 shows that PH-I A , PH-I B or PH-I C could enhance the 
in vivo migration of the peritoneal macrophages elicited by 
picolinic acid. In addition, fractions PH-I A, PH-I Aa, PH-I Ab 
and PH-I Cb were found to activate the resting peritoneal 
macrophages to release 工 L - l - l i k e substance in vitro (Fig.6.8 (a), 
(b) ) . Moreover, i.p. injection of PH-I C into mice could 
activate the effector functions of macrophages in vivo, as 
measured by the increased phagocytic activity of the 
thioglycollate-elicited peritoneal macrophages after 60 min. 
incubation period with yeast in vitro (Fig.6.9). 
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T〒ble 6.10 TNF - a-eliciting activity of PH-I C in EAT-bearing 
m i c e . 
TREATMENT TNF-a TITER 
(ng/ml) 
SERUM ASCITIC FLUID 
PBS U.D.* U.D. 
Zyin,LPS 6.86 士 0.56 8.85 土 0.49 
Zym,PH-I C 4.91 ± 0.17 8.50 ± 0.09 
PH-I,PH-I C 4.90 土 0.12 6.52 士 0.01 
On day 0, 10^ EAT cells were inoculated into groups of 10 mice. 
On day 1, 5 mg zymosan or PH-I was injected i.p.. On day 7, each 
mouse was inj ected i. v . with 2 5 jig LPS or 2 mg PH-I C. The sera 
and ascitic fluids were collected 2 h after LPS or PH-I C 
injection. TNF-a titers in the pooled sera and ascitic fluids 
were determined by the mouse TNF-a ELISA test kit (Genzyme) using 
recombinant murine TNF-a as the standard. 
*U.D. = Undetectable 
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Table 6.11 In vivo migration of macrophages in mice by i . p . 
injection of different fractions. 
TREATMENT NUMBER OF MACROPHAGES 
‘ RECOVERED PER MOUSE 
PBS 5.13 X 106 
PLA 6.50 X 106 
PLA, PH-I A 8.00 X 10^ 
PLA, PH-I B 1.07 X 107 
PLA, PH-I C 1.50 X 107 
On day 0, 5 mg PH-I A, PH_I B, PH-I C or PBS was injected i.p. 
into groups of three mice. On day 2, 3 mg PLA was injected i.p. 
into each mouse. The adherent peritoneal macrophages of pooled 
mouse in each group were harvested and counted on day 5. 
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Fig.6.8 In vitro induction of IL一1一:Like substance from resting 
p e r i t o n e a l macrophages. P. heterophylla fractions at various 
concentrations were incubated at 37°C with resting peritoneal 
macrophages cells/well) for 1 day. The supernatants were 
h a r v e s t e d and tested for IL_1 activity. Briefly. C57BL/6J 
thymocytes (5 x lOVwell) were cultured for 3 days _ in the 
p r L e n c e of 50 U/ml of MurIL-2 and 5 x 10"^ M 2-ME. Different 
IL一1一like substance containing culture supernatants in serial two 
fold dilutions were added to the cultures. Four hours prior to 
h a r v e s t , 0.5 \iCi of ^H-TdR was added to each well. Results were 
expressed as mean CPM 土 S.D.. 
(a) MEDIUM CONTROL (O) , PH-I A 500 ^ ig/ml (•) ' PH-I B 500 阳/ml 
(•), PH-工 C 500 jig/ML (A), LPS 1 |ig/ml (•) • 
(b) M E D I U M CONTROL (〇），PH-I Aa 500 i^g/ij^ l (•) , PH-工 ^ |00 lig/ml 
！ • ) , PH-工 Ca 500 ^ig/ml (•) , PH-I Cb 500 ^ig/ml (•), LPS 1 ^ig/ml 
( • ) . 
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Fig.6.9 In vivo activation of phagocytosis of thioglycollate 
elicited peritoneal macrophages. On day 0, 5 mg different 
samples were injected i.p. into groups of three C57BL/6J mice. 
On day 2, 2 ml thioglycollate was injected i.p. into each mouse. 
On day 5, the peritoneal macrophages were harvested. The 
phagocytic activity of macrophages of each group was determined 
after 60 min incubation period with yeasts by spectrofluorometric 
method. The differences between control group and treatment 
groups were determined by the Student's t-test. *P<0.05. 
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6.7 Effect of P. heterophylla on the activation 
of NK^ LAK and TIL 
Apart from activating macrophages, the anti-tumor activity 
of P. heterophylla might also be mediated through activation of 
cytotoxic anti-tumor cells. Therefore, the ability of various 
purified fractions from P. heterophylla to activate different 
types of non-specific cytotoxic cells such as NK cells, LAK cells 
and TILs was studied. It was found that i.v. injection of PH-I 
A, PH-I B and PH-I C could augment the cytotoxic activity of 
splenic NK cells (Table 6.12). On the other hand, although PH-I 
A could not stimulate the anti-tumor activity of LAK cells in 
vitro, however, it could enhance the cytotoxic activity of IL-2-
stimulated LAK cells (Fig.6.10) . In contrast, PH-I B or PH-1 C 
alone could stimulate the anti-tumor activity of LAK cells in 
vi tro. In addition, they also slightly augmented the IL_2-
induced LAK activity in vitro (Fig.6.10) . Moreover, in vivo 
administration of PH-工 Cb also augmented the anti-tumor activity 
of LAK cells in EAT-bearing mice (Fig.6.11). Furthermore, i.p. 
injection of the anti-tumor fraction PH-I C could increase the 
% of TILs in the WEH工一164 sarcoma of BALB/c mice (Table 6.13). 
6.8 The effect of combined treatment of EAT-bearing mice with 
P . heterophylla and Mur-TNF-a on the growth of EAT cells in vivo 
The efficacy of combined treatment of tumor - b e a r i n g mice 
with P. heterophylla and cytokines such as TNF-a was 
investigated. Table 6.14 shows that PH-I Cb and Mur-TNF-a 
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Table 6.12 In vivo induction of natural killer cells. 
% SPECIFIC 5icr RELEASE FROM YAC-1 TARGET 
TREATMENT 
5 0 : 1 1 0 0 ： 1 
CONTROL 0.00 ± 10.89 17.38 ± 10.24 
PH-I A 24.59 土 7.09* 61.31 土 37.22 
PH—工 B 36.72 士 25.47*** 33.11 土 11.62 
PH—工 C 61.31 土 28.8Cr 77.88 土 32.40" 
On day 0, different fractions (2 mg/mouse) were injected i.v. 
into groups of three BALB/c mice. On day 1, NK activity was 
assayed by a 4 h cytotoxic assay using ^^Cr-labelled YAC-1 cells 
as target at effector-to-target ratios of 50 : 1 and 100 : 1. 
The differences between control group and treatment groups were 
determined by the Student's t-test. *P<0.01, **P<0.02,…P<0.05. 
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Fig.6.10 In vitro induction of lymphokine activated killer cell 
activity b y different fractions. BALB/c lymphocytes (5 x l O V m l ) 
were co-incubated with different fractions (100 jig/ml) and/or 
MurIL-2 (50 U/ml) in 10 ml RPMI complete medium for 3 days at 
370c. Effector cells (1 x l O V O . l ml) were added to the target 
(WEH工-164) cells so that the E/T ratio was 2 5 : 1 . After 24 h 
incubation period at 37°C, the cell mixtures were washed and 
stained with neutral red. The dyes uptake by target, cells were 
completely dissolved in SDS. The absorbance in each well was 
read at 540 nm and the results were expressed as the % 
cytotoxicity on WEH工-164 cells. The differences between control 
group and treatment groups were determined by the Student's t_ 
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Fig.6.11 In vivo induction of lymphokine activated killer cell 
activity in EAT-bearing mice by PH—工 Cb. ICR mice in groups of 
three were inoculated i.p. with 1 x 10^ EAT cells in 0.2 ml PBS 
on day 0. On day 6, each mouse was injected i.v. with 2 mg PH-I 
Cb in 0.2 ml PBS. On day 7, the splenic lymphocytes of each 
group of mice were incubated with WEHI-164 (4 x 10^) such that 
the E/T ratio was 50 ： 1. After 24 h incubation period at 
the cell mixtures were washed and stained with neutral red. The 
dyes uptake by target cells were completely dissolved in SDS. 
The absorbance in each well was read at 540 nm and the results 
were expressed as the % cytotoxicity on WEH工-164 cells. The 
difference between control group and treatment group was 
determined by the Student's t-test. *P<0.001. 
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Table 6 .13 In vivo stimulation of TILs in WEHI-164 sarcoma by PH-
工 C . 
> 
TREATMENT 一 % NUMBER OF TILS 
PBS 19.78 土 3.91 
PH-工 C 34.54 土 3.29* 
WEHI-164 cells (2 x 10^ in 0.2 ml PBS) were inoculated s.c. into 
each BALB/c mice on day 0. PH-I C (500 [ig in 0.5 ml PBS) was 
injected i.p. from day 16 to day 22 for 7 consecutive days. On 
day 23, TILs were isolated from the sarcoma and the % number of 
TILs was determined by trypan blue dye exclusion method. The 
difference between the control group and treatment groups was 
determined by the Student's t-test. *P<0.01. 
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Table 6.14 Effect of combined treatment of EAT-bearing mice with 
PH-I Cb and Mur-TNF on the growth of EAT cells in vivo. 
) 
EAT NUMBER 
TREATMENT (x ICT? cells) SUPPRESSION (%) 
PBS 5.8 ± 1.4 0.0 
PH—工 C b 3 . 5 ± 1.9 3 9 . 1 士 16.3* 
Mur-TNF-a 3.7 ± 2.1 36.9 ± 18.3** 
PH-I Cb, Mur-TNF-a 0.5 ± 0.4 91.2 ± 16.2* 
ICR mice in groups of ten were inoculated i.p. with lO^ EAT cells 
in 0.2 ml PBS on day 0. On day 6, each mouse was injected i.v. 
with 2 mg PH-I Cb or 5.4 x ICP U Mur-TNF-a in 0.2 ml PBS. In the 
case of combined treatment, Mur-TNF-a was injected 2 h after the 
injection of PH-I Cb. The tumor cell number recoverable from the 
peritoneal cavity of each mouse was determined on day 8. The 
differences between control group and treatment groups were 
determined by the Student's t-test. *P<0.01, **P<0.02. 
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exhibited a synergistic anti-tumor effect on EAT-bearing mice. 
It was found that injection of PH-工 Cb or Mur-TNF-a only resulted 
in about 40 % suppression of EAT cell growth in vivo. However, 
the combined treatment of EAT-bearing mice with PH-I Cb and Mur-
TNF-a exhibited a synergistic effect on the suppression of EAT 
cell growth in vivo (about 90 %). 
6.9 Immunorestorative activities of P. heterophyl 1 a 
in aged mice and eye 1 ophosphamide-treated mice 
The abilities of P. heterophylla fractions to restore the 
depressed immune functions in aging mice and to reverse the 
suppressive effect of CY on splenic lymphocytes were examined. 
Table 6 .15 shows that i.p. injection of PH-I A could restore the 
depressed in vi tro mitogenic response of murine splenic 
lymphocytes to both T and B cell mitogens in aged mice. On the 
other hand, in vivo administration of PH-I A, PH-I B and PH-I C 
into CY-pretreated mice could reverse the suppressive effect of 
CY on splenic lymphocytes (Fig.6.12 (a), (b) ) • 
DISCUSSION 
Results in this chapter (Table 6.2) show that various murine 
tumor cell lines responded differently to the growth- i n h i b i t o r y 
effect of P. heterophylla. The order of increasing 
susceptibility to P. heterophylla is shown as follows : EAT < 
YAC-1 < WEH工-164 and MBL-2 < PUS-1.8 cells. The basis for this 
differential sensitivity of the tumors to the cytostatic action 
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Table 6.15 Immunorestorative activity of PH-I A on the depressed 
mitogenic response to T and B cell mitogens in aged mice. 
Stimulation index of splenic lymphocytes 
Age of 
mice 
Con A (1 |lg/ml) 
Mice treated with P B S P H - I A 
7 weeks 91.94 士 2.15 224.79 土 19.01* 
5 months 51.77 士 5.03 110.53 土 10.89* 
1.5 years 4.46 士 0.30 37.60 土 3.12* 
LPS (10 |lg/ml) 
Mice treated with P B S P H - I A 
7 weeks 327.69 土 46.45 270.87 土 2.02 
5 months 174.11 土 11.84 294.84 土 15.79* 
1.5 years 5.55 土 0.21 13.87 土 0.33* 
PHA (4 jig/ml) 
Mice treated with P B S P H -工 A 
7 weeks 11.08 土 1.09 19.98 土 2.95* 
5 months 8.22 ± 0.27 11.32 ± 0.83* 
1.5 years 0.8 ± 0.02 2.98 ± 0.37* 
DS (20 |lg/ml) 
Mice treated with P B S P H -工 A •• 
7 weeks 1.04 士 0.18 1.54 士 0.22 
5 months 1.17 土 0.27 1.69 士 0.58* 
1.5 years 2.36 ± 0.28 8.11 土 0.09 
PH-工 A (200 jig in 0.2 m l PBS) was injected into groups of three 
C57BL/6J mice on day 0 and from day 2 to day 6. Control mice 
w e r e injected with an equal volume of PBS. On day 7, splenic 
lymphocytes were isolated from different gro”ps mice and 
e S o s e d to con A, LPS, PHA or DS (5 x 10 cells/well) 二 二 r 1 
incubation period of 48 h , cultured cells were pulsed with 0 5 
ici/well 3H?rdR and radioactivity incorporated was determined 
Results were expressed as mean S.I. ± S.D.. The differences 
S t w i e n the cont^rol groups and treatment groups were determined 
b y the Student's t-test. *P<0.001. P<0.05. 
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Fig. 6.12 Immunorestorative activity of P. heterophylla on the 
suppressive effect of cyclophosphamide on splenic lymphocytes in 
CY-pretreated mice. On day 0 to day 2, 2 mg CY in 0.2 ml PBS was 
injected i.p. into BALB/c mice. On day 1 to day 5, 200 jig PH-I 
A, PH-I B or PH-I C in 0•2 ml PBS was injected i.p. into groups 
of three mice. On day 6, the number of splenic lymphocytes in 
each group was counted (a) and the ratio of spleen weight to body 
weight in each group was determined (b) • The differences between 
the control group and treatment groups were determined by the 
Student's t-test. *Difference between control and CY treated 
group. PcO.OOl. Difference between CY treated group and CY and 




of different fractions in vitro is not well understood. This 
could be due to the fact that macrophage-1 ike tumors such as PU5-
1.8 cells do exhibit some properties of macrophages such as 
phagocytosis. It is possible that phagocytosis facilitates the 
internalization of P. heterophylla polysaccharides into the cell 
interior which may be required for P. heterophylla 
polysaccharides to exert their cytostatic action on the tumor 
cells . However, whether the mechanisms of the suppressive effect 
of P. heterophyl1a on different tumor cells in vitro involved the 
apoptosis (Cohen and Duke, 1992; Cohen, 1993) or direct cytotoxic 
effect remain to be investigated. In addition, the activity of 
many natural antineoplastic compounds was found to relate to its 
chemical structure (Lou et al.,1988), therefore, the structures 
of the in vitro ant i-tumor fractions from P. het erophyl 1 a also 
need to be clarified. Among all different fractions tested, 
three fractions (i.e., PH-I C, PH-工 Ca and PH-I Cb) were found 
to exhibit relatively potent anti-tumor activities against 
different cell lines in vitro. 
Previous studies demonstrated that Candida albicans mannan-
induced suppression of DTH is a T lymphocyte-mediated phenomenon 
(Garner et al. , 1990) . The present study shows that P. 
heterophylla had no effect on the induction of DTH in vivo (Table 
6.5)• Whether this is due to the failure of PH-工，PH-工 A, PH_I 
B and PH-工 C to activated or Th precursor cells remains to be 
seen. 
It was found that nearly all purified fractions separated 
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from P. heterophylla failed to suppress EAT growth in vi tro. On 
the other hand, i.p. injection of PH-I Ab, PH-工 C and PH-I Cb 
significantly suppressed the growth of EAT cell in vivo. Based 
on the in vitro and in vivo anti-tumor assays, PH-I C and PH-I 
Cb were found to be the most potent anti-tumor fractions in P. 
heterophylla. Since PH-I C and PH-I Cb carry 1,3 linkages, it 
is similar to the well characterized anti-tumor S-(l,3) glucan 
isolated from Lentinan (Aoki, 1985)• The abundant amount of 
uronic acid content in PH-I Cb may be an essential determinant 
of its potent anti-tumor activity. It seems likely that the 
anti-tumor activities of P. heterophylla on EAT cells in vivo may 
be mediated through the activation of the host immune system 
rather than resulting from a direct cytotoxic effect of P. 
heterophylla on the tumor cells. One of the possible mechanisms 
whereby P. heterophylla can exert its anti-tumor effect is the 
induction of cytokines such as TNF-a and 工 F N - g a m m a . 
Although the phase 工工 clinical trials of recombinant TNF-a 
had been carried out, the side effects of this treatment are 
still a drawback (Fiedler et al., 1991; Frei and Spriggs, 1989； 
Lenk et al • , 1989; Spriggs et al., 1987) . Injection of high 
doses of TNF-a reproduces most of the effects of the endotoxin 
or septic shock in humans. In addition to hypotension, 
hypothermia, hypoglycemia, acidosis, focal hepatic necrosis and 
sometimes bowel necrosis, acute interstitial pneumonitis with 
neutrophil trapping will also appear (Vassalli, 1992). 
Therefore, the activation of the immune system to induce 
endogenous TNF-a production so as to kill the tumor cells or to 
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suppress the tumor growth may be a more safe and effective 
alternative for cancer treatment. Nowadays, many 
iimnunopotentiating polysaccharides ’ extracted from natural 
products were found to possess anti-tumor activities (Luettig et 
al., 1989; Okutomi et al. , 1989; Shen et al. , 1991) . Some of 
them was found to induce TNF-a (Luettig et al. , 1989; Mori et 
al., 1989; Takahashi et al., 1988a； 1988b; Usami et al., 1988). 
MGA, an anti-tumor mannoglucan prepared from Microel 1 obosporia 
grisea, was found to be one of the strong eliciting agents of 
TNF-a (Takahashi et al., 1988a； 1988b). OK-432, a lyophilized 
preparation of Streptococcus pyogenes, could elicit endogenous 
TNF-a in mice by intravenous administration (Sakagami and Takeda, 
1992). OK-432 could also promote an increase in the number of 
primed peritoneal macrophages and the release of TNF-a from these 
cells after i.p. administration into ovarian cancer patients 
(Mori et al. , 1989) . Some of the Chinese herbs (Haranaka et al., 
1985) and fungi (Mori et al, , 1987; Wong et al. , 1992) were found 
to act as priming agents for TNF-a release in mice. An 
arabinogalactan from plant cell cultures of Echinacea purpurea 
has been shown to stimulate the induction of TNF-a by 
thioglycollate-induced peritoneal macrophages, and the induction 
of interferon-:^ from bone marrow macrophages (Luettig et al., 
1989) • However, eliciting agents of TNF-a and INF-gamma isolated 
from higher plants and Chinese herbal medicine have seldom been 
reported. 
PH-工，a mitogenic fraction separated from P. heterophylla, 
had previously been shown to act as a priming agent for TNF-a 
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release in vivo. It could also suppress the growth of EAT cells 
in vivo but not in vitro (Chapter 5) . PH-I could be separated 
into three bioactive fractions (PH-I A, PH-I B and PH-I C) by gel 
filtration (Chapter 4) • The i.p. injection of PH-I A, PH-I B and 
PH-I C into mice could increase the number of peritoneal 
macrophages. The mechanism(s) for the enhancing of the 
elicitation of macrophages by P. heterophylla may be due to the 
increased secretion of cytokines or the increased chemotactic 
response of macrophages. Results in this chapter show that among 
these three fractions, PH-I C exerted the most potent effect for 
the phagocytosis (Fig.6.9) and the induction of endogenous TNF-a 
in vivo (Table 6.7). 
PH-工 C could be further fractionated into two bioactive 
fractions PH-I Ca and PH—工 Cb by anion—exchange chromatography 
(Chapter 4) . It was found that the acidic fraction PH-工 Cb 
exerted a strong effect on TNF-a release from macrophages in 
vitro (Table 6.6) and was the most potent inducer of endogenous 
TNF-a production in serum and in ascitic fluid of E A T - b e a r i n g 
mice (Table 6.7) . PH-I Cb was found to be a pure acidic 
polysaccharide with molecular weight of approximately 5000 by 
HPLC (Fig.4.4 (j) ) . The EAT cell number recoverable from the 
peritoneal cavity was greatly reduced after i.v. injection of PH-
工 Cb into EAT-bearing mice. Preliminary results show that i.v. 
injection of heparin but not a-D-galacturonic acid could also 
induce TNF-a production in the serum of normal and EAT-bearing 
mice as well as in the ascitic fluid of EAT-bearing mice (Table 
6.8) . Acetic acid treatment could not diminish the TNF-a 
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inducing ability of PH-I A, PH-I B and PH-I C, indicating that 
these fractions were free from LPS. Sodium periodate treament 
also could not diminish the the TNF-a inducing activity of PH-I 
C, indicating that the TNF-a inducing activity of PH-工 C and its 
subf raction PH-I Cb was related to the 1,3 linkages. 
Collectively, it seems likely that the acidic properties of the 
polysaccharide or uronic acidic structure of a polymer with 1,3 
linkages may be related to the TNF-a inducing and anti-tumor 
activities. However, this has yet to be elucidated. 
In vitro studies had shown that TNF-a acted in synergy with 
IFN—gamma in exhibiting cytotoxicity on tumor cells (Dubois et 
al,, 1989, Williamson et al., .1983). It was suggested that an 
IFN-gamma-dependent increase in TNF-a receptor expression might 
underline this synergy (Aggarwal et al. , 1985) . Phase 工 clinical 
trial showed that the combination of TNF-a and 工FN-gainina could 
induce synergistic therapeutic effects in cancer patients 
(Demetri et al., 1989). The present results also indicate that 
i.v. injection of anti-tumor fractions not only capable of 
activating the macrophages but also T cells as well because IFN— 
gairana was mainly released from the activated T cells. The 
endogenous induction of TNF-a and 工FN_gamma by P. heterophylla 
is probably one of the contributing factors for the observed 
anti-tumor activity of P. heterophylla in vivo (Table 6.1). 
Supporting evidence is the finding that TNF-a and IFN-gairana were 
present in the sera and peritoneal tumor sites shortly after the 




工L-1 has been found to play an important role in anti - t u m o r 
activities in vivo (Belardelli et al. , 1989, Ebina and 工 s h i k a w a , 
1989, Nakamura et al. , 1986) . Data in this chapter show that IL-
1 could be induced from PH-I Cb activated peritoneal macrophages 
(Fig.6.8). Therefore, the 工 L - l - i n d u c i n g activity of P. 
heterophylla may also contribute to its anti-tumor activities in 
vivo. 
Although TNF-a could be induced in zymosan-primed EAT-
bearing mice followed by the injection of LPS (Wong et al., 
1992) , nevertheless, mice began to die gradually due to endotoxin 
shock 1 day after LPS injection (Fig.6.7). In contrast, EAT-
bearing mice injected with PH-I Cb did not die until 8 days after 
the i.v. injection of PH-I Cb (Fig.6.7). Therefore, the use of 
PH-I Cb fraction to induce the TNF-a,工FN-gamma and IL-l for the 
treatment of EAT-bearing mice might provide a novel, safe and 
effective method to combat cancer. 
A recent report has shown that the protein-bound 
polysaccharide (PSK) can activate human natural killer cells 
independently of 工FN or 工L-2 (Kariya et al. , 1992) . Similarly' 
the present study shows that i.v. injection of PH-工 C into mice 
could activate the splenic NK cells activity in vivo. The 
activation of NK in vivo is probably mediated by the stimulation 
of cytokine IL一 1, IFIS[—gamma and TNF-a by P. heterophylla. 
Besides NK cells, LAK cells also play an important role in 
cell mediated anti-tumor immunity. Previous studies have shown 
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that Astragalus memhranaceus polysaccharides (Chu et al. , 1988b), 
Krestin (Hayashida et al., 1991) and Lentinan (Yamasaki et al., 
1989) could stimulate the 工L-2 activated LAK cell activity in 
vitro. Data in this chapter also strongly suggest that the PH-I 
A, PH-I B and PH-I C could potentiate the MurIL-2-induced LAK 
cell population in vitro. This potentiation of MurIL-2 activity 
by P. heterophylla may have clinical implications for the future 
use of rIL-2 in the treatment of cancer. There are a lot of 
evidences to support that a good correlation exists between LAK 
cell induction and anti-tumor effect following in vivo 
administration of high-dose rIL-2 in animals (Mule et al • , 1984) 
as well as in humans (Yasumoto et al. , 1987) . However, ”adoptive 
immunotherapy" using high dose of rIL-2 and the massive 
reinfusion of LAK cells is often associated with high prohibitive 
toxicity such as high fever, weight gain, hypotension, pulmonary 
edema, and renal as well as hepatic toxicity (Gaspari, 1991; 
Rosenberg et al. , 1987). As P. heterophylla can potentiate the 
induction of LAK. activity both in vitro and in vivo, therefore 
the concomitant use of P. heterophylla along with :rIL-2 in 
adoptive immunotherapy may reduce the requirements for both the 
number of LAK cells and the dose of rIL-2 administration. This 
will decrease the toxicity without a loss in therapeutic efficacy 
and thus increase the therapeutic index of this newly developed 
treatment modality. The mechanism by which P. heterophylla can 
potentiate the LAK cell activity induced by IL-2 is as yet 
unclear. Whether this is due to the upregulation of 工 L - 2 receptor 
expression on LAK precursor cells or due to an increase in the 




More recently, PSK has been shown to activate the in vitro 
autologus tumor killing activity of TILs (Kariya et al. , 1991). 
Moreover, intralesional injection of OK-432 or PSK significantly 
augmented the cytotoxicity of TILs in cancer patients . The ratio 
of 0KT8-positive (LAK), Leu7-positive (NK) cells were increased 
in the TIL subset by the injection of OK-432 (Gotoh et al., 
1991) . Preliminary results in this chapter show that i.p. 
injection of PH-I C into WEH工一 164-sarcoma—bearing mice could 
activate a T lymphocyte response and augment the number of TILs 
in the tumor site. The ability of PH-I C to activate the 
infiltration of lymphocytes into tumor site suggests that 
activation of TILs may be one of the possible mechanisms by which 
p. heterophylla can exert its anti-tumor effect in vivo. In view 
of the important role of TILs in anti-tumor immunity, the in 
vitro activation of TILs by P. heterophylla will be investigated 
in the future. Moreover, the characterization and identification 
of the particular cell subpopulations in TILs with increased 
tumor reactivity are also useful. Ideally these subpopulations 
could be selectively expanded and utilized for more effective 
adoptive immunotherapy. 
The increased incidence of cancers in aged subjects was 
found to be closely related to the decline in cell-mediated 
immunity and neoplastic defence mechanisms. Moreover, greater 
susceptibility of aged people to infectious diseases is clearly 
related to the impaired immunity (Rusting, 1992). The elderly 
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people usually have reduced number and functions of t 
lymphocytes, resulting in reduced proliferative capacity of T 
cells in response to different lectins. Aging is also 
characterized by a deficit of both the production of IL-2 and 
expression of IL-2 receptors on T cells (Antonaci et al. , 1987) • 
Results in this chapter (Table 6.15) show that i.p. injection of 
PH-I A could restore the mitogenic response of lymphocytes from 
aged mice to both T and B cell mitogens. The immunorestorative 
activity of PH-I A may be attributed to its intrinsic mitogenic 
or co-mi togenic activities on T and B lymphocytes in vivo. 
Therefore, the present study indicates that P. heterophyl1 a may 
be beneficial to the immune defence against cancer and infections 
in aged people by enhancing the number and functions of their 
lymphocytes. 
On the other hand, P. heterophylla has a similar 
immunorestorative function (Fig. 6.12) as PSK (Mizushima et al., 
1982) , Astragalus_ membranaceus (Chu et al. , 1988a) and Z —100' a 
polysaccharide-rich extract from Mycobacterium tuberculosis 
Aoyama B (Kaeamura et al., 1990) could reverse the suppressed 
immune functions induced by the anticancer agent 
cyclophosphamide. The results suggest that P. heterophylla can 
be used to enhance the therapeutic effect of CY in cancer 
patients by restoring their depressed immune functions following 
chemotherapy. 
In conclusion, the use of natural products such as P. 
heterophylla to induce TNF-a and 工FN—gamma for the treatment of 
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cancer has many advantages. The polysaccharides of p. 
heterophylla is easily soluble in water and hence offer a easy 
way of administration. It can minimize the lethal side effects 
such as anorexia, cachexia caused by the direct injection of 
recombinant TNF-a or IFN-gamma (Frei and Spriggs, 1989; Lenk et 
al., 1989) • Since P. heterophylla is an immunostimu 1 ating agent 
as well as an immunorestorative agent, it can also modulate other 
known host anti-tumor immune mechanisms in vivo such as the 
activation of T and B lymphocytes, LAK cells, NK cells, tumor-
infiltrating lymphocytes and macrophages. Anti-tumor 
polysaccharides with immunostimulating and immunorestorating 
properties are particularly useful in anti-neoplastic therapy, 
especially in combinations with other anti-cancer drugs (such as 
methotrexate, 5-fluorouracil, cyclophosphamide etc.) to restore 
the depressed immune functions resulting from chemotherapy and 
radiotherapy. Finally, the combined uses of anti-tumor 
polysaccharide of P heterophylla with cytokines such as TNF-a 




EFFECTS OF PSEUDOSTELLARIA HETEROPHYLLA ON 
DIFFERENTIATION OF MURINE BONE MARROW CELLS 
AND MYELOID LEUKAEMIC Ml CELLS 
INTRODUCTION 
Macrophages together with polymorphonuclear leukocytes 
constitute the first line defense of the body against most 
infections. Specific immunity requires B and T lymphocytes for 
long-term protection. Macrophages are derived from the 
pluripotent haematopoietic stem cells in the bone marrow. They 
synthesize and release a number of biologically important 
macromolecules, such as transferrin, interferon, complement 
components, and many hydro lytic enzymes into the extracellular 
fluid (Gordon et'al., 1974； Groscurth, 1989). Macrophages can 
also be activated for tumor killing both in vivo and in vitro 
(Alexander, 1976; Pace and Russell, 1981) . Recently, it has been 
shown that many Chinese herbal medicines with tonic effects can 
modulate immunologic functions (Kumazawa et al. , 1982； 1985). 
Some polysaccharides isolated from natural products were found 
to activate the macrophages in vitro (Adachi et al. , 1990) or in 
vivo (Gonda et al. , 1990) . However, there are very few studies 
on the effects of tonic Chinese herbal medicines on the 
proliferation and differentiation of bone marrow cells (Rou and 




bioactive fractions separated from P. heterophylla could induce 
the proliferation and differentiation of pluripotent 
haematopoietic stem cells in vitro. ‘ 
Some myeloid leukaemia cells are formed by impairment of a 
certain stage of differentiation of the normal haematopoietic 
process. There are increasing evidence suggesting that different 
myeloid leukaemia cells can be induced to differentiate into 
cells with the normal characteristics of macrophages, 
granulocytes, or erythrocytes by different haematopoietic 
regulatory proteins (Sachs 1990)• The differentiated cells 
normally stop to proliferate and lose their transplantability in 
syngeneic animals. Therefore, the induction of terminal cell 
differentiation by certain inducers is a promising approach to 
the therapy of myeloid leukaemias• 
Some inducers such as leukaemia inhibitory factor (LIF) or 
D-factor (Gough et al. , 1989; Hilton et al. , 1988, Tomida et al •, 
1986) and G-CSF (Tomida et al., 1986) were found to be capable 
of inducing the differentiation of mouse myeloid leukaemic Ml 
cells in vitro. In this chapter, the immuno stimulating fractions 
from P. heterophylla will be tested for their differentiation-




7.1 Effects of P. heterophylla on the proliferation and 
differentiation of murine bone marrow cells 
Fig.7.1 (a) shows that murine recombinant interleukin-3 
(MurIL-3) stimulated the in vitro proliferation of murine bone 
marrow cells in a dose-dependent manner. The effect of P. 
heterophylla fractions PH-I A, PH-I B and PH-I C on the 
proliferation of murine bone marrow cells in vitro were 
investigated. The results in Fig. 7.1 (b) shows that PH-工 A and 
PH-I C exhibited little mitogenic activity on bone marrow cells, 
even at higher concentrations (up to 500 jig/ml). In contrast, 
PH-I B induced the strongest mitogenic effect on murine bone 
marrow cells. It stimulated the proliferation of bone marrow 
cells in a dose-dependent manner. Therefore, PH-I Ba and PH-I 
Bb purified from PH-I B by anion-exchange chromatography were 
tested for their effects on the proliferation and differentiation 
on murine bone marrow cells . It was found that fraction PH-I Ba 
showed the strongest mitogenic effect (S.I. = 10) at a 
concentration of 125 |lg/ml (Fig.7.1 (c) ) • On the other hand' the 
mitogenic effect of PH—工 Bb on bone marrow cells was relatively 
weaker than that of PH-I Ba. Maximal stimulation of bone marrow 
cell proliferation by PH-I Bb was seen at a concentration of 
31.25 |ig/ml. The mitogenic of PH-I Ba was completely abrogated 
by the oxidation with sodium periodate. This result indicates 
that the mitogenic activity in PH-工 Ba was due to carbohydrate 
since periodate specifically damaged the structure of 
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Fia 7 1 Proliferation of bone marrow cells in vitro. Murine bone 
i^arrow cells were co-cultured in the presence or absence of 
different samples in 96-well flat-bottomed microtiter plates at 
a cell density of 1 x 10^  cells/well in a total volume of 0 2 ml 
Microtiter plates were incubated at 37。C ？n a humidified 
i t m o s S e r e with 5 % CO,-95 % air for 3 days. Tritxated t h ^ . d . n e 
(0 5 uci) in 50 Ul volume was added into each well. One day 
l a t L the culture was freezed and then thawed once DNA of bone 
Harrow S i s were collected on glass fibre filters by a Titertek 
cell harvester. Incorporation of ^H-TdR into cells was 
d^tirinJnerby a liquid scintillation counter^ 『 u l t s were 
expressed as the arithmetic mean 巧 i T 、 》 〒 i ， h ) n d e x (S •工）士 雰 ?^工 
cultures. (a MurIL—3 (•) ； (b) PH-I A (o) , Fn 丄 
f (I) PH I C r (c)-PH-I Ba (•), PH-I Bb (•) , PH-I Ba was 




Fig.7.2 (a) shows the morphology of pluripotent 
haematopoietic stem cells in the murine bone marrow. The cells 
had a relatively large nucleus to cytoplasm (N/C) ratio (over 90 
%) . Exposure of the bone marrow cells to MurIL-3 (200 U/ml) for 
3 days at 37°C induced differentiation in about 30 % of the cells 
which h a d macrophage-like characteristics (Fig 7.2 (b) ) . The 
differentiated cells had increased in size, the N/C ratio became 
smaller and many vacuoles were found in their cytoplasm. Similar 
to that of MurIL-3, PH-I Ba (125 |lg/ml) also induced the 
differentiation in about 80 % of the bone marrow cells with 
macrophage characteristics (Fig.7.2 (c)). In contrast, PH-I Bb 
(31.25 jig/ml) failed to trigger the differentiation of bone 
marrow cells (Fig.7.2 (d))• 
7.2 Effects of P. heterophylla on the proliferation and 
differentiation of murine myeloid leukaemia Ml cells 
Fig. 7 .3 (a) , (b) and Table 7.1 show that among all fractions 
that had been tested, PH一工(工^已。=45 jig/ml) and PH一工 Cb ( 工 匸 日 。 二 
50 jig/ml) exhibited the greatest dose-dependent suppressive 
effect on the proliferation of Ml cells in vitro. The morphology 
of M l cells is shown in Fig.7.4 (a). It can be seen that the 
cells were relatively immature blast cells with a large N/C 
ratio. Exposure of the Ml cells to LIF (500 U/ml) for 3 days at 
37°C induced monocytic differentiation of the Ml cells. Like the 
M u r I L - 3 - s t i m u l a t e d bone marrow cells, LIF-induced Ml cells 
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(d) PH-工 Bb (31.25 |ig/ml) 
(X 400) 
FiQ 7 2 Differentiation of bone marrow cells in ^itro. Murine 
b o L marrow cells (1 x 10^ cells per well) were seeded onto a 96-
w e l l X t e . They were treated with MurIL-3, PH-I Ba or PHI Bb 
I n 0 2 m l RPMI complete medium for 3 days at 37。C m a humidified 
a?mosph"er^with 5、 C O , - 9 5 % air. The 严 二 - 二 土 二 二 d 二 芸 
activities of different samples were evaluated by staining using 
Hemacolor Rapid Blood Smear staining set (Merck)• 
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(yug/ml) 
Fig.7.3 The suppressive effect of different fractions on Ml cells 
in vitro Ml cells were cultured at a cell density of 1.5 x lu 
cells/well in a total volume of 0.2 ml in the ^ s e n c e or presence 
of different concentrations of samples. (a) PH_I (•) , PH-i a 
P H - I B (•), P H - I C (I); (b) P H - I A a (O) P H - I A b ( a ) ,卯 ^工 
ca (•) and PH-I Cb (•) • After an incubation and 
cultured cells were given a pulse wxth。.。/Ci/well J 二 d R g j 
radioactivity incorporated was determined. Results were 
expressed as mean % suppression ± S.D.. 
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Table 7.1 Determination of ICs。of different fractions from P. 
heterophylla on Ml cell in vitro. 
Fractions from ICg。 
P. heterophylla (jig/ml) 
PH-I 45 
PH-I A >500 
PH-I B >500 
PH-I C 105 
PH-工 Aa 270 
PH-工 Ab 383 
PH-I Ca >500 
PH-工 Cb 50 
Ml cells were cultured at a cell density of 1.5 x 10^ cells/well 
in a total volume of 0.2 ml in the absence or presence of various 
concentrations of different fractions of P. heterophylla. After 
an incubation period of 48 h, cultured cells were given a pulse 
with 0.5 ilCi/well ^H-TdR and radioactivity incorporated was 
determined. ICj。 is the concentration of different fractions 
which gives a 50 .% suppression of tumor cell proliferation. 
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Fia 7 4 Differentiation of M l cells in vitro. Ml cells (1.5 x 
10^ cells per well) were seeded onto a 24-well plate. They were 
treated with LIF (500 U/ml) or different fractions ^n 1 ml RPMI 
complete medium for 3 days at 37。C in a humidified ^tmosphere 
^ i t h 5 % CO.-95 % air. The differentiation-inducing activities 
ofdifferent samples were evaluated by staining using Hemacolor 
Rapid Blood Smear staining set (Merck)• 
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demonstrated increases in cell size and vacuolation but the N/C 
ratio was decreased (Fig.7.4 (b)). Fig.7.4 (c) shows that PH-I 
(250 jig/ml) could induce differentiation in about 2 0 % of the Ml 
cells into macrophage-like cells. Similar results (%) were 
observed with fractions PH-I A, PH-I B and PH-I Ab; while PH-I 
C, PH-I Aa, PH-I Ba, PH-I Bb, PH-I Ca and PH-I Cb showed no 
differentiation inducing activity (Fig.7.4, Table 7.2). 
7.3 Effects of P. heterophylla on GM-CSF production by 
y bone marrow cells and myeloid leukaemia Ml cells 
As a preliminary attempt to study the mechanism by which P. 
heterophylla fractions can induce the differentiation of bone 
marrow cells and Ml cells, the ability of P. heterophylla 
fractions to induce GM-CSF production in cultures of bone marrow 
cells and Ml cells was investigated. Table 7.3 shows that 
fraction PH—工 Ba but not PH—工 Bb could induce significant GM-CSF 
production from the bone marrow cells after 14 h, 38 h and 72 h 
in culture. MurIL—3 and L929 conditioned medium were acted as 
the positive controls for the induction of GM-CSF. On the other 
hand, fractions PH-I, PH-I A, PH-I B, PH-I Aa and PH-I Ab failed 
to augment GM-CSF production in cultures of Ml cells after 72 h 
culture period (Table 7.4). 
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Table 7.2 The in vitro induction of differentiation of Ml cells 
by different fractions of P. heterophylla. 
TREATMENT of % of differentiated 




PH-I A 20 
PH-I B 15 
PH-I C 0 
PH-I Aa 0 
PH-工 Ab 25 
PH-I Ba 0 
PH-工 Bb 0 
PH-I Ca 0 
PH_I Cb 0 
Ml cells (1 5 X lOVwell) were incubated with different fractions 
of P. heterophylla (250 |lg/inl) for three days.: The % of 
differentiated Ml cells was evaluated by morphological staining 
using Hemacolor Rapid Blood Smear staining set. 
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Table 7.3 Induction of GM-CSF from bone marrow cells. 
TREATMENT TITER OF GM-CSF (pg/ml) 
14 h 38 h 72 h 
MEDIUM 0.15 土 0.22 0.00 土 0.43 0.40 ±1.41 
PH-I Ba 2.79 土 2.20 1.70 土 1.08 3.63 土 2.22 
PH-I Bb 0.00 士 0.43 0.00 士 0.65 0.00 土 1.29 
MurIL—3 1.39 ± 0.65 0.62 ± 0•87 6.15 ± 3.02 
L929 CM 4.18 土 2.85 0.31 土 0.87 2.92 土 0.71 
Murine bone marrow cells (1 x 10^ cells per well) were seeded 
onto a 96-well plate. They were treated with MurIIj-3 (200 U/ml), 
50 % L929 conditioned medium, PH—工 Ba (125 jxg/ml) , PH—工 Bb (31.25 
ng/ml) in 0.2 ml RPMI complete medium for 14 h, 38 h and 72 h at 
370c in a humidified atmosphere with 5 % C〇2_95 % air. GM-CSF in 
the supernatant of bone marrow cells culture was assayed by a 
murine GM-CSF ELISA test kit (Endogen) using murine recombinant 
GM-CSF as the standard. 
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T a b l e 7.4 Induction of GM-CSF from Ml cells. 
) 
TREATMENT TITER OF GM-CSF 
(pg/itil) 
MEDIUM 3.63 土 2.22 
PH-工 3.93 土 1.01 
PH-I A 2.52 ± 0.14 
PH-I B 1.51 土 0.40 
PH-工 Aa 4.54 ± 1.21 
PH-工 A b 2.82 ± 1.21 
MurIL-3 1.81 士 0.28 
M l cells (1.5 X 104 cells per well) were seeded onto a 24 well 
p l a t e . They were treated with MurIL_3 (200 U/ml) or different 
fractions (250 |lg/ml) in 1 ml RPMI complete medium for 72 h at 
370c in a humidified atmosphere with 5 % C〇2-95 % air. GM-CSF in 
the supernatant of Ml cells culture was assayed by a murine GM-





Macrophages originate in the bone marrow from pluripotent 
haematopoietic stem cells (Van and Cohn, 1968) • The 
differentiation of macrophages is accompanied by the acquisition 
of common macrophage characteristics such as the expression of 
the differentiation antigens Mac-1 and F4/80, and the capacity 
for immune phagocytosis (Hirsch et al., 1981； Springer et al., 
1979; Van et al. , 1980) . Previous studies have shown that some 
polysaccharides separated from natural products could induce the 
DNA synthesis of bone marrow cells (Liu et al•' 1991). On the 
other hand, Radix astragali was found to promote the 
proliferation and differentiation of mouse marrow pluripotent 
stem cells and granulocytic progenitor cells in vivo (Rou and 
Renfu, 1983) . More recently, PSK (Krestin), a protein-bound 
polysaccharide extracted from Coriolus versicolor, has been shown 
to induce enlargation, elongation and the expression of higher 
NBT—reducing activity of mouse resident peritoneal macrophages 
in vitro (Kurakata et al. , 1991). Therefore, some 
immunostimulating polysaccharides are capable of stimulating 
mouse marrow haematopoiesis and enhancing the immunological 
functions of the host by inducing the proliferation and 
differentiation of the host immune cells such as bones marrow 
progenitor cells and macrophages. 
The roots of P. heterophylla are commonly used in China as 
a mild tonic drug in the treatment of asthenia-syndrome cases 
which manifest as insufficiency of vital energy. PH-工，a 
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mitogenic fraction separated from P. heterophylla, was previously 
shown to act as a priming agent for TNF-a release in vivo 
} 
(Chapter 5). It could also stimulate IL-l release from resting 
peritoneal macrophages in vitro and suppress the growth of EAT 
cells in vivo but not in vitro (Chapter 5,6). Results in this 
chapter show that fraction PH-I Ba could stimulate the 
proliferation of bone marrow cells in a dose-dependent manner. 
In addition, it could induce differentiation of bone marrow cells 
into more mature macrophage-like cells. In view of the 
stimulating effects of P. heterophylla on normal haematopoiesis 
in bone marrow, P. heterophylla may be clinically useful in 
restoring the bone marrow cell populations in patients receiving 
organ transplants or after cytotoxic cancer therapy. 
The mechanism(s) whereby PH-I Ba can induce differentiation 
of the bone marrow cells is unclear. It has been well documented 
that the complex pathways of haematopoiesis are controlled by a 
number of haematopoietic growth factors, including colony 
stimulating factors and various cytokines (Gough et al., 1989; 
Nakaya et al • , 1988; Nakayama et al. , 1989; Tomida et al • , 1986). 
It is conceivable that regulatory factors from the culture medium 
of bone marrow cells incubated with PH-I Ba may be responsible 
for the induction of bone marrow cell differentiation. Results 
in Table 7.3 supported this hypothesis since high level of GM-CSF 
was found in the culture medium of PH-I Ba stimulated bone marrow 
cells. in contrast, PH-I Bb which did not induce bone marrow 
cell differentiation also failed to trigger GM-CSF release from 
the PH-I Bb stimulated bone marrow cells. Thus, GM-CSF released 
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from the PH-I Ba stimulated bone marrow cells may act in an 
autocrine or paracrine manner in inducing the proliferation and 
differentiation of bone marrow cells in vitro. 
Many previous studies have indicated that the activities of 
the immunopotentiating fractions from Chinese herbs are strongly 
related to its carbohydrate structure (Lien and Gao, 1990； 
Miyazaki et al. , 1979) • The intact carbohydrate structure of PH-
工 Ba is required for its stimulating effect on bone marrow cells. 
Fractions PH-I Ba has a unique structure as it contains large 
amount of hexosamine. Whether this structural feature of PH-I 
Ba would contribute to its stimulating effect on bone marrow 
cells has yet to be determined. In order to understand more 
about these, the structure-activity relationship of PH-I Ba need 
to be elucidated in the future. 
Mouse myeloid leukaemic Ml cells can be induced in vitro and 
in vivo to differentiate into macrophages and granulocytes, by 
different compounds including protein factors (Hozumi 1983； 
1985) • The differentiated Ml cells not only have decreased 
replicative potential in vitro but also have reduced 
leukaemogenicity in syngeneic mice. Many different 
haematopoietic regulatory proteins including G-CSF, IL一6, IL—1 
and LIF (D-factor) were found to induce the differentiation of 
Ml cells (Sacha, 1990) • The development of leukaemia of Ml cells 
can be inhibited in mice by increasing the amount of 
differentiation-inducing proteins as described above, either by 
direct injection of the proteins or by injecting compounds that 
220 
Chapter seven 
can induce their production in the body (Lotem and Sachs, 1981; 
1984). 
A previous report demonstrated that the methanol extracts 
of clove (Syzygi um aroma ti cum Merrill et Perry, Myrtaceae) 
markedly induced the differentiation of Ml cells into macrophage-
like cells. The active components in the extract were found to 
be oleanolic acid and crategolic acid (Umehara et al. , 1992). 
The present study shows that the mitogenic and ant i-tumor 
fractions PH-I, PH-I A, PH-I B and PH-I Ab were capable of 
inducing differentiation in about 20 % of Ml cells in vi tro. The 
in vitro suppressive effect of the above four fractions on the 
proliferation of Ml cells, at least in part, was due to their 
differentiation inducing activity on Ml cells in vitro. Unlike 
bone marrow cells, the differentiation-inducing activities of P. 
heterophylla on Ml cells could not be attributed to the increased 
production of GM-CSF in the cell cultures (Table 7.4). It has 
been reported that Ml-clone 11 can be induced to differentiate 
by 工L-6, whereas Ml-clone T22 can be induced to 
differentiate by IL-6, IL-1 and LIF (Sachs, 1990) . Whether 
induction of Ml cell differentiation by P. heterophylla is due 
to the induction of other regulatory proteins such as IL一6, IL-l 
and LIF etc is worth of further investigation. 
In the therapy of cancer, suppression of malignancy by 
inducing tumor cell differentiation is an alternative approach 
to the use of cytotoxic drugs that kill many normal cells as well 
as tumor cells. Previous work showed that D-factor could be 
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applied to prolong the life of mice implanted with Ml cells by 
inducing the differentiation of Ml cells into macrophages 
(Yamamoto-Yamaguchi, 1992) . It remains to be seen whether the 
differentiation-inducing activity of P. heterophyl 1 a can be 
exploited in the therapeutic treatment of myeloid leukaemias in 
patients. 
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CHAPTER EIGHT 
CONCLUSIONS AND FUTURE PERSPECTIVES 
Pseudostellaria heterophylla is widely used as a mild herbal 
tonic medicine in China. Its roots have traditionally been used 
as a tonifying crude drug for the treatment of asthenia-syndrome 
cases which manifest as insufficiency of vital energy. Although 
p. heterophylla has a long history of therapeutic use in humans' 
its bioactive constituents have not yet been unequivocally 
identified and its modes of action remain obscure. In this 
thesis project, the immunopharmacological properties of P. 
heterophylla were studied, both in vitro and in vivo. P. 
heterophylla was found to contain bioactive polysaccharides which 
can trigger and enhance the immune responses to tumor (Fig.8.1). 
The macromolecular fraction PH-I Ab has potent mitogenic activity 
for lymphocytes and can induce polyclonal activation of B cells. 
Although the ant i-tumor activity of PH-I Ab in vivo is 
insignificant, it can induce the differentiation of Ml cells in 
vitro and may be beneficial to the therapy of some forms of 
leukaemia. On the other hand, fractions PH-I C and PH-I Cb 
exhibit the most potent anti-tumor activity and can trigger the 
host cell-mediated anti-tumor responses such as the activation 
of macrophages, LAK cells, NK cells and TILs. Moreover, these 
two fractions can also stimulate macrophages to release cytokines 
with anti-tumor activity such as IL-1, TNF-a and IFN-gaimna. 
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Fig.8.1 A schematic diagram showing the hypothetical 
mechanisms of immunostimulating and anti-tumor 
activities of Pseudostellaria heterophylla 
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proliferation and differentiation of murine bone marrow cells and 
stimulate haematopoiesis in vitro• 
} 
By comparing the immunopharmacological activities of various 
fractions separated from P. heterophylla, it becomes clear that 
different fractions having different molecular weight, 
composition and structure display diverse iininunopharmacological 
activities. As shown in Table 8.1, PH-I A and its purified 
fraction PH-I Ab exhibit the most potent mitogenic effect on 
lymphocytes, both in vitro and in vivo. PH-工 B and its purified 
fraction PH-I Ba demonstrate the most potent effect on 
haematopoiesis of bone marrow cells in vitro. PH-I C and its 
purified fraction PH—工 Cb exhibit the most potent anti-tumor 
effect and TNF-a inducing activity. Since the structure of a 
bioactive compound may have profound influence on its biological 
and immunopharmacological activities. For examples, linear 
1,3-glucan are effective in inducing PMN cytotoxicity than that 
of 4-glucan with mannosyl branching (Morikawa et al. , 1985) • 
In addition, the a n t i - c o m p l e m e n t a r y activities of polysaccharides 
are found to relate to their acidity, molecular weight and 
hydroxyl groups (Lien and Gao, 1990). Therefore, further 
investigation of the structure-function relationship of different 
fractions of P. heterophylla is necessary in order to increase 
our understanding of their action mechanisms. 
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Table 8.1 The major effects of different purified polysaccharide 
fractions from P. het erophyl 1 a on the immune system. 
I 
Purified 
Fraction from Component Linkage Activity 
P. heterophylla M.W. monosaccharides 






PH-I Ba 9500- Galactosamine:Glu: Not 1,3 Stimulation 
5000 Glucosamine of haema-
(1.0:1.2:1.4) topoiesis 
PH-工 Cb 5000 Gal:Glu：Unknown 1,3 Activation 






According to Table 8.1, PH_I A, PH-I B and PH-I C has their 
own major effects on the iiranune system. Therefore, the crude 
f r a c t i o n PH—工 w h i c h c o m p o s e of PH一工 A , PH一工 B a n d PH一工 C m a y 
exhibit all the diversified immunopharmacological effects of 
fraction PH-工 A, PH-工 B and PH-工 C. From the results, all the 
fractions PH_I A, PH-工 B and PH-工 C exhibit the similar mitogenic 
effects and TNF-a eliciting activities but different potencies. 
It may be due to the fact that the gel filtration cannot clearly 
separated all the fractions. 
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The complement system plays an important role in our immune 
defence against inflammation and infections (Porter and Reid, 
1978) . Recently, a number of polysaccharides have been shown to 
possess anti-complementary activity (Gao et al. , 1988 ； Yaitiada, 
1989; Yamada et al. , 1990a; Yamada et al. , 1990b) . The ability 
of P. heterophylla polysaccharides to activate the complement 
system via the classical and/or alternative pathway is obviously 
an intriguing aspect that is worth of further investigation. 
Although polysaccharides of P. heterophylla can act as a co-
mitogen for the T cell response in vitro, nevertheless, the 
precise T cell subsets being affected have not been identified. 
Therefore, the investigation of the stimulating effects of P. 
heterophylla polysaccharides on Th and Ts cell functions may 
provide a useful means in the better understanding of immune 
regulation. 
Results from the present study indicate that polysaccharides 
from P. heterophylla can effectively induce the differentiation 
of bone marrow cells as well as myeloid leukaemia Ml cells in 
vitro. It would be of great interest to examine whether 
polysaccharides from P. heterophylla can synergize with other 
BRMS in the induction of tumor cell differentiation. In 
addition, the ability of PH-工 to stimulate the terminal 
differentiation of other types of tumor cells requires further 
investigation. If the induction of reversal of malignancy to 
normal and/or mature form is promising, the induction of cell 
differentiation by natural-occurring polysaccharides will provide 
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a new strategy in the treatment of certain cancer (e.g. 
leukaemia) in the future and it may widen the clinical 
application of P. heterophylla. , 
Adoptive immunotherapy of cancer involves the transfer of 
activated immune cells that can mediate direct or indirect anti-
tumor effects in vivo. Preclinical studies in murine tumor 
models have demonstrated that cytokines, used alone or in 
combination with adoptive immunotherapy, can induce significant 
anti-tumor responses (Hillman et al. , 1992) . The anti-tumor 
activities of P. heterophylla have been found to be mediated 
primarily through activation of the host immune system such as 
the induction of the anti-tumor cytotoxic cells (e.g. 
macrophages, NK cells, LAK cells, Tc cells, TILs) and the release 
of the anti-tumor cytokines (e.g. IL-l, TNF-a, IFN-gamma). It 
is conceivable that combined effects of cell-mediated immunity 
and cytokine-mediated immunity will result in greatly enhanced 
anti-tumor activity in vivo. Therefore, the application of 
polysaccharides purified from P. heterophylla may have 
therapeutic advantages over conventional methods of cancer 
treatment as P. heterophylla can activate cytotoxic effector 
cells as well as induce cytokine production. In addition, 
clinical trials involving adoptive iimnunotherapy with TILs are 
currently in progress (Kariya et al.丨 1991; Mizutani and Yoshida, 
1991) . If the cell subpopulation in TILs with potent tumor 
reactivity activated by the P. heterophylla can be identified and 
selectively expanded, this cell population can also be used for 
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adoptive immunotherapy with higher therapeutic index. 
} 
Most chemotherapeutic drugs (e.g. MTX, 5-FU, CY etc.) act 
by direct cytotoxic effect but they also exhibit potent 
immunosuppressive activity at high dosages (Chu et al. , 1988; 
Mizushima et al. , 1982). On the other hand, the anti-tumor 
activity of immunostimulating polysaccharides from P. 
heterophylla is mainly mediated through the enhancement of immune 
responses. Therefore, the combination of these two modalities, 
chemo immuno therapy, will take advantage of their different 
mechanisms of action. Some tumors show a good initial response 
to chemotherapy, reducing the tumor burden, but they often recur 
in the form of drug-resistant variants. The application of 
immunotherapy may produce an additive/synergistic ant i-tumor 
activity in vivo. Chemotherapy reduces the tumor size and allows 
iiranuno therapy, elicited by the use of P. heterophylla 
polysaccharides , to function in a minimal residual disease 
setting. This chemo immuno therapy based on the integration of 
Western and Oriental medicines may provide a new and effective 
clinical method with minimal side effects for the treatment of 
cancer. Besides the traditional chemotherapeutic drugs, 
monoclonal antibodies which can deliver "agents" (radionuclides, 
cytotoxic drugs, or other toxins) to the specific tumor target 
have great potentials in cancer therapy. The combined use of 
this kind of monoclonal antibodies or immunotoxins and P. 
heterophylla with irmnunostimulating activities can also 
facilitate tumor destruction. 
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An important consequence of aging is a low response of the 
immune system to combat infections but a high incidence of 
autoimmunity (Rusting 1992) . Polysaccharides from P. 
heterophylla may function as an anti-aging agent as it can 
restore the depressed immune functions in aged mice. More 
recently, anti-aging property of some Chinese herbal medicines 
has been found to be related to their antioxidant activity by 
scavenging the free radicals generated (Hong et al., 1992； Lin 
et al., 1992; Wang and Xie, 1992). It was found that heparins 
and related strongly acidic polysaccharides may function as 
endogenous antioxidants (Ross et al. , 1992). It would be of 
interest to know whether acidic polysaccharides from P. 
heterophylla may also be able to remove the free radicals 
generated. Moreover, mechanistic studies on the anti—aging 
property of P. heterophylla besides the immun ostimulating 
activities will be carried out in the future. 
Polysaccharide preparations from sea algae (SAE) (Nakashima 
et al., 1987) and PSK (Hirose et al•, 1987； Tochikura et al., 
1987) have been found to inhibit the activity of human 
immunodeficiency virus (HIV) reverse transcriptase, thus 
inhibiting virus replication in vitro. Whether P. heterophylla 
polysaccharides have any anti-HIV effect is worth of further 
investigation. It is because polysaccharides with anti-viral 
effect and iimnunopotentiating properties will be potentially an 
effective and ideal therapeutic modality for the treatment of 
AIDS. 
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It is because the oral administraction of P. heterophylla 
needs a large amount of materials to test for the 
immunopharmacological and anti-tumor effects in vivo, therefore 
the i.p. and i.v. administration was chosen in the in vivo 
studies. The preclinical development of a successful drug with 
immunotherapeutic application requires an understanding of the 
mechanism of activity and tumor models in order to evaluate the 
significance of anti-tumor activity. It is important to find out 
the optimal immunomodulatory dose (〇ID) in initial clinical 
trials. The OID is the minimal dose of a BRM (e.g. bioactive 
polysaccharide) which can result in a significant augmentation 
of effector cell activity or elicitation of anti-tumor cytokines. 
Therefore, studies on the pharmacokinetics of bioactive 
polysaccharides, including peak dose achieved, area under the 
curve and plasma half-life, can provide critical information 
about the optimal route, dosages and schedule of administration. 
The doses used in human trial is usually 6 folds less than that 
in mouse. It is hoped that future pharmacokinetical study may 
potentiate the effectiveness of P. heterophylla for the treatment 
of cancer. 
P. heterophylla has been used by Chinese people as a tonic 
drug for centuries. It is much cheaper than that of other tonic 
herbal medicine such as Panax ginseng (Qian et al. , 1987) and 
Ganoderma lucidum (He et al., 1992; Miyazaki and Nishijima, 1981) 
but represent a new characterized TCM with similar 
iimnunopharmacological activities. The results presented in this 
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thesis clearly show that P. heterophylla possesses 
iirnnunomodulatory and anti-tumor activities, both in vitro and in 
vivo. Since traditional modalities 'used in cancer treatment 
often have many undesirable side effects, therefore, the 
isolation and characterization of potent immunomodulatory and 
anti-tumor compounds from P. heterophylla may open a way for more 
effective treatment of cancer. Nevertheless, detailed 
characterization and even structural modifications of the 
bioactive polysaccharides by enzymatic and chemical methods may 
be necessary for the development of more specific and potent 
compounds with anti-tumor activity. In addition, further 
analysis of the molecular mechanisms by molecular biology (e.g. 
regulation of the transcription and translation of gene) and 
cellular mechanisms (e.g. intracellular signal transduction such 
as intracellular calcium, protein kinase C, cyclic AMP etc.) of 
the anti-tumor activities of P. heterophylla may provide a more 
rational scientific basis for better utilization of P. 
heterophylla in cancer treatment. Finally, my methods (Fig.1.2) 
adopted in the purification and investigation of 
immunopharmacological and anti-tumor activities of natural-
occurring polysaccharides provide a comprehensive analytical 
system for the study as well as the modernization of bioactive 
polysaccharides. 
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